// Jest Snapshot v1, https://goo.gl/fbAQLP

exports[`JATS importer parses JATS AuthorQueries example to Manuscripts models 1`] = `
Array [
  Object {
    "_id": "MPManuscript:test",
    "acceptanceDate": 1599091200,
    "articleType": "other",
    "equationCount": 0,
    "figureCount": 0,
    "genericCounts": Array [
      Object {
        "count": 0,
        "countType": "box",
      },
    ],
    "objectType": "MPManuscript",
    "receiveDate": 1576195200,
    "referencesCount": 2,
    "revisionReceiveDate": 1597276800,
    "tableCount": 0,
    "wordCount": 2916,
  },
  Object {
    "_id": "MPTitles:test",
    "objectType": "MPTitles",
    "title": "LW4 Demo Doc basic – change title add date here",
  },
  Object {
    "ISSNs": Array [
      Object {
        "ISSN": "0885-6222",
        "publicationType": "ppub",
      },
      Object {
        "ISSN": "1540-1235",
        "publicationType": "epub",
      },
    ],
    "_id": "MPJournal:test",
    "abbreviatedTitles": Array [
      Object {
        "abbrevType": "pubmed",
        "abbreviatedTitle": "Human Psychopharmacology: Clinical and Experimental",
      },
    ],
    "journalIdentifiers": Array [
      Object {
        "journalID": "HUP-19-0076",
        "journalIDType": "publisher-id",
      },
      Object {
        "journalID": "Human Psychopharmacology: Clinical and Experimental",
        "journalIDType": "nlm-ta",
      },
    ],
    "objectType": "MPJournal",
    "publisherName": "Atypon ReX",
    "title": "Human Psychopharmacology: Clinical and Experimental",
  },
  Object {
    "_id": "MPAuthorNotes:test",
    "containedObjectIDs": Array [
      "MPCorresponding:test",
    ],
    "objectType": "MPAuthorNotes",
  },
  Object {
    "ORCIDIdentifier": "https://orcid.org/0000-0001-6162-1335",
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Hui",
      "given": "Li",
      "objectType": "MPBibliographicName",
    },
    "corresp": Array [
      Object {
        "correspID": "MPCorresponding:test",
        "correspLabel": "*",
      },
    ],
    "isCorresponding": true,
    "objectType": "MPContributor",
    "priority": 0,
    "role": "author",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Hu",
      "given": "Wei Ming",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 1,
    "role": "author",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Zhu",
      "given": "Zhen Hua",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 2,
    "role": "author",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Gao",
      "given": "Song Tian",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 3,
    "role": "author",
  },
  Object {
    "_id": "MPAffiliation:test",
    "addressLine1": "Suzhou, Jiangsu",
    "country": "China",
    "department": "Research Center of Biological Psychiatry",
    "institution": "The Affiliated Guangji Hospital of Soochow University",
    "objectType": "MPAffiliation",
    "priority": 0,
  },
  Object {
    "_id": "MPAffiliation:test",
    "addressLine1": "Mental Health Center of Yanqing District",
    "addressLine2": "Beijing",
    "country": "China",
    "institution": "",
    "objectType": "MPAffiliation",
    "priority": 1,
  },
  Object {
    "_id": "MPAffiliation:test",
    "addressLine1": "Xinghua, Jiangsu",
    "country": "China",
    "institution": "Xinghua Forth People’s Hospital",
    "objectType": "MPAffiliation",
    "priority": 2,
  },
  Object {
    "_id": "MPCorresponding:test",
    "contents": "To whom correspondence should be addressed: Li Hui, PhD, Research Center of Biological Psychiatry, The Affiliated Guangji Hospital of Soochow University, No. 11 Guangqian Road, Suzhou 215137, Jiangsu Province, China, Tel: +86 51265794237; Fax: +86 51265794237, Email: huili004100@126.com.",
    "label": "*",
    "objectType": "MPCorresponding",
  },
  Object {
    "_id": "MPKeywordsElement:test",
    "contents": "<div></div>",
    "elementType": "div",
    "objectType": "MPKeywordsElement",
  },
  Object {
    "_id": "MPKeywordGroup:test",
    "objectType": "MPKeywordGroup",
    "type": "author",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "suicide attempters",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "schizophrenia",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "DβH",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "attention",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "polymorphism",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:abstract",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 1,
    "title": "Abstract",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Patients with schizophrenia are at a higher risk for suicide compared with the general population. Dopamine-beta-hydroxylase (DβH) plays a key role in the conversion of dopamine to norepinephrine, which is related to suicidal behavior and cognitive regulation.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">To examine whether there is the effect of <i>DβH</i> 5’<i>-</i>insertion/deletion (Ins/Del) polymorphism on cognitive performance in suicide attempters with chronic schizophrenia.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This polymorphism was detected in 114 suicide attempters and 617 non-suicide attempters with chronic schizophrenia. Cognitive performance was assessed by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The allelic and genotypic frequencies of this polymorphism between two groups did not differ after controlling for covariaties (both, p&gt;0.05). There were no differences in RBANS scores between two groups after adjusting for covariaties (all, p&gt;0.05). However, based on the genotype grouping in suicide attempters and non-attempters, the attention score significantly differed after adjusting for covariaties (both, p&lt;0.05). Further analysis indicated that this polymorphism was associated with attention score in suicide attempters (p&lt;0.05), but not in non-suicide attempters (p&gt;0.05).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\"><i>DβH</i> 5’-Ins/Del polymorphism was not a risk locus of suicide attempters, but it was implicated in attention regulation in suicide attempters with chronic schizophrenia.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:introduction",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 2,
    "title": "Introduction",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Patients with schizophrenia are at a higher risk for suicide compared with the general population. Suicide is an important cause of schizophrenic mortality (<span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Hor and Taylor, 2010</span>). The lifetime prevalence of completed suicide is ranging from 10% to15% in schizophrenia, which is about 8.5-20 times higher than in the general population (<span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Caldwell and Gottesman, 1992</span>). The risk factors of suicide in schizophrenia are nearly similar to those in the general population (Table 1). However, other risk factors of suicide may be specific to schizophrenia including decreased negative symptom, increased positive symptom, mental disintegration fear, higher premorbid IQ, and non-compliance with antipsychotics. Moreover, several studies examining the correlation of cognitive performance with suicidal risk in patients with schizophrenia have reported inconsistent findings. For example, higher cognitive function is found to increase suicidal risk in patients with schizophrenia. In contrast, other studies have indicated that suicide risk is not associated with cognitive performance in patients with schizophrenia. Therefore, the impact of cognitive function on suicidal risk in patients with schizophrenia still needs to be fully understood. In addition, both familial and twins studies found that genetic factors have been involved in suicide attempts, and are associated with cognitive function. These studies have provided evidence that genetic mutations may influence suicide attempts and cognitive regulation in patients with chronic schizophrenia.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Dopamine beta-hydroxylase (DβH) is a key enzyme that is in charge of catalyzing the conversion of dopamine (DA) to norepinephrine (NE). Inhibiting DβH activity will increase DA levels and decrease NE levels, and both of them are linked to suicidal behavior. Several studies have found that NE abnormality might cause behavior and mood deviance that was also closely associated with suicidal behavior. Moreover, <i>DβH</i> promoter polymorphisms are reported to be involved in positive psychotic symptom, cognitive deficits, depression and mental disorders that all of which are associated with suicidal risk. <i>DβH</i> haplotype (consisting of rs1611115, rs1108580, rs2519152 and rs129882) is found to significantly contribute to the development of suicide behavior for alcohol-dependent patients. The above studies suggest that <i>DβH</i> genetic variants may be associated with suicide attempts in chronic schizophrenia.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">DβH catalyzes the conversion of DA to NE in the central nervous system that both of which influence cognitive performance in schizophrenia. Cognitive deficits have been reported to be inversely associated with plasma DβH (pDβH) activity in patients with schizophrenia. DβH has been shown to be involved in mood regulation and attention deficits. Also, the <i>DβH</i> knockout mice are unable to synthesis NE that is involved with cognitive deficits. Several studies have shown that <i>DβH</i> genetic variants are associated with cognitive deficits. For example, it has been found that <i>DβH</i> 5’-1021C/T polymorphism is involved in executive performance in children and adolescents with attention-deficit/hyperactivity disorder (ADHD). It is also involved in attention abnormality for neural facial expression and sustained attention in the healthy population. Other <i>DβH</i> genetic variants are reported to contribute to sustained attention deficits in ADHD and spatial working memory deficits in the healthy population. Taken together, these results support that <i>DβH</i> genetic variants might be associated with cognitive function in suicide attempters with chronic schizophrenia.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">A 19-bp insertion/deletion polymorphism localized 4.5kb from <i>DβH</i> 5’ flank transcriptional starting site on chromosome 9q34 is named <i>DβH</i> 5’-Ins/Del polymorphism. It is a functional locus, which has been reported to influence DβH activity. The pDβH activity in individuals with <i>DβH</i> 5’-Del/Del is only half of those in individuals with <i>DβH</i> 5’-Ins/Ins. Previous studies have indicated that this polymorphism is associated with cognitive abnormality in older women, average reaction response time in Chinese females, attention bias for negative faces in the young subjects, and post-error slowing in the young Caucasian healthy adults that are correlated with suicidal behavior. <i>DβH</i> haplotype (consisting of <i>DβH</i> 5'-del allele and 11 allele of GT<sub>n</sub> repeats) is linked to suicide attempts in schizophrenia. Interestingly, <i>DβH</i> 5’-Ins/Del polymorphism is implicated in attention in patients with chronic schizophrenia. Taken together, these results suggest that this polymorphism might be involved in cognitive regulation and the development of suicide attempts in chronic schizophrenia. However, no studies have examined <i>DβH</i> 5’-Ins/Del polymorphism in relation to cognitive function and the development of suicide attempts in chronic schizophrenia. Thus, the objectives of this study are to examine whether <i>DβH</i> 5’-Ins/Del polymorphism influences cognitive regulation, and further contributes to the development of suicide attempts in chronic schizophrenia.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:materials-method",
    "elementIDs": Array [],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 3,
    "title": "Methods",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 4,
    "title": "Subjects",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">731 patients with chronic schizophrenia (male = 615, female=116) were enrolled from Beijing HuiLongGuan Hospital. The following inclusion criteria were applied: (a) 19-73 years of age; (b) DSM–IV diagnosis of schizophrenia; (c) length of illness longer than of two years; (d) receiving a stable dose of oral antipsychotics for more than one year; and (e) provided signed informed consent. Oral antipsychotics mainly included clozapine, perphenazine, risperidone, sulpiride, haloperidol and chlorpromazine. The mean dose of antipsychotics (as chlorpromazine equivalents) was 457.1 mg/days.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">All patients were Han Chinese recruited from the Beijing area. Any patients with any abnormalities whatsoever were excluded, including cardiovascular disease, cerebrovascular disease, infections, cancer, unstable diabetes, uncontrolled hypertension, pregnancy, and drug or alcohol abuse. The Institutional Review Board, HuiLongGuan Hospital approved the protocol and informed consent of this study, and signed informed consent was obtained from each patient before recruitment.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 5,
    "title": "Clinical and neuropsychological assessment",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">A detailed questionnaire included the social-demographic and clinical information, which was obtained from each patient and their available medical records.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Based on the World Health Organization (WHO) report, the outcome-based term \\"fatal suicide behavior\\" or \\"completed suicide\\" was proposed for the actions of suicide that caused death, and \\"non-fatal suicidal behavior\\" was for the actions of suicide that did not lead to death. Such actions were called \\"attempted suicide\\". Hence, suicide attempt was defined as an intentionally self-destructive action that performed some intent to die, but not causing death in this study. During the interview, each patient was asked about the following details information: the attempts number, the method and date of each suicide attempt. \\"In your entire life, did you ever attempt suicide?\\" was asked. Afterwards, each patient was asked to say “yes” or “no”. The suicide attempts history was confirmed by the information of medical records or subject (s) relatives.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Cognition was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS, Form A). The detailed contents and assessing process of RBANS have been reported in previous studies of our research group.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 6,
    "title": "Genotyping",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The genotype of <i>DβH</i> 5’-Ins/Del was identified by the same method as reported in our previous study. Two independent investigators who were blinded to the clinical information of subjects confirmed the genotype of this polymorphism. If the assignments of genotype that they confirmed were inconsistent, these samples would further be repeated.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 7,
    "title": "Statistical analysis",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The Hardy–Weinberg equilibrium (HWE) for the genotype distributions of this polymorphism was examined using the program of HWSIM. The frequencies of this polymorphism allele and genotype were compared between suicide attempters and non-attempters with chronic schizophrenia by Chi Squared (χ<sup>2</sup>) tests. The differences of the groups were compared by χ<sup>2</sup> for categorical variables, and one-way analysis of variance (ANOVA) for continuous variables. Fisher’s least significant difference procedure performed post-hoc comparisons between the sub-groups. When ANOVA identified the differences in RBANS scores based on genotype grouping in each research group, the effects of demographic and clinical characters were examined by adding them to the analysis model as covariates.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">For the main models, analyses of covariance (ANCOVA) were constructed. The <i>DβH</i> 5’-Ins/Del genotypes were considered as the independent variables, and RBANS scores, including RBANS total score, 5 subscale scores, and 12 subtests scores were considered as the dependent variables. Age, sex, education, age of the first hospitalization, age of onset, duration of illness, daily antipsychotic doses, and duration of current antipsychotics were considered as covariates.The main effects of genotype, diagnosis, and genotype x diagnosis were tested in each model. Stepwise multivariate analysis was further used to investigate the impacts of the variables on RBANS scores. SPSS 17.0 was performed for the statistical analysis.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The sample power was calculated by Quanto software that has been reported in previous study, with the frequencies of known risk allele, and the suicide attempt prevalence of 9.2% in schizophrenia, and examining dominant, recessive, and log additive models. The significance levels were set at 0.05.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:results",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 8,
    "title": "Results",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The comparisons of demographic, clinical and DβH polymorphism data between suicide attempters and non-attempters with chronic schizophrenia are summarized in the ether. Two groups differed significantly in the duration of illness (F=4.86, p&lt;0.05). The distributions of <i>DβH</i> 5’-Ins/Del genotypes were consistent with HWE in suicide attempters group or suicide non-attempters group (both, p&gt;0.05). A significant difference in <i>DβH</i> allele distribution was found between two groups (χ<sup>2</sup>=3.92, df=1, p&lt;0.05), but no difference in <i>DβH</i> genotype distribution (χ<sup>2</sup>=4.60, df=2, p=0.10). After controlling for age and sex, there were no significant differences in <i>DβH</i> allele and genotype distributions between two groups (both, p&gt;0.05).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The RBANS data was available for 87 suicide attempters and 449 non-suicide attempters with chronic schizophrenia. The RBANS total and subscores in suicide attempters versus non-attempters with chronic schizophrenia grouped by DβH 5’-Ins/Del genotype are summarized in the ether. There were no significant differences in RBANS scores between two groups (all, p&gt;0.05). The interaction role between DβH genotype and diagnosis did not influence RBANS scores in all patients (all, p&gt;0.05). However, there were significant differences in attention and semantic fluency scores among three groups (all patients with Del/Del, all patients with Ins/Del and all patients with Ins/Ins) (F=3.96, p=0.02; F=3.98, p=0.02). Further analysis found that the comparisons of RBANS scores were still not difference between two groups (all, p&gt;0.05) as well as no effect of genotype x diagnosis on RBANS scores in all patients (all, p&gt;0.05) after adjusting for the confounding variables. However, there was a significant difference in attention score among genotype grouping in suicide attempters (F=3.73, p=0.03) as well as this difference also was found in non-suicide attempters (F=3.00, p=0.04) after adjusting for the confounding variables.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Stepwise multivariate regression analysis identified that the variables including genotype of this polymorphism (β=5.74, t=-2.62, p=0.01), and sex ((β=25.74, t=5.17, p&lt;0.001) were independently related to attention score in suicide attempters with chronic schizophrenia, with R<sup>2</sup>=34.9. The variables including sex (β=7.13, t=2.82, p=0.01), education (β=0.61, t=3.76, p&lt;0.001), age of the first hospitalization (β=0.66, t=5.06, p&lt;0.001), and daily antipsychotic dose (β=0.003, t=1.98, p=0.05) contributed to attention score in non-suicide attempters with chronic schizophrenia, with R<sup>2</sup>=14.3.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This sample had 0.78-0.99 statistical power to detect this polymorphism associated with suicide attempts in chronic schizophrenia through three models, with a genetic effect of 2.0 (a=0.05, two-tailed test).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:discussion",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 9,
    "title": "Discussion",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">To our knowledge, it is the first study to investigate the relationships among <i>DβH</i> 5’-Ins/Del polymorphism, cognition and suicide attempts in chronic schizophrenia. We found that this polymorphism was significantly associated with attention function in suicide attempters with chronic schizophrenia. However, this polymorphism was not a risk genetic locus for suicide attempts in chronic schizophrenia and there were no significant differences in cognitive function between two groups.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Our finding showed that <i>DβH</i> 5’-Ins/Del polymorphism might not directly contribute to suicide attempts in patients with chronic schizophrenia. This finding was consistent with a study reporting that this polymorphism did not play a role in suicide attempts with chronic schizophrenia in the European population. Another study has reported that <i>DβH</i> rs2519152 polymorphism was not related to suicide attempts in subjects with psychiatric disorders. Any one of these <i>DβH</i> polymorphisms, such as rs1611115, rs1108580, rs2519152 and rs129882 was not significantly associated with suicidal behavior in alcohol-dependent patients. However, the <i>DβH</i> haplotype including <i>DβH</i> 5'-del allele was reported to influence suicide attempts in chronic schizophrenia. Also, a study supported a significant relationship between <i>DβH</i> haplotype (including rs1611115, rs1108580, rs2519152 and rs129882) and suicidal behavior in alcohol-dependent patients. These results suggested that further studies investigating <i>DβH</i> haplotype associated with suicide attempts in chronic schizophrenia are warranted.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This study found no significant differences in all cognitive domains between both groups, which was consistent with the findings of two previous studies. However, higher cognitive function may increase the suicide risk in patients with schizophrenia. Another study also indicated that individuals with higher executive performance were more likely to perform the plan of their suicide. We still could not provide a reasonable explanation for these inconsistent findings of cognitive performance in suicide attempts with schizophrenia. Several factors including age, sex, education, body mass index, smoking status, age of onset, age of the first hospitalization, duration of illness, antipsychotic information, genetic background and the difference in cognitive assessment instruments may be responsible for these discrepancies, which deserves future investigation.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Interestingly, this study also found that <i>DβH</i> 5’-Ins/Del polymorphism was related to attention function in suicide attempters with chronic schizophrenia. The underlying mechanism responsible for <i>DβH</i> 5’-Ins/Del polymorphism influenced on attention function could reflect the variables of <i>DβH</i> transcriptional activity and alter the balance of DA and NE in the relevant brain regions. This mechanism was consistent with poorer cognitive function in elderly women and patients with chronic schizophrenia. A study has found that the interaction between <i>DβH</i> 5’-Ins/Del polymorphism and the variants of monoamine oxidase A significantly influenced attention performance for the expression of negative face in the young Han population. Previous studies also indicated the effect of <i>DβH</i> 5’-1021C/T polymorphism on attention bias for the expression of neural face and sustained attention in the healthy subjects. The other variants in <i>DβH</i> gene also were reported to influence attention deficits in children ADHD. DβH was in charge of conversion of DA to NE that also was closely associated with the regulation of attention function. These findings further supported that <i>DβH</i> 5’-Ins/Del polymorphism might be involved in the regulation of attention in the suicide attempters with chronic schizophrenia.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This study had several limitations. Firstly, due to limited resources, it was very difficult for us to recruit a large sample of suicide attempters with chronic schizophrenia, which may cause the bias of our findings in the statistical analysis. Hence, our findings need to be replicated in a larger and matched sample. Secondly, only a functional single nucleotide (<i>DβH</i> 5'-Ins/Del) polymorphism was tested. Further studies will investigate other <i>DβH</i> functional polymorphisms and haplotypes whether all of which were involved in cognitive regulation, and were associated with suicide attempts in chronic schizophrenia. Finally, although we performed quality controls, genotype misclassification was still possible. These factors related to cognitive performance and suicide behavior in chronic schizophrenia should be considered in future studies.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:conclusions",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 10,
    "title": "Conclusions",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This study indicated that <i>DβH</i> 5’-Ins/Del polymorphism might not influence suicide attempts in chronic schizophrenia, and cognitive function in suicide attempters is similar to that in non-suicide attempters with chronic schizophrenia. However, this polymorphism might contribute to the regulation of attention in suicide attempters with chronic schizophrenia. Moreover, these findings remain preliminary, which need to be replicated in the larger and matched sample of the different ethnicities.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:competing-interests",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 11,
    "title": "Conflict of Interest",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">No conflicts of interest have been declared.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:financial-disclosure",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 12,
    "title": "Sources of Funding",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This work was supported by the National Natural Science Foundation of China (81771439), Jiangsu Provincial Key Research and Development Program (BE2020661 and BE2018662), Jiangsu Provincial Health Commission Science Research Program (QNRC2016228, H2019056 and LGY2018010), Jiangsu Provincial Six Talent Peaks Project (WSN-165), Suzhou Municipal Health Commission Science Research Program (SZYJTD201715, LCZX201820, Kjxw2018048 and Gwzx201801), Suzhou Municipal Sci-Tech Bureau Program (SZS201722, SS201706, SYS2019113 and SS2019009), and CAS Key Laboratory of Mental Health, Institute of Psychology (KLMH2019K03).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:acknowledgement",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 13,
    "title": "Acknowledgments",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We should like to thank Dr. Da Chun Chen, Zhi Ren Wang, Jia Li, Song Chen, and Gui Gang Yang for all of their hark work and significant contributions toward this work.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:bibliography",
    "elementIDs": Array [
      "MPBibliographyElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 99,
    "title": "References",
  },
  Object {
    "_id": "MPBibliographyElement:test",
    "containedObjectIDs": Array [
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
    ],
    "contents": "",
    "elementType": "div",
    "objectType": "MPBibliographyElement",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Caldwell",
        "given": "C.B.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Gottesman",
        "given": "I.I.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Suicide Life Threat Behav.",
    "issue": "4",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "1992",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "479-493",
    "title": "Schizophrenia-a high-risk factor for suicide: clues to risk reduction.",
    "type": "article-journal",
    "volume": "22",
  },
  Object {
    "DOI": "https://doi.org/10.1177/1359786810385490",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Hor",
        "given": "K.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Taylor",
        "given": "M.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "J Psychopharmacol.",
    "issue": "4",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2010",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "81-90",
    "supplement": "Suppl",
    "title": "Suicide and schizophrenia: a systematic review of rates and risk factors.",
    "type": "article-journal",
    "volume": "24",
  },
  Object {
    "DOI": "https://doi.org/10.1177/1359786810385490",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Hor",
        "given": "K.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Taylor",
        "given": "M.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "J Psychopharmacol.",
    "issue": "4",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2010",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "81-90",
    "supplement": "Suppl",
    "title": "Suicide and schizophrenia: a systematic review of rates and risk factors.",
    "type": "article-journal",
    "volume": "24",
  },
  Object {
    "_id": "MPCommentAnnotation:test",
    "contents": "CrossRef reports the issue should be &quot;4_suppl&quot;, not &quot;4&quot;. (Ref. &quot;Hor, Taylor, 2010&quot;)",
    "contributions": Array [
      Object {
        "_id": "MPContribution:test",
        "objectType": "MPContribution",
        "profileID": "MPUserProfile:test",
        "timestamp": 1111111111,
      },
    ],
    "objectType": "MPCommentAnnotation",
    "target": "MPBibliographyItem:test",
  },
  Object {
    "_id": "MPCommentAnnotation:test",
    "contents": "CrossRef reports the issue should be &quot;4_suppl&quot;, not &quot;4&quot;. (Ref. &quot;Hor, Taylor, 2010&quot;)",
    "contributions": Array [
      Object {
        "_id": "MPContribution:test",
        "objectType": "MPContribution",
        "profileID": "MPUserProfile:test",
        "timestamp": 1111111111,
      },
    ],
    "objectType": "MPCommentAnnotation",
    "target": "MPBibliographyItem:test",
  },
  Object {
    "_id": "MPCommentAnnotation:test",
    "contents": "No table matches the in-text citation &quot;Table 1&quot;. Please supply the missing table or delete the citation.",
    "contributions": Array [
      Object {
        "_id": "MPContribution:test",
        "objectType": "MPContribution",
        "profileID": "MPUserProfile:test",
        "timestamp": 1111111111,
      },
    ],
    "objectType": "MPCommentAnnotation",
    "selector": Object {
      "from": 959,
      "to": 959,
    },
    "target": "MPParagraphElement:test",
  },
]
`;

exports[`JATS importer parses JATS article to Manuscripts models 1`] = `
Array [
  Object {
    "_id": "MPManuscript:test",
    "articleType": "other",
    "equationCount": 0,
    "figureCount": 0,
    "genericCounts": Array [
      Object {
        "count": 0,
        "countType": "box",
      },
    ],
    "objectType": "MPManuscript",
    "referencesCount": 2,
    "tableCount": 0,
    "wordCount": 2910,
  },
  Object {
    "_id": "MPTitles:test",
    "objectType": "MPTitles",
    "title": "A complete manuscript",
  },
  Object {
    "ISSNs": Array [],
    "_id": "MPJournal:test",
    "abbreviatedTitles": Array [],
    "journalIdentifiers": Array [],
    "objectType": "MPJournal",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "User",
      "given": "Developer",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 0,
    "role": "author",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 1,
    "title": "Paragraphs",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">A paragraph.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPListElement:test",
      "MPListElement:test",
      "MPListElement:test",
      "MPListElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 2,
    "title": "Lists",
  },
  Object {
    "_id": "MPListElement:test",
    "contents": "<ol xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPListElement:test\\" list-type=\\"order\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">An ordered list</li><li data-placeholder-text=\\"List item\\">With two items</li></ol>",
    "elementType": "ol",
    "listStyleType": "order",
    "objectType": "MPListElement",
  },
  Object {
    "_id": "MPListElement:test",
    "contents": "<ol xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPListElement:test\\" list-type=\\"order\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">An ordered list<ol id=\\"MPListElement:test\\" list-type=\\"order\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">With a nested ordered list</li><li data-placeholder-text=\\"List item\\">With two items</li></ol></li></ol>",
    "elementType": "ol",
    "listStyleType": "order",
    "objectType": "MPListElement",
  },
  Object {
    "_id": "MPListElement:test",
    "contents": "<ul xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPListElement:test\\" list-type=\\"bullet\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">A bullet list<ul id=\\"MPListElement:test\\" list-type=\\"bullet\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">With a nested bullet list</li><li data-placeholder-text=\\"List item\\">With two items</li></ul></li></ul>",
    "elementType": "ul",
    "listStyleType": "bullet",
    "objectType": "MPListElement",
  },
  Object {
    "_id": "MPListElement:test",
    "contents": "<ul xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPListElement:test\\" list-type=\\"bullet\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">A bullet list<ol id=\\"MPListElement:test\\" list-type=\\"order\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">With a nested ordered list</li><li data-placeholder-text=\\"List item\\">With two items</li></ol></li></ul>",
    "elementType": "ul",
    "listStyleType": "bullet",
    "objectType": "MPListElement",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPFigureElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 3,
    "title": "Figures",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">Test</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "contentType": "image/jpeg",
    "objectType": "MPFigure",
    "src": "graphic/MPFigure_035B52CA-C486-4AC1-B44E-40F36F422686.jpeg",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPTableElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 4,
    "title": "Tables",
  },
  Object {
    "_id": "MPTableElement:test",
    "caption": "Test",
    "containedObjectID": "MPTable:test",
    "elementType": "table",
    "listingID": "MPListing:test",
    "objectType": "MPTableElement",
  },
  Object {
    "_id": "MPTable:test",
    "contents": "<table xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPTableElement:test\\" class=\\"MPElement\\" data-contained-object-id=\\"MPTable:test\\"><thead style=\\"display: table-header-group;\\"><tr><th data-placeholder-text=\\"Data\\">Test</th><th data-placeholder-text=\\"Data\\">Test</th></tr></thead><tbody><tr><td data-placeholder-text=\\"Data\\">Test</td><td data-placeholder-text=\\"Data\\"></td></tr><tr><td data-placeholder-text=\\"Data\\">Test</td><td data-placeholder-text=\\"Data\\"></td></tr></tbody><tfoot style=\\"display: table-footer-group;\\"><tr><td data-placeholder-text=\\"Data\\"></td><td data-placeholder-text=\\"Data\\">Test</td></tr></tfoot></table>",
    "objectType": "MPTable",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPEquationElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 5,
    "title": "Equations",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph contains an inline equation:<span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"tex\\">2+3=5</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPEquationElement:test",
    "containedObjectID": "MPEquation:test",
    "elementType": "div",
    "label": "",
    "objectType": "MPEquationElement",
  },
  Object {
    "_id": "MPEquation:test",
    "contents": "E=mc^2",
    "format": "tex",
    "objectType": "MPEquation",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPListingElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 6,
    "title": "Listings",
  },
  Object {
    "_id": "MPListingElement:test",
    "caption": "",
    "containedObjectID": "MPListing:test",
    "elementType": "figure",
    "objectType": "MPListingElement",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 7,
    "title": "Inline",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph contains <b>bold</b>, <i>italic</i>, <u>underlined</u>, <sup>superscript</sup> and <sub>subscript</sub> text.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph contains <a href=\\"https://example.com\\">a link</a>.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPQuoteElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 8,
    "title": "Quotes",
  },
  Object {
    "_id": "MPQuoteElement:test",
    "contents": "<blockquote xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPQuoteElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPQuoteElement\\"><p id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This is a block quote.</p><footer>It came from here.</footer></blockquote>",
    "elementType": "div",
    "objectType": "MPQuoteElement",
    "placeholderInnerHTML": "",
    "quoteType": "block",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This is a block quote.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 9,
    "title": "Citations",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph ends with a citation.<span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">1</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph ends with two citations.<span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test MPBibliographyItem:test\\">2,3</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph ends with all three citations.<span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test MPBibliographyItem:test MPBibliographyItem:test\\">1–3</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:competing-interests",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 10,
    "title": "CONFLICT OF INTEREST",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">No conflicts of interest have been declared.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:financial-disclosure",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 11,
    "title": "FUNDING INFORMATION",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This work was supported by the National Natural Science Foundation of China (81771439), Jiangsu Provincial Key Research and Development Program (BE2020661 and BE2018662), Jiangsu Provincial Health Commission Science Research Program (QNRC2016228, H2019056 and LGY2018010), Jiangsu Provincial Six Talent Peaks Project (WSN-165), Suzhou Municipal Health Commission Science Research Program (SZYJTD201715, LCZX201820, Kjxw2018048 and Gwzx201801), Suzhou Municipal Sci-Tech Bureau Program (SZS201722, SS201706, SYS2019113 and SS2019009), and CAS Key Laboratory of Mental Health, Institute of Psychology (KLMH2019K03).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPFigureElement",
    "elements": Array [
      "MPFigureElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPTableElement",
    "elements": Array [
      "MPTableElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPEquationElement",
    "elements": Array [
      "MPEquationElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPListingElement",
    "elements": Array [
      "MPListingElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:bibliography",
    "elementIDs": Array [
      "MPBibliographyElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 99,
    "title": "References",
  },
  Object {
    "_id": "MPBibliographyElement:test",
    "containedObjectIDs": Array [
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
    ],
    "contents": "",
    "elementType": "div",
    "objectType": "MPBibliographyElement",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "container-title": "Cartographic Perspectives",
    "issue": "62",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2009",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "52-54",
    "title": "Creating Graphically Complex Indexes With InDesign",
    "type": "article-journal",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "container-title": "The KIPS Transactions:PartD",
    "issue": "4",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2003",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "603-612",
    "title": "Technique for extracting reusable XML Schema from schema-less XML Documents",
    "type": "article-journal",
    "volume": "10D",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "container-title": "The KIPS Transactions:PartD",
    "issue": "1",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2009",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "27-42",
    "title": "XML Fragmentation for Resource-Efficient Query Processing over XML Fragment Stream",
    "type": "article-journal",
    "volume": "16D",
  },
]
`;

exports[`JATS importer parses JATS article with tables and table footnotes 1`] = `
Array [
  Object {
    "_id": "MPManuscript:test",
    "acceptanceDate": 1599004800,
    "articleType": "other",
    "equationCount": 0,
    "figureCount": 3,
    "genericCounts": Array [
      Object {
        "count": 0,
        "countType": "box",
      },
    ],
    "objectType": "MPManuscript",
    "receiveDate": 1588550400,
    "referencesCount": 21,
    "revisionReceiveDate": 1595721600,
    "tableCount": 3,
    "wordCount": 6069,
  },
  Object {
    "_id": "MPTitles:test",
    "objectType": "MPTitles",
    "runningTitle": "low-dose anti-PD1 antibodies in cHL",
    "title": "Low-dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: experience in a resource-constrained setting",
  },
  Object {
    "ISSNs": Array [
      Object {
        "ISSN": "0278-0232",
        "publicationType": "ppub",
      },
      Object {
        "ISSN": "1540-1233",
        "publicationType": "epub",
      },
    ],
    "_id": "MPJournal:test",
    "abbreviatedTitles": Array [
      Object {
        "abbrevType": "pubmed",
        "abbreviatedTitle": "Hematological Oncology",
      },
    ],
    "journalIdentifiers": Array [
      Object {
        "journalID": "HON",
        "journalIDType": "publisher-id",
      },
      Object {
        "journalID": "Hematological Oncology",
        "journalIDType": "nlm-ta",
      },
    ],
    "objectType": "MPJournal",
    "publisherName": "John Wiley and Sons",
    "title": "Hematological Oncology",
  },
  Object {
    "_id": "MPAuthorNotes:test",
    "containedObjectIDs": Array [
      "MPCorresponding:test",
      "MPFootnote:test",
    ],
    "objectType": "MPAuthorNotes",
  },
  Object {
    "_id": "MPFootnote:test",
    "contents": "
          <p>Manuscript information</p>
        ",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Chan",
      "given": "Thomas S.Y.",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 0,
    "role": "author",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Hwang",
      "given": "Yu-Yan",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 1,
    "role": "author",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Khong",
      "given": "Pek-Lan",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 2,
    "role": "author",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Leung",
      "given": "Anskar Y.H.",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 3,
    "role": "author",
  },
  Object {
    "ORCIDIdentifier": "https://orcid.org/0000-0003-2427-915X",
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Chim",
      "given": "Chor-Sang",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 4,
    "role": "author",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Tse",
      "given": "Eric",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 5,
    "role": "author",
  },
  Object {
    "ORCIDIdentifier": "https://orcid.org/0000-0001-8156-6978",
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Kwong",
      "given": "Yok-Lam",
      "objectType": "MPBibliographicName",
    },
    "isCorresponding": true,
    "objectType": "MPContributor",
    "priority": 6,
    "role": "author",
  },
  Object {
    "_id": "MPAffiliation:test",
    "country": "Hong Kong",
    "department": "Department of Medicine",
    "institution": "Queen Mary Hospital",
    "objectType": "MPAffiliation",
    "priority": 0,
  },
  Object {
    "_id": "MPAffiliation:test",
    "country": "Hong Kong",
    "department": "Department of Diagnostic Radiology",
    "institution": "Queen Mary Hospital",
    "objectType": "MPAffiliation",
    "priority": 1,
  },
  Object {
    "_id": "MPCorresponding:test",
    "contents": "CorrespondenceY.L. Kwong, Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China, Email:
          ylkwong@hkucc.hku.hk",
    "objectType": "MPCorresponding",
  },
  Object {
    "_id": "MPKeywordsElement:test",
    "contents": "<div></div>",
    "elementType": "div",
    "objectType": "MPKeywordsElement",
  },
  Object {
    "_id": "MPKeywordGroup:test",
    "objectType": "MPKeywordGroup",
    "type": "author",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "pembrolizumab",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "nivolumab",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "low-dose",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "relapsed",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "refractory",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "Hodgkin lymphoma",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:abstract",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 1,
    "title": "Abstract",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The efficacy and safety of low-dose anti-PD1 antibodies in relapsed/refractory classical Hodgkin lymphoma (cHL) require confirmation. Pembrolizumab (100 mg every 3 weeks, Q3W) or nivolumab (40 mg Q2W) were administered to patients with relapsed/refractory cHL. In the pembrolizumab cohort ( <i>N</i> = 11), who had failed a median of 3 (1–6) therapies (brentuximab vedotin, BV: 91%; autologous hematopoietic stem cell transplantation, auto-HSCT: 18%), the overall-response rate (ORR) by positron emission tomography computed tomography was 100% (metabolic complete response, mCR: 73%; partial response, PR: 27%). Median cumulative dose for achieving best response was 400 (300–800) mg. Median progression-free-survival (PFS) was 35 months. Median overall-survival (OS) was not reached. Adverse events (AEs) of grade 1–2 were observed in 3 patients. In the nivolumab cohort ( <i>N</i> = 6), who had failed a median of 3 (2–6) therapies (BV: 50%; auto-HSCT: 17%, allogeneic HSCT: 34%), the ORR was 100% (mCR: 67%; PR: 17%; indeterminate response: 17%). Median cumulative dose for achieving best response was 160 (160–360) mg. Median PFS was 33 months. Median OS was not reached. AEs of grade 1–2 were observed in 4 patients, 2 of whom had pre-existing autoimmune conditions. Five patients with Epstein-Barr virus (EBV) positive Reed-Sternberg cells underwent monitoring of plasma EBV DNA, which became negative in four mCR patients but remained positive in one PR patient who died ultimately from refractory lymphoma. Low-dose pembrolizumab and nivolumab were highly efficacious and safe in relapsed/refractory cHL. These observations have significant financial implications in resource-constrained settings.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:introduction",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 2,
    "title": "INTRODUCTION",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Amplification of chromosome 9p24.1 and JAK/STAT pathway activation are characteristic of the neoplastic Reed-Sternberg cells of classical Hodgkin lymphoma (cHL). <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">1</span> These aberrations result in overexpression of two proteins, programmed death ligand 1 (PD-L1) and PD-L2, cognate ligands for the T-cell immune checkpoint programmed cell death protein 1 (PD1). Ligation of PDL1 and PDL2 on Reed-Sternberg cells with PD1 on effector T-cells leads to suppression of anti-lymphoma cell-mediated immunity. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">2</span> Accordingly, PD1 blockade restores anti-lymphoma immunity, and has become a highly effective treatment for relapsed/refractory cHL.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Two anti-PD1 antibodies nivolumab and pembrolizumab are approved for relapsed/refractory cHL. During their development, different dosing schedules had been employed. For nivolumab, in its phase 1 study in different malignancies, doses from 0.1 to 10 mg/kg every 2 weeks (Q2W) were used. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">3</span> In its phase 1 in cHL, 1–3 mg/kg Q2W was used. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">4</span> Its currently approved dose for cHL is 240 mg Q2W or 480 mg Q4W. For pembrolizumab, 2–10 mg/kg Q2W was used in its phase 1 study in melanoma. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">5</span> In the ensuing phase 1b study in cHL, 10 mg/kg Q2W was used. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">6</span> In a later phase 2 study, pembrolizumab was used at 200 mg Q3W. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">7</span> Its currently approved dose for cHL is 200 mg Q3W. Interestingly, a direct dose–response relationship has not been demonstrated for anti-PD1 antibodies, with escalations above currently recommended dosing not associated with improved efficacy. Nevertheless, in translational studies using preclinical modeling, with receptor occupancy regarded as driving tumor inhibition, pembrolizumb at 2mg/kg Q3W was observed to be efficacious. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">8</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Reimbursement of expensive novel drugs is typically slow in resource-constrained regions. Very few Asian countries reimburse nivolumab or pembrolizumab for relapsed/refractory cHL. Outside trials, these drugs are available only to patients of means. Non-affluent patients have to settle for toxic and often ineffective salvage chemotherapies.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In Hong Kong, neither pembrolizumab nor nivolumab is reimbursed for cHL. In order that needy patients might receive these expensive drugs, we initially treated relapsed/refractory cHL with low-dose pembrolizumab (100 mg, the smallest vial available, Q3W), <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">9</span> at a time when published data suggested dosing with 10 mg/kg Q2W. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">7</span> Subsequent small case series showed that low-dose pembrolizuamb (100 mg Q3W) resulted in high response rates. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test MPBibliographyItem:test\\">9,10</span> Similarly, we showed that low-dose nivolumab at 40 mg (smallest vial available) Q2W was also effective in relapsed/refractory cHL. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">11</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In this report, we described the use of low-dose anti-PD1 antibodies in a larger cohort of relapsed/refractory cHL.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:materials-method",
    "elementIDs": Array [],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 3,
    "title": "MATERIALS AND METHODS",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 4,
    "title": "Patients",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This retrospective single-center study included all consecutive patients with relapsed/refractory cHL treated with low-dose anti-PD1 antibodies in a 4.8-year period (May 2015 to February 2020), who had at least one radiologic response assessment after treatment. There were otherwise no inclusion or exclusion criteria. Patients gave informed consent to treatment. The study was approved by the institute review board. Data were censored on February 29, 2020.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 5,
    "title": "Treatment and monitoring",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Patients received pembrolizumab at 100 mg Q3W or nivolumab at 40 mg Q2W. The choice was determined by affordability (nivolumab was less expensive than pembrolizumab at the doses administered), and the choice of patients or physicians. Blood counts, glucose and serum biochemistry, chest radiograph, morning cortisol level and thyroid function test were monitored regularly. Additional endocrine tests were instituted as appropriate. Responding patients were offered autologous hematopoietic stem cell transplantation (auto-HSCT) if not previously performed. Patients not consenting to auto-HSCT were treated with anti-PD1 antibody for up to 2 years, followed by observation. Immune-related adverse events (AE) were monitored for, and if present were treated according to standard recommendations. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">12</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 6,
    "title": "Response assessment",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Responses were assessed with 18-F fluorodeoxyglucose (FDG) positron emission tomography computed tomography (PET/CT) according to the 5-point Deauville score. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test MPBibliographyItem:test\\">13,14</span> The first post-treatment PET/CT scan was performed after 4–6 cycles of treatment. Subsequent frequencies of PET/CT scan were determined by the attending physicians. Metabolic complete response (mCR) required a Deauville score of ≤ 3. For patients whose lymphoma showed Reed-Sternberg cells positive for Epstein Barr virus (EBV) encoded early RNA (EBER) on <i>in</i>- <i>situ</i> hybridization (ISH), plasma EBV DNA was quantified by quantitative polymerase chain reaction (Q-PCR) as a surrogate biomarker of lymphoma load. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">15</span> Briefly, plasma samples were collected during follow-up visits (usually at 4-weekly intervals). Cell-free plasma DNA was extracted, and EBV DNA was quantified with reference to a World Health Organization standard (NIBSC code: 09/260) as reported. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">15</span> Complete molecular response required undetectable plasma EBV DNA on ≥ 2 consecutive occasions.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 7,
    "title": "Survivals",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Overall-survival (OS) was defined as time from initiation of treatment to last follow-up or death from all causes. Progression-free-survival (PFS) was defined as time from initiation of treatment to the date of disease progression, relapse, last follow-up or death from all cause. Survivals were analyzed by the Kaplan-Meier method.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:results",
    "elementIDs": Array [],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 8,
    "title": "RESULTS",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPTableElement:test",
      "MPTableElement:test",
      "MPTableElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 9,
    "title": "Patients",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In study period, 17 patients with relapsed/refractory cHL were treated with low-dose anti-PD1 antibodies pembrolizumab ( <i>N</i> = 11) ( <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span>) and nivolumab ( <i>N</i> = 6) ( <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 2</b></span></span>). The two cohorts contained similar patients ( <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 3</b></span></span>). Preliminary findings of five patients had been described; <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test MPBibliographyItem:test MPBibliographyItem:test MPBibliographyItem:test MPBibliographyItem:test\\">9–11,16,17</span> with data of their extended follow-up presented here.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPTableElement:test",
    "caption": "",
    "containedObjectID": "MPTable:test",
    "elementType": "table",
    "listingID": "MPListing:test",
    "objectType": "MPTableElement",
    "tableElementFooterID": "MPTableElementFooter:test",
    "title": "Eleven patients with relapsed/refractory Hodgkin lymphoma treated with low-dose pembrolizumab",
  },
  Object {
    "_id": "MPTable:test",
    "contents": "<table xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPTableElement:test\\" class=\\"MPElement\\" data-contained-object-id=\\"MPTable:test\\"><colgroup><col width=\\"3%\\" /><col width=\\"4.19%\\" /><col width=\\"2.36%\\" /><col width=\\"1.18%\\" /><col width=\\"1.77%\\" /><col width=\\"23.68%\\" /><col width=\\"6.51%\\" /><col width=\\"3.55%\\" /><col width=\\"1.77%\\" /><col width=\\"10.06%\\" /><col width=\\"4.14%\\" /><col width=\\"19.53%\\" /><col width=\\"18.26%\\" /></colgroup><thead style=\\"display: table-header-group;\\"><tr><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" scope=\\"colgroup\\" style=\\"border-top: solid 0.50pt\\"><b>Stage</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" scope=\\"colgroup\\" style=\\"border-top: solid 0.50pt\\"><b>Best response</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th></tr><tr><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Case</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Sex/age</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Dx</b></th><th colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"colgroup\\" style=\\"border-bottom: solid 0.50pt\\"><b>CPI</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Previous regimens (number of cycles)</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Response</b> <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">1</span></th><th colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"colgroup\\" style=\\"border-bottom: solid 0.50pt\\"><b>Dose</b> <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">2</span></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>irAE (grade)</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Cycles</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Clinical course</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Status / survivals (time)</b></th></tr></thead><tbody><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">P1</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">M/20</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">II</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">ABVD (6), DHAP (2), Benda (6), BV (6), AHSCT, BV + Gem (3)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">300 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">32</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">completed 2 years of treatment <br />relapsed 11 months afterwards</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR (33 m); PFS (35 m) <br />Relapsed</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">M/24</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\"></td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">Pembrolizumab (32)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1500 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">25</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">ongoing CR</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR (11 m); PFS (22 m); OS (57 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"background-color:rgb(191,191,191)\\">P2</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">F/38</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">IV</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">III</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">ABVD (3), BEACOPP (4), BV + Gem (4)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">800 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">colitis (1)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">17</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">gave birth to a daughter 33 m after stopping pembrolizumab, ongoing CR</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">CR (42 m); PFS (49 m), OS (49 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">P3</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">M/32</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">IV</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">ABVD (6), DHAP (3), BV (3)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">390 mg <sup>3</sup></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">eczema(1) <br />hypothyroidism (2)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">36</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">Ongoing CR</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR (46 m); PFS (48 m); OS (48 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"background-color:rgb(191,191,191)\\">P4</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">F/39</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">III</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">ABVD (4), DHAP (2), BV (3), AHSCT</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">PR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">400 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">25</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">PR for 24 m, then PD; <br />switched to nivolumab</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">PFS (26 m); OS (39 m) <br />SD (8 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">P5</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">M/71</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">IV</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">BV + Benda (6)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">300 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">33</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">Ongoing CR</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR (29 m); PFS (32 m); OS (32 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"background-color:rgb(191,191,191)\\">P6</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">F/47</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">II</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">II</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">ABVD (2), BEACOPP (2), DHAP (2)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">PR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">300 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">17</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">PR for 11 m, then PD; <br />No response to BV and GDP</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">PR (11 m); PFS (14 m); OS (22 m) <br />Died of disease</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">P7</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">F/26</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">III</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">III</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">ABVD (6), GDP (2), BV (7)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">400 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">34</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR for 32 m; then relapsed</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR (32 m); PFS (35m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">F/29</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">III</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">Pembrolizumab (34)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">200 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">10</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR after 2 cycles of Pem + BV <br />Ongoing CR, still on BV + Pem</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR (4 m); PFS (7 m); OS (41 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"background-color:rgb(191,191,191)\\">P8</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">M/19</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">IV</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">ABVD (4), BEACOPP (2), BV + Gem (3)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">400 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">urticaria (1)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">10</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">CR for 6 m</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">CR (6 m); PFS (9 m); OS (9 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">P9</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">M/35</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">III</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">BV(8)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">600 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">8</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">Changed to nivolumab because of cost concerns</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR (13 m); PFS (19 m); OS (19 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"background-color:rgb(191,191,191)\\">P10</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">M/34</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">IV</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">ABVD (2), AAVD (4)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">PR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">300 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">24</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">In PR for 12 m</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">PR (12 m); PFS (16 m); OS (16 m)</td></tr></tbody><tfoot style=\\"display: table-footer-group;\\"><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"border-bottom: solid 0.50pt\\">P11</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"border-bottom: solid 0.50pt\\">F/23</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"border-bottom: solid 0.50pt\\">IV</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"border-bottom: solid 0.50pt\\">IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"border-bottom: solid 0.50pt\\">AAVD (6), GDP (3)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">600 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">16</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">Ongoing CR</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">CR (10 m); PFS (14 m); OS (14 m)</td></tr></tfoot></table>",
    "objectType": "MPTable",
  },
  Object {
    "_id": "MPTableElementFooter:test",
    "containedObjectIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPTableElementFooter",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Dx: stage at diagnosis; CPI: stage at the start of checkpoint inhibitor; 1: response determined by positron emission tomography computed tomography; 2: total dose at the time of best response; 3: dose of pembrolizumab at 2 mg/kg and hence 130 mg per cycle; CR: complete response; PR: partial response; PD: progressive disease; SD: stable disease; ABVD: adriamycin, bleomcyin, vinblastine, dacarbazine; DHAP: cytarabine, cisplatinum, dexamethasone; Benda: bendamustine; BV: brentuximab vedotin; AHSCT: autologous hematopoietic stem cell transplantation; Gem: gemcitabine; BEACOPP: bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisolone; GDP: gemcitabine, cisplatinum, dexamethasone; AAVD: brentuximab, adriamycin, vinblastine, dacarbazine; pem: pembrolizumab; CR: complete response; PR: partial response; m: months;</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPTableElement:test",
    "caption": "",
    "containedObjectID": "MPTable:test",
    "elementType": "table",
    "listingID": "MPListing:test",
    "objectType": "MPTableElement",
    "tableElementFooterID": "MPTableElementFooter:test",
    "title": "Six patients with relapsed/refractory Hodgkin lymphoma treated with low-dose nivolumab",
  },
  Object {
    "_id": "MPTable:test",
    "contents": "<table xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPTableElement:test\\" class=\\"MPElement\\" data-contained-object-id=\\"MPTable:test\\"><colgroup><col width=\\"3.22%\\" /><col width=\\"5.03%\\" /><col width=\\"3.14%\\" /><col width=\\"1.25%\\" /><col width=\\"1.88%\\" /><col width=\\"27.69%\\" /><col width=\\"6.92%\\" /><col width=\\"4.37%\\" /><col width=\\"1.92%\\" /><col width=\\"13.21%\\" /><col width=\\"5.66%\\" /><col width=\\"10.07%\\" /><col width=\\"15.64%\\" /></colgroup><thead style=\\"display: table-header-group;\\"><tr><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" scope=\\"colgroup\\" style=\\"border-top: solid 0.50pt\\"><b>Stage</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" scope=\\"colgroup\\" style=\\"border-top: solid 0.50pt\\"><b>Best response</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></th></tr><tr><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Case</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Sex/age</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Dx</b></th><th colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"colgroup\\" style=\\"border-bottom: solid 0.50pt\\"><b>CPI</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Previous regimens (number of cycles)</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Response</b> <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">1</span></th><th colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"colgroup\\" style=\\"border-bottom: solid 0.50pt\\"><b>dose</b> <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">2</span></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>irAE (grade)</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Cycles</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Clinical course</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"><b>Status / survivals (time)</b></th></tr></thead><tbody><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\"></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">N1</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">F/44</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">II</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">II</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">ABVD (6), BV + Benda (1)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">160 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">eczema (1) <br />hypocortisolism (1)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">52</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">Ongoing CR</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR (28 m); PFS (30 m); <br />OS (30 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"background-color:rgb(191,191,191)\\">N2</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">M/36</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">III</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">III</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">ABVD (8), DHAP (3), AHSCT</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">160 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">ITP (4) <br />Hypophysitis (2) with <br />diabetes insipidus</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">52</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">CR for 30 m, <br />then relapsed</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">CR (30 m); PFS (33 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"background-color:rgb(191,191,191)\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\"></td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">Nivolumab</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">360 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">Hypophysitis (2)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">10</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">Ongoing CR</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">CR (1 m); PFS (5 m); <br />OS (38 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">N3</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">F/64</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">IV</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">I</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">ABVD (6), DHAP (2), COPP (2), Allo-HSCT, GDP (6), Benda (4), radiotherapy</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">160 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">Nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">23</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">Ongoing CR</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">CR (20 m); PFS (22 m); <br />OS (22 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"background-color:rgb(191,191,191)\\">N4</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">F/34</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">IV</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">III</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">ABVD (6), BV (2)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">CR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">160 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">Thyroiditis (1) <br />Hypocortisolism (1) <br />Rash (1)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">23</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\" style=\\"background-color:rgb(191,191,191)\\">Ongoing CR</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"background-color:rgb(191,191,191)\\">CR (8 m); PFS (10 m); <br />OS (10 m)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">N5</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">M/37</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">IV</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">ABVD (8), DHAP (2), GDP(3), BV (3), Allo-HSCT</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">PR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">240mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">Nil</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">15</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"justify\\">Ongoing PR</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">PR (4 m); PFS (6 m); OS (6 m)</td></tr></tbody><tfoot style=\\"display: table-footer-group;\\"><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"border-bottom: solid 0.50pt; background-color:rgb(191,191,191)\\">N6</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt; background-color:rgb(191,191,191)\\">M/57</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt; background-color:rgb(191,191,191)\\">II</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt; background-color:rgb(191,191,191)\\">IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt; background-color:rgb(191,191,191)\\">RT, ABVD (2)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt; background-color:rgb(191,191,191)\\">IR</td><td colspan=\\"2\\" data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt; background-color:rgb(191,191,191)\\">360 mg</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt; background-color:rgb(191,191,191)\\">Hypothyroidism (2)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt; background-color:rgb(191,191,191)\\">20</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt; background-color:rgb(191,191,191)\\">Ongoing IR</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt; background-color:rgb(191,191,191)\\">IR (1 m); PFS (10 m); <br />OS (10 m)</td></tr></tfoot></table>",
    "objectType": "MPTable",
  },
  Object {
    "_id": "MPTableElementFooter:test",
    "containedObjectIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPTableElementFooter",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Dx: stage at diagnosis; CPI: stage at the start of checkpoint inhibitor; 1: response determined by positron emission tomography computed tomography; 2: total dose at the time of best response; CR: complete response; PR: partial response; PD: progressive disease; SD: stable disease; IR: indeterminate response; ABVD: adriamycin, bleomcyin, vinblastine, dacarbazine; DHAP: cytarabine, cisplatinum, dexamethasone; COPP: cyclophosphamide, vincristine, procarbazine, prednisolone; allo-HSCT: allogeneic hematopoietic stem cell transplantation; Benda: bendamustine; BV: brentuximab vedotin; RT: radiotherapy; AHSCT: autologous hematopoietic stem cell transplantation; Gem: gemcitabine; BEACOPP: bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisolone; GDP: gemcitabine, cisplatinum, dexamethasone</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPTableElement:test",
    "caption": "",
    "containedObjectID": "MPTable:test",
    "elementType": "table",
    "listingID": "MPListing:test",
    "objectType": "MPTableElement",
    "tableElementFooterID": "MPTableElementFooter:test",
    "title": "Clinicopathologic features and treatment outcome of patients with relapsed/refractory classical Hodgkin lymphoma treated by pembrolizumab and nivolumab",
  },
  Object {
    "_id": "MPTable:test",
    "contents": "<table xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPTableElement:test\\" class=\\"MPElement\\" data-contained-object-id=\\"MPTable:test\\"><colgroup><col width=\\"64.16%\\" /><col width=\\"18.86%\\" /><col width=\\"16.98%\\" /></colgroup><thead style=\\"display: table-header-group;\\"><tr><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"><b>Clinicopathologic features and outcome</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"><b>Pembrolizumab</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\"><b>Nivolumab</b></th></tr></thead><tbody><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-bottom: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\"></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"border-top: solid 0.50pt\\">Number</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\">11</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\">6</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Gender (male: female)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">6: 5</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">3: 3</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Age, median (range) in years</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">34 (20–71)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">40.5 (34–57)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\"><u>Histology</u></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\"></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Nodular sclerosing</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">9 (82%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">4 (67%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Mixed cellularity</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1 (9%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1 (17%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Lymphocyte-rich</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1 (17%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Not specified</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1 (9%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\"><u>At initial diagnosis</u></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\"></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Stage I/II</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">2 (81%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">2 (33%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Stage III/IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">9 (82%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">4 (67%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">B symptoms</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">7 (64%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Extra-nodal involvement</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">4 (36%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">3 (50%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Frontline therapy with ABVD</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">8 (72%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">5 (83%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Refractoriness to frontline therapy</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">8 (73%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">2 (33%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">PET2-adapted approach</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">3 (27%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1 (17%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\"><u>At start of checkpoint inhibitor</u></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\"></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Stage I/II</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1 (9%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">2 (33%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Stage III/IV</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">10 (91%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">4 (67%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">B symptoms</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">6 (55%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Extra-nodal involvement</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">8 (73%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">2 (33%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Prior lines of regimens, median (range)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">3 (1–6)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">2.5 (2–7)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Prior exposure to brentuximab vedotin</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">10 (91%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">3 (50%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Prior autologous HSCT</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">2 (18%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1 (17%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Prior allogeneic HSCT</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">2 (34%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Refractoriness to last regimen</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">8 (73%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">3 (50%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Time from last regimen, median (range) in months</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1 (1–30)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">6.5 (1–59)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Time from initial diagnosis, median, (range) in months</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">14 (5–72)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">64 (12–118)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\"><u>Best outcome to checkpoint inhibitor</u></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\"></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\"></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Complete response</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">8 (73%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">4 (67%)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Partial response</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">3 (27%)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1 (17%)</td></tr></tbody><tfoot style=\\"display: table-footer-group;\\"><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"border-bottom: solid 0.50pt\\">Indeterminate response</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">0</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">1 (17%)</td></tr></tfoot></table>",
    "objectType": "MPTable",
  },
  Object {
    "_id": "MPTableElementFooter:test",
    "containedObjectIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPTableElementFooter",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">ABVD: adriamycin, bleomycin, vinblastine, dacarbazine; PET2-adpated approach: treatment approach based on positron emission tomography computed tomography data after two cycles of treatment; HSCT: hematopoietic stem cell transplantation</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 10,
    "title": "Pembrolizumab cohort",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Six men and five women at a median age of 34 (range: 19–71) years were treated. On presentation, nine patients had advanced (stage III/IV) disease, and two patients had early (stage II) disease. At relapsed/refractory disease, 10 patients had advanced disease. There was a median of 3 (range: 1–6) lines of prior therapy, including brentuximab vedotin (BV) in 10 patients (91%), and auto-HSCT in two patients (18%). Median time from last regimen to treatment was 1 (range: 1–30) months ( <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 3</b></span></span>). Ten patients received 100 mg Q3W, whereas one case (patient P3) received 130 mg (at 2 mg/kg) Q3W.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPFigureElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 11,
    "title": "Response to pembrolizumab",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The best radiologic response was mCR in eight patients (73%) (Deauville score: 1, <i>N</i> = 3; 2, <i>N</i> = 5; all with &gt; 50% shrinkage of tumors), and partial response (PR) in three patients (27%) ( <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure 1 A–D</b></span></span>), giving an overall response rate (ORR) of 100%. The median cumulative dose of pembrolizumab leading to best response was 400 mg (range: 300–800 mg).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">Radiologic response assessed by positron emission tomography computed tomography in patients with classical Hodgkin lymphoma treated by low-dose anti-PD1 antibodies pembrolizumab and nivolumab.</p>",
    "containedObjectIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "FIGURE 1",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">A. Patient P4, pembrolizumab cohort. Relapse with cervical lymphadenopathy (arrowhead), bilateral axillary lymphadenopathy (vertical arrows), multiple pulmonary nodules (open arrows), splenic nodules (open arrow), and para-aortic lymphadenopathy (open arrow) (left panel). Resolution of most of the lesions after 400 mg of pembrolizumab, except the right axillary lymphadenopathy (vertical arrow), splenic nodules and para-aortic lymphadenopathy (open arrows) (middle left panel). Further improvement in lesions after a cumulative dose of 1300 mg of pembrolizumab, with persistence of minimally hypermetabolic lesions (open arrows) (middle right panel). Disease progression after a cumulative dose of 2600 mg of pembrolizumab, with re-appearance of right axillary lymphadenopathy (arrow), porta hepatis lymphadenopathy and para-aortic lymphadenopathy (open arrows). There was new-onset left cervical lymhadenopathy (arrowhead).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">B. Patient P6, pembrolizumab cohort. Relapse with mediastinal lymphadenopathy (arrow), together with two lesions in the chest and left internal mammary region (open arrows) (right panel). Resolution of most of the lesions, with persistence of minimally hypermetabolic mediastinal lymphoadenopathy (arrow) after 300 mg of pembrolizumab (middle panel). Disease progression after 1400 mg of pembrolizumab, with multiple lung nodules, the more prominent ones being indicated by open arrows (right panel).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">C. Patient P7, pembrolizumab cohort. Refractory disease with large right and left cervical lymphadenopathy (arrows) (left panel). Complete response of all lesions after 400 mg of pembrolizumab (middle left panel). Relapse with right cervical lymphadenopathy and left peri-parotid lesion (arrows) (middle right panel). Complete response of lesions after two cycles of pembrolizumab (100 mg/cycle) and brentuximab vedotin (100 mg/cycle) (right panel).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">D. Patient P11, pembrolizumab cohort. Refractory disease with persistent lesion in the C1 and S1 vertebrae (arrows) (left panel). Complete response of all lesions after 400 mg of pembrolizumab (middle left panel). Enlarged views of the two lesions and their complete response (right two panels).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">E. Patient N2, nivolumab cohort. Complete response of cervical, axillary, mediastinal, abdominal and pelvic lymphadenopathy after 160 mg of nivolumab (images before treatment not available) (left panel). Disease relapse after completion of 2 years of nivolumab treatment, showing left cervical lymphadenopathy (arrows) (middle panel). Complete response after 320 mg of nivolumab (right panel).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">F. Patient N4, nivolumab cohort. Refractory disease with left cervical, multiple mediastinal and left hilar lymphadenopathy (arrows). Complete response after 160 mg of nivolumab.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">G. Patient N6. Refractory disease, showing peri-pancreatic and para-aortic lymphadenopathy (arrows), together with osseous involvement in the left humerus, sternum and left acetabulum (open arrows) (left panel). Resolution of these lesions after 360 mg of nivolumab. A right axillary lymph node of mild activity was noted (arrow) (middle panel). Right axillary lymph node of uncertain nature and minimal activity was still present, after 840 mg of nivolumab (arrow) (right panel).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigure:test",
    "contentType": "image/tiff",
    "objectType": "MPFigure",
    "src": "https://siam-x5432.ciplit.com/action/leanworkflowDownloadAttachment?id=e6585ce0-2402-4ca8-9c60-5ac6d40e6872&name=figure+1+revised.tif",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPFigureElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 12,
    "title": "Outcome of mCR patients",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Of eight mCR cases, two cases had relapsed after completion of 2 years of treatment ( <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure 2</b></span></span>). Patient P1 relapsed 11 months after stopping pembrolizumab. The relapsed lymphoma showed EBV-positive Reed-Sternberg cells, whereas the original lymphoma was EBV-negative. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">16</span> Patient P7 relapsed 9 months after stopping pembrolizumab. The other six patients had remained in continuous mCR, for a median of 21 (range: 6–46) months, with three of whom already off treatment. Patient P9 achieved mCR after 6 cycles, received two more cycles, and then changed to the less expensive nivolumab (40 mg Q2W) for financial reasons. Patient P2 delivered a healthy baby girl 33 months after stopping pembrolizumab. Pregnancy was uncomplicated.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><b>Swimmer plot of patients in the pembrolizumab and nivolumab cohorts.</b> mCR: metabolic complete response; PR: partial remission; IR: indeterminate response. Drug cessation (blue circle) in seven patients (P1, P3, P4, P5, P7, N1, N2) represented completion of 2&nbsp;years of treatment. In patient P2, drug cessation represented truncation of treatment in an attempt to conceive. In patient P9, drug cessation was because of financial constraints.</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "FIGURE 2",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "contentType": "image/jpeg",
    "objectType": "MPFigure",
    "src": "https://siam-x5432.ciplit.com/action/leanworkflowDownloadAttachment?id=e6585ce0-2402-4ca8-9c60-5ac6d40e6872&name=figure+2.jpg",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 13,
    "title": "Outcome of PR patients",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Patient P4 was in PR for 24 months, before disease progression occurred. Treatment was changed to nivolumab (40 mg Q2W), and she has since remained in stable disease for 8 months, pending the next radiologic assessment. Patient P6 remained in PR for 11 months before disease progression. She did not respond to BV and salvage chemotherapy (gemcitabine, cisplatin, dexamethasone), and died 8 months afterwards. Patient 10 has been in PR for 12 months, pending the next radiologic reassessment.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 14,
    "title": "Re-treatment of relapses with pembrolizumab",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Both relapsed patients were re-treated with pembrolizumab at 100 mg Q3W. Patient P1 achieved mCR again, after a cumulative dose of 1500 mg. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">16</span> Patient P7 achieved mCR after two cycles of pembrolizumab (100 mg Q3W) combined with BV (100 mg Q3W) ( <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span>). Both patients have remained in continuous mCR.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 15,
    "title": "Adverse events of pembrolizumab treatment",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">After 287 treatment cycles, AEs were only observed in three cases ( <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span>). Patient P2 developed grade 1 diarrhea after 17 cycles (1700 mg). Sigmoidoscopy revealed minimal inflammation, and colonic biopsy showed mild acute inflammation. The diarrhea subsided with budesonide. Pembrolizumab was truncated at that point because the patient wanted to conceive. Patient P3 developed intermittent grade 1 eczema. After 25 cycles (2500 mg), he developed grade 1 hypothyroidism (elevated thyroid stimulating hormone, TSH), which progressed to grade 2 hypothyroidism (decreased thyroxine, requiring replacement) after 28 cycles (2800 mg). There were no detectable anti-thyroid antibodies. Patient P8 had intermittent grade 1 urticaria, which responded to symptomatic treatment. In both cases, therapy was uninterrupted.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 16,
    "title": "Nivolumab cohort",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Three men and three women at a median age of 40.5 (range: 34–57) years were treated ( <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 2</b></span></span>). On presentation, two patients had early (stage I/II) disease, and four patients had advanced (stage III/IV) disease. At relapsed/refractory disease, four patients had advanced disease. There was a median of 3 (range: 2–7) lines of prior therapy, which included BV in three cases (50%), auto-HSCT in one case (17%), and allogeneic HSCT (allo-HSCT) in two cases (33%). Median time from last regimen to treatment was 6.5 (range: 1–59) months ( <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 3</b></span></span>). All patients received a flat-dose of 40 mg Q2W.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 17,
    "title": "Response to nivolumab",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The best radiologic response was mCR in four cases (67%) (Deauville score: 1, <i>N</i> = 2; 3, <i>N</i> = 2; two cases with &gt; 50% shrinkage of tumor) and partial response in one case (17%) ( <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure 1 E–G</b></span></span>). One case (patient N6) showed resolution of all index lesions on PET/CT scan performed after 9 cycles (360 mg) ( <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure 1 G</b></span></span>), except for a small minimally FDG-avid right axillary lymph node, which was an involved site on presentation but not at refractory disease. The lesion further decreased in size and metabolic activity 6 months later, suggesting that it represented pseudo-progression. At that juncture and before the next radiologic assessment, the patient was best considered to have an indeterminate response (IR). <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">14</span> The median dose of nivolumab required to give the best response was 160 (range: 160–360) mg.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 18,
    "title": "Outcome of CR patients",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">One case (patient N2) completed 2 years of treatment, and relapsed 8 months later ( <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure 2</b></span></span>). The other three patients have remained in continuous mCR for a median of 20 (range: 8–28) months, with one of them already off treatment.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 19,
    "title": "Outcome of PR/IR patients",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Patient N5 has remained in PR, pending the next radiologic reassessment. Patient N6 has remained asymptomatic, with his IR status to be re-examined in 3 months.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 20,
    "title": "Re-treatment with nivolumab",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Patient N2 achieved mCR again after a cumulative dose of 320 mg. He has remained in mCR for about 2 months.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 21,
    "title": "Adverse events of nivolumab treatment",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">After 195 treatment cycles, AEs were observed in four cases ( <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 2</b></span></span>). Patient N1 developed intermittent grade 1 eczema, which responded to symptomatic treatment. Persistently depressed morning cortisol levels occurred after nine cycles (360 mg) (nadir: 88 nmol/L; reference range: 130–600 nmol/L). There was no evidence of hypoadrenalism clinically (hypotension, asthenia) or biochemically (hyponatremia, hyperkalemia). One month after completion of 2 years of treatment, morning cortisol levels became normal. Patient N3 had a history of immune thrombocytopenia, and nivolumab expectedly resulted in exacerbation (nadir platelet count: 4 × 10 <sup>9</sup>/L). Immune thrombocytopenia responded fully to corticosteroid therapy, and did not recur afterwards. Grade 1 hypoadrenalism developed after 19 cycles (760 mg) (nadir morning cortisol: 69 nmol/L). Symptoms of hypogonadism and diabetes insipidus appeared after the first 2 years of treatment. With relapse and after the second cycle (80 mg) of re-treatment, hypogonadism and diabetes insipidus were documented biochemically, requiring hormonal replacement. Overall features were consistent with grade 2 hypophysitis. Patient N4 developed grade 1 hypoadrenalism after four cycles (160 mg) (nadir morning cortisol: 77 nmol/L). There was immunological evidence of thyroiditis (elevated anti-thyroid peroxidase antibody) and a transient increase in thyroxine after seven cycles (280 mg), but thyroxine/TSH levels became normal spontaneously 4 months later. Patient N6 had subclinical hypothyroidism (elevated TSH) at baseline before nivolumab treatment. After 20 cycles (800 mg) of treatment, grade 2 hypothyroidism occurred, requiring thyroxine replacement.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 22,
    "title": "Molecular responses",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">EBER-ISH was performed in 16 cases, with six cases (patients P1, P3, P5, P6, P9, N2) showing EBER-positive Reed-Sternberg cells. Plasma EBV DNA was serially monitored in five cases (patients P1, P5, P6, P9, N2). In four cases reaching mCR (patients P1, P5, P9, N2), molecular remission with undetectable plasma EBV DNA was also achieved. In patient P6, who only achieved PR, plasma EBV DNA remained persistently quantifiable. Terminally, her pleural fluid also contained high levels of cell-free EBV DNA, confirming lymphomatous involvement, although cytologically no neoplastic cells were evident.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPFigureElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 23,
    "title": "Survivals",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The median PFS of the pembrolizumab and nivolumab cohorts were 35 and 33 months respectively ( <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure 3 A-C</b></span></span>). The median OS has not been reached for the two cohorts.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><b>Survivals of patients in the pembrolizumab and nivolumab cohorts.</b> A. Progression free survival of the pembrolizumab cohort. B: Overall survival of the pembrolizumab cohort. C: Progression free survival for the nivolumab cohort. Overall survival of the nivolumab cohort is not shown, as there were no events associated with overall survival in the Kaplan-Meier plot.</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "FIGURE 3",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "contentType": "image/jpeg",
    "objectType": "MPFigure",
    "src": "https://siam-x5432.ciplit.com/action/leanworkflowDownloadAttachment?id=e6585ce0-2402-4ca8-9c60-5ac6d40e6872&name=figure+3.jpg",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:discussion",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 24,
    "title": "DISCUSSION",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This study describes our experience of low-dose anti-PD1 antibodies in relapsed/refractory cHL. We used pembrolizumab at one-half and nivolumab at one-sixth of the approved doses. This strategy has hitherto not been tried in other studies.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">With pembrolizumab used at 100 mg Q3W (2 mg/kg Q3W in one case), ORR was 100%, with CR at 73%. A previous phase 1 study used pembrolizumab at 10 mg/kg Q2W (about 10 times our dose). <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">7</span> In 31 patients failing BV with or without previous auto-HSCT, ORR was 65%, with CR only at 16%. A subsequent phase 2 study used pembrolizumab at 200 mg Q3W (twice our dose). <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">8</span> ORR was 75%, with CR also low at 23%. A recent update of 210 patients (receiving pembrolizumab at 200 mg Q3W) reported an ORR of 72%, with CR at 28%. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">18</span> We observed a high ORR with particularly a high CR rate in our cohort. This is unlikely related to differences in prior therapies, which in fact had not been shown to significantly impact on ORR/CR. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test MPBibliographyItem:test\\">8,18</span> Furthermore, the median cumulative dose required for best response was merely 400 mg in our patients; as compared with 50 mg/kg (8–10 times our dose) in the phase 1 study; <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">7</span> and 1200 mg (three times our dose) in the phase 2 study. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">8</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">After 287 treatment cycles, only three patients developed AEs, all grade 1–2. Conversely, in the high-dose phase 1 study, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">7</span> the frequency of AEs was very high at 68% (grade 3/4: 16%), with a drug discontinuation rate of 6.5%. In the phase 2 study using a lower dose, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">8</span> the frequency of AEs was less at 30%, with a drug discontinuation rate of 1%. In the latest update of this phase 2 cohort, the frequency of AEs was 73% (grade 3/4: 12%), with a drug discontinuation rate of 6.7%. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">18</span> Hence, AEs were dose-related. Our use of low-dose pembrolizumab significantly decreased AEs and their severity, wtih no drug discontinuation.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">With nivolumab used at 40 mg Q2W, ORR was 100%, with CR at 67%. A previous phase 1 study used nivolumab at 3 mg/kg Q2W (about 6 times our dose). <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">5</span> In 23 patients, 80% of whom had failed BV, auto-HSCT and radiotherapy, the ORR was 87%, with CR only at 17%. A subsequent phase 2 study also used nivolumab at 3 mg/kg Q2W. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">19</span> In 80 patients failing auto-HSCT and BV, the ORR was 73%, with CR at 28%. A more recent update of a larger combined cohort of 243 patients treated with nivolumab at 3 mg/kg Q2W showed an ORR of 69%, with CR at 16%. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">20</span> In our low-dose nivolumab cohort, there was high ORR and CR rate. Again, this was unlikely attributable to prior therapies, which had not been shown to impact significantly on responses. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">20</span> The median cumulative dose needed to achieve best responses was also much lower in our approach (160 mg), as compared with 12 mg/kg (about six times our dose) in both the phase 1 and phase 2 studies. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test MPBibliographyItem:test MPBibliographyItem:test\\">5,19,20</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">After 195 treatment cycles, AEs were observed in four cases. However, two cases (patients N3 and N6) had pre-existing autoimmune conditions, and they would typically be excluded from previous clinical trials. Hence, in patients without autoimmune diseases, AEs were observed only in two cases (50%), all merely grade 1. Conversely, in the phase 1 nivolumab study, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">5</span> the AE frequency was 78% (grade 3/4: 22%), with a drug discontinuation rate of 8.7%. In another phase 2 study, rates of grade 3/4 AEs and grade 5 AE (death) were 41% and 1%. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">19</span> Hence, our low-dose approach decreased the frequency and severity of AEs, with no drug discontinuation.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In most countries, approvals for anti-PD1 antibodies in cHL stipulate failure after several lines of therapy, including BV and auto-HSCT. BV is not reimbursed in Hong Kong. On a per-dose basis, depending on bodyweight, BV at 1.8 mg/kg is more expensive than pembrolizumab (100 mg) by 5–7.5 times, and nivolumab (40 mg) by 20–30 times. In four of our patients, anti-PD1 antibodies were used before BV, which was unaffordable to them. Because of good responses, none of our patients opted for auto-HSCT. Our approach of continuing anti-PD1 antibodies differs from conventional HSCT-based strategies, where auto-HSCT is recommended after successful BV treatment, and allo-HSCT is recommended for failed auto-HSCT. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">21</span> In our cohort, 71% (12/17) of patients were less than 40 years old. In such young patients, maintenance with anti-PD1 antibodies avoids the long-term toxicities of high-dose chemotherapy. Fertility may be preserved in selected cases, exemplified by the successful pregnancy in patient P2.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Re-treatment with anti-PD1 antibodies has not been extensively studied. Three patients in our series relapsed after completion of 2 years of anti-PD1 antibody treatment. Re-treatment with the original anti-PD1 antibodies at the same dose led to mCR in all of them. Longer follow-up will be needed to determine if such remissions are durable.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This was a retrospective analysis involving a relatively limited number of patients. Therefore, the long-term efficacy of low-dose pembrolizumab and nivolumab requires validation prospectively in comparison with standard doses of these drugs. Furthermore, it should be noted that autologous HSCT is potentially curative for over half of eligible patients with relapsed/refractory cHL. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">21</span> Whether such durable results are achievable with anti-PD1 antibodies will need longer observations.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In conclusion, low-dose anti-PD1 antibodies were highly efficacious and safe in relapsed/refractory cHL. In resource-constrained regions, this approach has far-reaching financial implications. It significantly economizes on medication expenses, so underprivileged patients will not be barred from receiving these important drugs because of unaffordability. By minimizing AEs, the costs of managing complications of PD1 blockade are also reduced. Finally, with longer follow-up, it remains to be determined if auto-HSCT might be obviated in some cases, thereby further reducing immediate and long-term healthcare costs.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:con",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 25,
    "title": "AUTHOR CONTRIBUTIONS",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Thomas S.Y. Chan: treated the patients, wrote and approved the manuscript</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Yu-Yan Hwang: treated the patients, wrote and approved the manuscript</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Pek-Lan Khong: performed the radiologic diagnosis, and approved the manuscript</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Anskar Y.H. Leung: treated the patients, and approved the manuscript</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Chor-Sang Chim: treated the patients, and approved the manuscript</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Eric Tse: treated the patients, and approved the manuscript</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Yok-Lam Kwong: treated the patients, wrote and approved the manuscript</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:competing-interests",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 26,
    "title": "Acknowledgment and conflicts of interests",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The authors have no acknowledgment to make and no conflicts of interests to declare.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPFigureElement",
    "elements": Array [
      "MPFigureElement:test",
      "MPFigureElement:test",
      "MPFigureElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPTableElement",
    "elements": Array [
      "MPTableElement:test",
      "MPTableElement:test",
      "MPTableElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:bibliography",
    "elementIDs": Array [
      "MPBibliographyElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 99,
    "title": "References",
  },
  Object {
    "_id": "MPBibliographyElement:test",
    "containedObjectIDs": Array [
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
    ],
    "contents": "",
    "elementType": "div",
    "objectType": "MPBibliographyElement",
  },
  Object {
    "DOI": "https://doi.org/10.1200/JCO.2016.66.4482",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Roemer",
        "given": "M. G.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Advani",
        "given": "R. H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Ligon",
        "given": "A. H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Natkunam",
        "given": "Y.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Redd",
        "given": "R. A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Homer",
        "given": "H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Shipp",
        "given": "M. A.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Clinical Oncology",
    "issue": "23",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2016",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "2690-2697",
    "title": "PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.",
    "type": "article-journal",
    "volume": "34",
  },
  Object {
    "DOI": "https://doi.org/10.1182/blood-2017-06-781989",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Liu",
        "given": "W. R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Shipp",
        "given": "M. A.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Blood",
    "issue": "21",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "2265-2270",
    "title": "Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.",
    "type": "article-journal",
    "volume": "130",
  },
  Object {
    "DOI": "https://doi.org/10.1200/JCO.2009.26.7609",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Brahmer",
        "given": "J. R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Drake",
        "given": "C. G.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Wollner",
        "given": "I.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Powderly",
        "given": "J. D.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Picus",
        "given": "J.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Sharfman",
        "given": "W. H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Topalian",
        "given": "S. L.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Clinical Oncology",
    "issue": "19",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2010",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "3167-3175",
    "title": "Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: Safety, clinical activity, pharmacodynamics, and immunologic correlates.",
    "type": "article-journal",
    "volume": "28",
  },
  Object {
    "DOI": "https://doi.org/10.1056/NEJMoa1411087",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Ansell",
        "given": "S. M.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Lesokhin",
        "given": "A. M.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Borrello",
        "given": "I.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Halwani",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Scott",
        "given": "E. C.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Gutierrez",
        "given": "M.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Armand",
        "given": "P.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "The New England Journal of Medicine",
    "issue": "4",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2015",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "311-319",
    "title": "PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma.",
    "type": "article-journal",
    "volume": "372",
  },
  Object {
    "DOI": "https://doi.org/10.1056/NEJMoa1305133",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Hamid",
        "given": "O.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Robert",
        "given": "C.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Daud",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Hodi",
        "given": "F. S.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Hwu",
        "given": "W. J.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kefford",
        "given": "R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Ribas",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "The New England Journal of Medicine",
    "issue": "2",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2013",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "134-144",
    "title": "Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.",
    "type": "article-journal",
    "volume": "369",
  },
  Object {
    "DOI": "https://doi.org/10.1200/JCO.2016.67.3467",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Armand",
        "given": "P.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Shipp",
        "given": "M. A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Ribrag",
        "given": "V.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Michot",
        "given": "J. M.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Zinzani",
        "given": "P. L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kuruvilla",
        "given": "J.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Moskowitz",
        "given": "C. H.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Clinical Oncology",
    "issue": "31",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2016",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "3733-3739",
    "title": "Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure.",
    "type": "article-journal",
    "volume": "34",
  },
  Object {
    "DOI": "https://doi.org/10.1200/JCO.2016.72.1316",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Chen",
        "given": "R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Zinzani",
        "given": "P. L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Fanale",
        "given": "M. A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Clinical Oncology",
    "issue": "19",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "2125-2132",
    "title": "KEYNOTE-087. Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.",
    "type": "article-journal",
    "volume": "35",
  },
  Object {
    "DOI": "https://doi.org/10.1002/psp4.12130",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Lindauer",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Valiathan",
        "given": "C. R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Mehta",
        "given": "K.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Sriram",
        "given": "V.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "de Greef",
        "given": "R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Elassaiss-Schaap",
        "given": "J.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "de Alwis",
        "given": "D. P.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "CPT: Pharmacometrics and Systems Pharmacology",
    "issue": "1",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "11-20",
    "title": "Translational pharmacokinetic / pharmacodynamic modeling of tumor growth inhibition supports dose-range selection of the anti-PD-1 antibody pembrolizumab.",
    "type": "article-journal",
    "volume": "6",
  },
  Object {
    "DOI": "https://doi.org/10.1111/bjh.13920",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kwong",
        "given": "Y. L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Lopes",
        "given": "D.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Khong",
        "given": "P. L.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "British Journal of Haematology",
    "issue": "1",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "131-132",
    "title": "Low-dose pembrolizumab induced remission in patients with refractory classical Hodgkin lymphoma.",
    "type": "article-journal",
    "volume": "176",
  },
  Object {
    "DOI": "https://doi.org/10.1007/s00277-017-2931-z",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Chan",
        "given": "T. S.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Luk",
        "given": "T. H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Lau",
        "given": "J. S.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Khong",
        "given": "P. L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kwong",
        "given": "Y. L.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Annals of Hematology",
    "issue": "4",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "647-651",
    "title": "Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: High efficacy with minimal toxicity.",
    "type": "article-journal",
    "volume": "96",
  },
  Object {
    "DOI": "https://doi.org/10.1007/s00277-017-3007-9",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Hwang",
        "given": "Y. Y.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Khong",
        "given": "P. L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kwong",
        "given": "Y. L.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Annals of Hematology",
    "issue": "7",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1219-1220",
    "title": "Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma.",
    "type": "article-journal",
    "volume": "96",
  },
  Object {
    "DOI": "https://doi.org/10.1200/JCO.2017.77.6385",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Brahmer",
        "given": "J. R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Lacchetti",
        "given": "C.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Schneider",
        "given": "B. J.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Atkins",
        "given": "M. B.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Brassil",
        "given": "K. J.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Caterino",
        "given": "J. M.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Thompson",
        "given": "J. A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "National Comprehensive Cancer Network",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Clinical Oncology",
    "issue": "17",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2018",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1714-1768",
    "title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.",
    "type": "article-journal",
    "volume": "36",
  },
  Object {
    "DOI": "https://doi.org/10.1200/JCO.2013.54.8800",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Cheson",
        "given": "B. D.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Fisher",
        "given": "R. I.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Barrington",
        "given": "S. F.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Cavalli",
        "given": "F.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Schwartz",
        "given": "L. H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Zucca",
        "given": "E.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Lister",
        "given": "T. A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "Alliance, Australasian Leukaemia and Lymphoma Group",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "Eastern Cooperative Oncology Group",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "European Mantle Cell Lymphoma Consortium",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "Italian Lymphoma Foundation",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "European Organisation for Research",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "Treatment of Cancer/Dutch Hemato-Oncology Group",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "Grupo Español de Médula Ósea",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "German High-Grade Lymphoma Study Group",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "German Hodgkin’s Study Group",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "Japanese Lymphorra Study Group",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "Lymphoma Study Association",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "NCIC Clinical Trials Group",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "Nordic Lymphoma Study Group",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "Southwest Oncology Group",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "literal": "United Kingdom National Cancer Research Institute",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Clinical Oncology",
    "issue": "27",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2014",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "3059-3068",
    "title": "Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification.",
    "type": "article-journal",
    "volume": "32",
  },
  Object {
    "DOI": "https://doi.org/10.1182/blood-2016-05-718528",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Cheson",
        "given": "B. D.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Ansell",
        "given": "S.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Schwartz",
        "given": "L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Gordon",
        "given": "L. I.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Advani",
        "given": "R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Jacene",
        "given": "H. A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Armand",
        "given": "P.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Blood",
    "issue": "21",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2016",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "2489-2496",
    "title": "Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy.",
    "type": "article-journal",
    "volume": "128",
  },
  Object {
    "DOI": "https://doi.org/10.1038/leu.2013.212",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kwong",
        "given": "Y. L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Pang",
        "given": "A. W.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Leung",
        "given": "A. Y.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Chim",
        "given": "C. S.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Tse",
        "given": "E.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Leukemia",
    "issue": "4",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2014",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "865-870",
    "title": "Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: Diagnostic and prognostic significance.",
    "type": "article-journal",
    "volume": "28",
  },
  Object {
    "DOI": "https://doi.org/10.1007/s00277-019-03762-3",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kwong",
        "given": "Y. L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Loong",
        "given": "F.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Khong",
        "given": "P. L.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Annals of Hematology",
    "issue": "10",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2019",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "2451-2455",
    "title": "Low-dose pembrolizumab re-treatment induced complete radiologic and molecular remission in Hodgkin lymphoma recurring from a previous relapse successfully treated by pembrolizumab.",
    "type": "article-journal",
    "volume": "98",
  },
  Object {
    "DOI": "https://doi.org/10.1007/s00277-019-03856-y",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Sim",
        "given": "J. P. Y.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Au-Yeung",
        "given": "R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kwong",
        "given": "Y. L.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Annals of Hematology",
    "issue": "2",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2020",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "385-388",
    "title": "Low-dose pembrolizumab induced complete radiologic and molecular response of posttransplant lymphoproliferative disorder presenting as classical Hodgkin lymphoma.",
    "type": "article-journal",
    "volume": "99",
  },
  Object {
    "DOI": "https://doi.org/10.1182/blood.2019000324",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Chen",
        "given": "R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Zinzani",
        "given": "P. L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Lee",
        "given": "H. J.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Armand",
        "given": "P.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Johnson",
        "given": "N. A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Brice",
        "given": "P.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Moskowitz",
        "given": "C. H.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Blood",
    "issue": "14",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2019",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1144-1153",
    "title": "Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.",
    "type": "article-journal",
    "volume": "134",
  },
  Object {
    "DOI": "https://doi.org/10.1016/S1470-2045(16)30167-X",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Younes",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Santoro",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Shipp",
        "given": "M.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Zinzani",
        "given": "P. L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Timmerman",
        "given": "J. M.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Ansell",
        "given": "S.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Engert",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "The Lancet. Oncology",
    "issue": "9",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2016",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1283-1294",
    "title": "Nivolumab for classical Hodgkin’s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: A multicentre, multicohort, single-arm phase 2 trial.",
    "type": "article-journal",
    "volume": "17",
  },
  Object {
    "DOI": "https://doi.org/10.1200/JCO.2017.76.0793",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Armand",
        "given": "P.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Engert",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Younes",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Fanale",
        "given": "M.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Santoro",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Zinzani",
        "given": "P. L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Ansell",
        "given": "S. M.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Clinical Oncology",
    "issue": "14",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2018",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1428-1439",
    "title": "Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.",
    "type": "article-journal",
    "volume": "36",
  },
  Object {
    "DOI": "https://doi.org/10.1182/blood-2017-09-772673",
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Shah",
        "given": "G. L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Moskowitz",
        "given": "C. H.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Blood",
    "issue": "15",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2018",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1689-1697",
    "title": "Transplant strategies in relapsed/refractory Hodgkin lymphoma.",
    "type": "article-journal",
    "volume": "131",
  },
]
`;

exports[`JATS importer parses JATS article without references and doesn't create empty references section 1`] = `
Array [
  Object {
    "_id": "MPManuscript:test",
    "acceptanceDate": 1590537600,
    "articleType": "other",
    "equationCount": 0,
    "figureCount": 3,
    "genericCounts": Array [
      Object {
        "count": 0,
        "countType": "box",
      },
    ],
    "objectType": "MPManuscript",
    "receiveDate": 1578528000,
    "referencesCount": 25,
    "tableCount": 2,
    "wordCount": 4484,
  },
  Object {
    "_id": "MPTitles:test",
    "objectType": "MPTitles",
    "runningTitle": "Blood pressure after stroke",
    "title": "Blood pressure after follow up in a stroke prevention
          clinic",
  },
  Object {
    "ISSNs": Array [
      Object {
        "ISSN": "2162-3279",
        "publicationType": "epub",
      },
    ],
    "_id": "MPJournal:test",
    "abbreviatedTitles": Array [
      Object {
        "abbrevType": "pubmed",
        "abbreviatedTitle": "Brain Behav.",
      },
    ],
    "journalIdentifiers": Array [
      Object {
        "journalID": "APA6",
        "journalIDType": "publisher-id",
      },
      Object {
        "journalID": "Brain Behav",
        "journalIDType": "nlm-ta",
      },
    ],
    "objectType": "MPJournal",
    "publisherName": "John Wiley and Sons",
    "title": "Brain and Behavior",
  },
  Object {
    "_id": "MPAuthorNotes:test",
    "containedObjectIDs": Array [
      "MPCorresponding:test",
      "MPFootnote:test",
      "MPFootnote:test",
    ],
    "objectType": "MPAuthorNotes",
  },
  Object {
    "_id": "MPFootnote:test",
    "contents": "
          <label>*</label>
          <p>Mai Bang Poulsen, MD, PhD Department of
            Neurology Nordsjællands Hospital Dyrehavevej
            29 3400 Hillerød Denmark</p>
        ",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPFootnote:test",
    "contents": "
          <p>ClinicalTrials.gov NCT03782857.</p>
        ",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "ORCIDIdentifier": "https://orcid.org/0000-0003-2217-5904",
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Hornnes",
      "given": "Agnete Hviid",
      "objectType": "MPBibliographicName",
    },
    "isCorresponding": true,
    "objectType": "MPContributor",
    "priority": 0,
    "role": "author",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Poulsen",
      "given": "Mai Bang",
      "objectType": "MPBibliographicName",
    },
    "footnote": Array [
      Object {
        "noteID": "MPFootnote:test",
        "noteLabel": "*",
      },
    ],
    "objectType": "MPContributor",
    "priority": 1,
    "role": "author",
  },
  Object {
    "_id": "MPAffiliation:test",
    "addressLine1": "Borgmester Ib Juuls Vej 1",
    "addressLine2": "2730
            Herlev",
    "country": "Denmark",
    "department": "Department of
          Neurology",
    "institution": "Herlev og Gentofte
          Hospital",
    "objectType": "MPAffiliation",
    "postCode": "2730",
    "priority": 0,
  },
  Object {
    "_id": "MPCorresponding:test",
    "contents": "Corresponding author: Agnete Hviid
          Hornnes 
          agnete.hviid.hornnes@regionh.dk FAX: 0045 3868
          4031",
    "objectType": "MPCorresponding",
  },
  Object {
    "_id": "MPKeywordsElement:test",
    "contents": "<div></div>",
    "elementType": "div",
    "objectType": "MPKeywordsElement",
  },
  Object {
    "_id": "MPKeywordGroup:test",
    "objectType": "MPKeywordGroup",
    "type": "author",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "secondary prevention",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "stroke recurrence",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "blood pressure",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "blood pressure target",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "randomized controlled trial",
    "objectType": "MPKeyword",
  },
  Object {
    "MIME": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
    "_id": "MPSupplement:test",
    "href": "attachment:7d9d686b-5488-44a5-a1c5-46351e7f9312",
    "objectType": "MPSupplement",
    "title": "final manuscript-hum-huili-dbh-suicide-20200707_figures (9)
          ",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:abstract",
    "elementIDs": Array [],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 1,
    "title": "Abstract",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 2,
    "title": "Objectives",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In Denmark 25% of hospital admissions with stroke are recurrent strokes. With thrombolytic treatment more patients survive with only minor disability. This promising development should be followed up by intensive secondary prevention. Hypertension is the most important target. We aimed at testing the hypotheses that early follow up in a preventive clinic would result in 1) A higher proportion of patients with blood pressure at target, 2) Time to stroke recurrence, myocardial infarction and death would be longer in the intervention group compared to controls.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:materials-method",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 3,
    "title": "Materials and Methods",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Eligible patients admitted to the stroke unit of Herlev Hospital were randomized shortly before discharge to intervention or control group. Of 78 included participants data from 73 was available for follow up nine months after inclusion. Patients in the intervention group were seen in the clinic within one week. In case of hypertension treatment was initiated or supplied with a new drug. We used individual targets for blood pressure according to diagnosis of stroke and patients’ comorbidity. Patients in the intervention group had a median of five visits to the preventive clinic.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:results",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 4,
    "title": "Results",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In the intervention group blood pressure was treated to target in 25 patients (69%) versus 14 (38%) in the control group ( <i>p</i> = 0.007). Median time to first event was 44 months (4–49) in the intervention group and 19 months (4–37) in controls ( <i>p</i> = 0.316).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:conclusions",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 5,
    "title": "Conclusions",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Treatment of hypertension to individual targets after stroke is feasible. It may postpone recurrent stroke and death in stroke survivors.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:introduction",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "label": "1",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 6,
    "title": "INTRODUCTION",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Over the last two decades continuous development of thrombolytic treatment of acute ischemic stroke (IS) has improved safety and functional outcome in treated patients <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0001 BRB3-2019-12-0787-bib-0002\\">1;2</span> thus increasing the possibility of survival with no or only minor disability. With this fact and the ongoing aging of populations in mind <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0003\\">3</span> the secondary prevention after stroke seems more important than ever. In 1998 the Copenhagen Stroke Study reported a recurrence rate of 23%. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0004\\">4</span> According to the Danish Stroke Registry our national recurrence rate was 25% in 2011. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0005\\">5</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Hypertension is an important risk factor for stroke recurrence. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0004 BRB3-2019-12-0787-bib-0006 BRB3-2019-12-0787-bib-0007 BRB3-2019-12-0787-bib-0008\\">4;6–8</span> Lowering blood pressure (BP) after stroke or transitory ischemic attack (TIA) by 10/5 mm Hg has been associated with reduced risk of stroke recurrence by 24% and myocardial infarction (MI) by 21%. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0009\\">9</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Observational studies have demonstrated the difficulties in lowering BP after stroke with rates of BP treated to target ranging from 28% to 73% <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0010 BRB3-2019-12-0787-bib-0011 BRB3-2019-12-0787-bib-0012 BRB3-2019-12-0787-bib-0013\\">10–13</span> and interventions aimed at control of BP after stroke have not yet found a successful model. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0014 BRB3-2019-12-0787-bib-0015 BRB3-2019-12-0787-bib-0016 BRB3-2019-12-0787-bib-0017 BRB3-2019-12-0787-bib-0018 BRB3-2019-12-0787-bib-0019\\">14–19</span> Fahey and coworkers have reviewed the literature aimed at improving control of BP in hypertensive subjects. One large study using an organized system of regular visits to a clinic was efficient in producing a large decrease in BP and reduction of all-cause mortality compared to referral to usual primary care. This was achieved by using a stepwise escalation of treatment until target was reached. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0020\\">20</span> Other methods had variable or no effect, only nurse or pharmacist led care seemed promising.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 7,
    "title": "Aims and hypotheses",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The aim of the present study was to test the hypotheses that follow up after stroke in a specialized nurse led physician supervised clinic with stepwise escalation of BP- and lipid lowering treatment would result in</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 8,
    "title": "Primary endpoint",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 9,
    "title": "A greater proportion of participants with BP at target",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Secondary endpoints: A greater reduction of BP A greater proportion of participants with LDL-cholesterol treated to target A greater reduction of LDL-cholesterol Longer time to recurrence of stroke, MI and death in the intervention group compared to controls</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:materials-method",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "label": "2",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 10,
    "title": "MATERIELS AND METHODS",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Before the initiation of the study the authors attended a three-day course in treatment of hypertension arranged by the Danish Society of Hypertension. The recommendations of our national guidelines regarding BP targets were in line with those given by the American Stroke Association in force at the time of initiation of the study: “An absolute target BP level and reduction are uncertain and should be individualized.” <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0021\\">21</span> Following the advice given by the Danish Society of Hypertension we used the following targets: A BP &lt; 140/90 mm Hg was considered at target in non-diabetic patients. In patients aged 80 years or more a BP of 150/90 mm Hg was acceptable if further treatment was not tolerated. In case of severe carotid stenosis or a history of ischemic heart disease BP should not be lower than 130/80 mm Hg. In patients with diabetes or hemorrhagic stroke we aimed at a BP &lt; 130/80 mm Hg. Untreated patients without hypertension were categorized as normotensive, untreated hypertensive patients as having unknown hypertension, treated patients without hypertension as treated to target, and treated patients with hypertension as having untreated hypertension.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">LDL-cholesterol should be &lt; 2.5 mmol/l in patients with IS or TIA in non-diabetic patients and in case of diabetes &lt; 2.0 mmol/l.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">A sample size calculation showed that 24 patients in each group were needed to show a difference of 10 mm Hg in the development of systolic BP (80% power).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "label": "2.1",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 11,
    "title": "Study sample and setting",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">From June 2012 to February 2013 all patients diagnosed with a stroke or TIA at the stroke unit of Herlev Gentofte Hospital, University of Copenhagen were considered for inclusion in the study. Patients should be without cognitive deficits that would prevent their active participation and they should be discharged to their own home. The last author used computer-generated block randomization procedures with stratification by hypertension (1:1). The allocation sequence was concealed, and we aimed at equal numbers in the two groups. Shortly before discharge the first author approached eligible patients for oral and written information about the study. Where written informed consent to participation was achieved BP was measured before a concealed envelope administered by a secretary was opened revealing the allocation to either intervention or control group.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The research protocol was approved by the ethics committee of the Capital Region of Denmark (H-3-2011–152) and by the Danish Data Protection Agency (2012–41-0429). The study was conducted according to all common ethical standards including the rules given by the Declaration of Helsinki. Patients randomized to the control group had the usual treatment: one visit in the outpatient clinic of the stroke unit three months after discharge. Patients randomized to the intervention group had an appointment with the first author within one week after discharge. The first author undertook all visits in the preventive clinic.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "label": "2.2",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 12,
    "title": "Procedures and intervention",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">BP was measured at every visit after at least five minutes rest in a sitting position in an arm chair. BP was measured simultaneously in both arms followed by two measurements with 10-min intervals using the arm with the highest systolic BP. In case of hypertension the first author would suggest initiation or intensification of antihypertensive treatment. The last author would accept or suggest an alternative and do the prescription. Patients would come to the clinic for control of BP and relevant blood tests every 3–4 weeks until BP was at target. After five weeks on lipid lowering drugs treatment was intensified if needed. Patients who did not tolerate lipid lowering medication were referred to a dietitian. In motivated patients home BP measurements were performed using patients’ own monitor or by lending patients a BP monitor between visits.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Patients in the intervention group had a mean of five visits to the clinic with addition of new drugs rather than adding more of the same drug in case of hypertension. Although we used minimum doses to prevent adverse effects, many patients had unacceptable side effects necessitating change to another class of antihypertensive drug.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Patients were informed about the importance of life-long adherence with all preventive medication. Those with elevated BP or receiving antihypertensive treatment were advised in salt reduction, smokers were advised to stop smoking and all patients were informed about the benefits of 30 min of moderate physical activity daily. Likewise, information about the risk of an intake of alcohol above seven drinks per week in women and 14 drinks in men was part of the program as well as the benefits of weight reduction in overweight patients with hypertension or diabetes.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "label": "2.3",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 13,
    "title": "Follow up",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Participants in both groups were invited to the usual follow up visit three months after discharge at the outpatient clinic of the stroke unit as well as a follow up visit in the study a median of 9 (IQR 8–11) months after inclusion.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In accordance with the protocol the final follow up visits were performed by nurses in the outpatient clinic with measurement of BP and blood-cholesterols. Patients were asked not to reveal their group allocation but blinding of the nurses was not possible. Patients were interviewed about adherence to all preventive medications as well as their present life style. For practical purposes a minority of visits were performed by the first author. To do intention to treat analyses  we used last observation carried forward regarding the endpoints of the study where patients had died or did not respond to the invitation to a follow up visit. Thus, we used the last recorded values in five patients in the intervention group and in seven controls.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">After a median of 65 months (IQR: 61–66) from inclusion data on vascular events and death were attained from the hospital based medical records covering all hospitals of the region.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "label": "2.4",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 14,
    "title": "Statistics",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Data were entered into Excel and imported into SAS. Statistical analyses  were performed by the first author according to a pre-established statistical analysis plan. We used Chi square test (for the primary outcome) or Fisher’s exact test as appropriate for comparison of proportions, and for change from baseline we used McNemar’s test. For continuous variables we used t-test or Mann-Whitney’s test*. Change from baseline was analyzed by the paired t-test or Wilcoxon signed rank sum test* (*where data were not normally distributed). We used SAS 9.4 for Windows and <i>p</i> &lt; 0.05 was considered significant.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:results",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPFigureElement:test",
      "MPTableElement:test",
      "MPParagraphElement:test",
      "MPFigureElement:test",
    ],
    "label": "3",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 15,
    "title": "RESULTS",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We included 78 patients in the study. Due to revision of stroke diagnoses in four participants and as one participant never turned up for the intervention, data on 73 participants were available for follow up ( <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure 1</b></span></span>). The median stay in hospital was 4 days (IQR: 3–6). As seen from <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span> most participants had no or slight disability.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">Flow chart of participants</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "FIGURE 1",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "contentType": "image/png",
    "objectType": "MPFigure",
    "src": "BRB3-2019-12-0787-fig-0001.PNG",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPTableElement:test",
    "caption": "",
    "containedObjectID": "MPTable:test",
    "elementType": "table",
    "listingID": "MPListing:test",
    "objectType": "MPTableElement",
    "tableElementFooterID": "MPTableElementFooter:test",
    "title": "Baseline characteristics of 73 patients",
  },
  Object {
    "_id": "MPTable:test",
    "contents": "<table xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPTableElement:test\\" class=\\"MPElement\\" data-contained-object-id=\\"MPTable:test\\"><colgroup><col width=\\"52.14%\\" /><col width=\\"11.92%\\" /><col width=\\"14.9%\\" /><col width=\\"13.1%\\" /><col width=\\"7.94%\\" /></colgroup><thead style=\\"display: table-header-group;\\"><tr><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\">Characteristics</th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\">All <br />( <i>n</i> = 73)</th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\">Intervention ( <i>n</i> = 36)</th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\">Control ( <i>n</i> = 37)</th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\">P</th></tr></thead><tbody><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\" style=\\"border-top: solid 0.50pt\\">Sex, female</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\">29 (40)</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\">15 (42)</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\">14 (38)</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\">0.74</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\">Age (years), mean ± SD</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\">66 ± 12</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\">63 ± 13</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\">68 ± 11</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\">0.08</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Length of education <br />&lt; 10 years <br />10 – 12 years <br />&gt; 12 years</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">12 (17) <br />22 (30) <br />38 (53)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">6 (17) <br />10 (29) <br />19 (54)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">6 (16) <br />12 (33) <br />19 (51)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.95</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Diagnosis of stroke <br />Ischemic Stroke <br />TIA <br />Hemorrhagic stroke</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">63 (87) <br />9 (12) <br />1 (1)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">33 (92) <br />3 (8)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">30 (81) <br />6 (16) <br />1 (3)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.60 <sup>a</sup></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Recurrent stroke</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">11 (15)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">5 (14)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">6 (16)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1.00 <sup>a</sup></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Modified Rankin Scale score &gt; 2</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">5 (6)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1 (3)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">4 (11)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.36 <sup>a</sup></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Antihypertensive medication before stroke</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">39 (53)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">15 (42)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">24 (65)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.047</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Antihypertensive medication at discharge</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">46 (63)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">20 (56)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">26 (70)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.19</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Cholesterol lowering medication before stroke</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">25 (34)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">11 (31)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">14 (38)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.51</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Cholesterol lowering medication at discharge</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">65 (89)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">35 (97)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">30 (81)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.03</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Diabetes at baseline</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">14 (19)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">5 (14)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">9 (24)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.37 <sup>a</sup></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Diabetes at discharge</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">16 (22)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">6 (17)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">10 (27)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.29</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Atrial fibrillation at baseline</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">7 (10)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">3 (8)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">4 (11)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1.00 <sup>a</sup></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Atrial fibrillation at discharge</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">12 (16)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">6 (16)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">6 (17)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1.00</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Unhealthy dieting <sup>b</sup></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">59 (82)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">25 (71)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">34 (92)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.03</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Current smoking</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">19 (26)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">11 (31)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">8 (22)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.62</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Alcohol above limits <sup>c</sup></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">23 (32)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">12 (34)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">11 (30)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.68</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Sedentary lifestyle <sup>d</sup></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">17 (24)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">9 (26)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">8 (22)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.68</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">BMI ≥ 25</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">46 (63)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">24 (67)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">22 (59)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.52</td></tr></tbody><tfoot style=\\"display: table-footer-group;\\"><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"border-bottom: solid 0.50pt\\">Self-rated health: fair, poor, or very poor</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">34 (47)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">15 (43)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">19 (51)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">0.47</td></tr></tfoot></table>",
    "objectType": "MPTable",
  },
  Object {
    "_id": "MPTableElementFooter:test",
    "containedObjectIDs": Array [
      "MPParagraphElement:test",
      "MPFootnotesElement:test",
    ],
    "objectType": "MPTableElementFooter",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Values are expressed as frequencies (%) or as mean ± standard deviations</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnotesOrder:test",
    "containedObjectID": "MPFootnotesElement:test",
    "footnotesList": Array [
      Object {
        "id": "MPFootnote:test",
        "index": 0,
      },
    ],
    "objectType": "MPFootnotesOrder",
  },
  Object {
    "_id": "MPFootnotesElement:test",
    "contents": "<div></div>",
    "elementType": "div",
    "objectType": "MPFootnotesElement",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\"><sup>a</sup></p><p id=\\"MPParagraphElement:test\\">Fisher’s exact test. <sup>b</sup> Less than 600 g of fruit and vegetables per day, fish for dinner less than twice per week. <sup>c</sup> More than 7 drinks per week in women/more than 14 drinks per week in men. <sup>d</sup> Less than 30 min of moderate physical activity per day.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\"><sup>a</sup></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Fisher’s exact test. <sup>b</sup> Less than 600 g of fruit and vegetables per day, fish for dinner less than twice per week. <sup>c</sup> More than 7 drinks per week in women/more than 14 drinks per week in men. <sup>d</sup> Less than 30 min of moderate physical activity per day.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Less than 20% of patients had a baseline BP treated to target ( <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure 2</b></span></span>). Twenty-eight patients (78%) in the intervention group and 29 patients (78%) in the control group had a 3-month visit in the outpatient clinic. Here 15 patients (42%) in the intervention group had their BP and blood cholesterol measured and so had 23 patients (62%) in the control group. At follow up patients in both groups reported a median of two visits including BP measurement at the general practitioner´s office since discharge from hospital.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">Blood pressure and treatment of hypertension at baseline in 73 patients (%)</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "FIGURE 2",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "contentType": "image/png",
    "objectType": "MPFigure",
    "src": "BRB3-2019-12-0787-fig-0002.PNG",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPFigureElement:test",
    ],
    "label": "3.1",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 16,
    "title": "Primary endpoint",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Follow up visits showed that 25 patients (69%) in the intervention group had a BP at target versus 14 (38%) of controls ( <i>p</i> = 0.007). In four patients (10%) in the intervention group antihypertensive medication remained unchanged since discharge versus 23 (62%) of controls ( <i>p</i> &lt; 0.0001) illustrated by the differences in BP treated to target as well as untreated hypertension in <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure 3</b></span></span>.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">Blood pressure and treatment of hypertension at follow up in 73 patients (%)</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "FIGURE 3",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "contentType": "image/png",
    "objectType": "MPFigure",
    "src": "BRB3-2019-12-0787-fig-0003.PNG",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPTableElement:test",
      "MPParagraphElement:test",
    ],
    "label": "3.2",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 17,
    "title": "Secondary endpoints",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Median reduction in systolic BP was 11 mm Hg (-5-19) with 14 mm Hg (IQR: 5–21) in the intervention group and 3 mm Hg (IQR -11-17) in the control group ( <i>p</i> = 0.045). Median reduction in diastolic BP was 2 mm Hg (-2-11) with 7 mm Hg (IQR -1-13) in the intervention group and 1 mm Hg (IQR -6-8) in the control group ( <i>p</i> = 0.04).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">There was no difference between the groups regarding LDL-cholesterol treated to target with 32 patients (89%) at target in the intervention group versus 29 patients (78%) in the control group ( <i>p</i> = 0.21). We found significant reductions in LDL-cholesterol in both groups, but no difference between the groups: 1.6 (IQR: 0.4–2.2) mmol/l in the intervention group versus 0.8 (IQR: 0.4–1.8) mmol/l among controls ( <i>p</i> = 0.18).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In 11 patients (31%) in the intervention group cholesterol lowering medication remained unchanged since discharge versus 29 (78%) of controls ( <i>p</i> &lt; 0.0001).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The combined endpoint of both BP and LDL-cholesterol at target was achieved in 22 (61%) of patients in the intervention group and in 10 patients (27%) in the control group ( <i>p</i> = 0.003). At the end of the study 24 patients (68%) in the intervention group measured their BP at home versus 14 (38%) of controls ( <i>p</i> = 0.03).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The only significant change in lifestyle was a reduction in current smokers by four in the control group ( <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 2</b></span></span>).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPTableElement:test",
    "caption": "",
    "containedObjectID": "MPTable:test",
    "elementType": "table",
    "listingID": "MPListing:test",
    "objectType": "MPTableElement",
    "tableElementFooterID": "MPTableElementFooter:test",
    "title": "Nine months follow up of 73 patients",
  },
  Object {
    "_id": "MPTable:test",
    "contents": "<table xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPTableElement:test\\" class=\\"MPElement\\" data-contained-object-id=\\"MPTable:test\\"><colgroup><col width=\\"52.91%\\" /><col width=\\"11.06%\\" /><col width=\\"14.16%\\" /><col width=\\"11.5%\\" /><col width=\\"10.37%\\" /></colgroup><thead style=\\"display: table-header-group;\\"><tr><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\">Characteristics</th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\">All <br />( <i>n</i> = 73)</th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\">Intervention <br />( <i>n</i> = 36)</th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\">Control <br />( <i>n</i> = 37)</th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\">P</th></tr></thead><tbody><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"border-top: solid 0.50pt\\">Systolic BP, mm Hg, mean ± SD</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\">134 ± 21</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\">130 ± 17</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\">137 ± 24</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-top: solid 0.50pt\\">0.12</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Diastolic BP, mm Hg, mean ± SD</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">78 ± 11</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">78 ± 10</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">78 ± 12.8)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.94</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Antihypertensive medication</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">55 (75)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">29 (81)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">26 (70)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.31</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">100% compliance with AHM ( <i>n</i> = 45)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">38 (84)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">23 (89)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">15 (79)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.38</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">LDL-cholesterol, mmol/l ( <i>n</i> = 72), mean ± SD</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1.9 ± 0.8</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">1.9 ± 0.7</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">2.0 ± 0.8</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.66</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Cholesterol lowering medication</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">64 (88)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">32 (89)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">32 (86)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.76</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">100% compliance with CLM ( <i>n</i> = 52)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">46 (89)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">24 (86)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">22 (92)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.50</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Unhealthy dieting <sup>b</sup></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">59 (81)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">26 (72)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">33 (89)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.76</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Current smoker</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">15 (21)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">11 (31)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">4 (11)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.046 <sup>a</sup></td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Alcohol &gt; limits <sup>c</sup></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">20 (27)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">11 (31)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">9 (24)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.55</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Sedentary lifestyle <sup>d</sup></td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">16 (22)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">7 (20)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">9 (24)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\">0.66</td></tr></tbody><tfoot style=\\"display: table-footer-group;\\"><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"border-bottom: solid 0.50pt\\">BMI ≥ 25</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">43 (59)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">21 (58)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">22 (60)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" style=\\"border-bottom: solid 0.50pt\\">0.92</td></tr></tfoot></table>",
    "objectType": "MPTable",
  },
  Object {
    "_id": "MPTableElementFooter:test",
    "containedObjectIDs": Array [
      "MPParagraphElement:test",
      "MPFootnotesElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPTableElementFooter",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Values are expressed as frequencies (%) or as mean ± standard deviations. Abbreviations: AHM, antihypertensive medication; CLM, cholesterol lowering medication.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnotesOrder:test",
    "containedObjectID": "MPFootnotesElement:test",
    "footnotesList": Array [
      Object {
        "id": "MPFootnote:test",
        "index": 0,
      },
    ],
    "objectType": "MPFootnotesOrder",
  },
  Object {
    "_id": "MPFootnotesElement:test",
    "contents": "<div></div>",
    "elementType": "div",
    "objectType": "MPFootnotesElement",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\"><sup>a</sup></p><p id=\\"MPParagraphElement:test\\">Fisher’s exact test. <sup>b</sup> Less than 600 g of fruit and vegetables per day, fish for dinner less than twice per week. <sup>c</sup> More than 7 drinks per week in women/more than 14 drinks per week in men. <sup>d</sup> Less than 30 min of moderate physical activity per day.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\"><sup>a</sup></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Fisher’s exact test. <sup>b</sup> Less than 600 g of fruit and vegetables per day, fish for dinner less than twice per week. <sup>c</sup> More than 7 drinks per week in women/more than 14 drinks per week in men. <sup>d</sup> Less than 30 min of moderate physical activity per day.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\"></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Regarding vascular complications and death, we found 32 events in 22 patients after a median of 65 months. Median time to first event was 26 months (IQR: 4–49) with a median of 44 months (IQR: 11–49) in the intervention group and 19 months (IQR: 4–37) in the control group ( <i>p</i> = 0.32). All in all, we found 11 events in nine patients in the intervention group: two recurrent strokes, three cases of TIA, and six patients died versus 21 events in 13 patients in the control group: seven recurrent strokes, five cases of TIA, one MI, and seven patients died ( <i>p</i> = 0.49).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:discussion",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "label": "4",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 18,
    "title": "DISCUSSION",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In this randomized clinical trial, a larger proportion of patients in the intervention group compared to controls had BP within the above-mentioned limits and the study fulfilled the aim of the primary endpoint.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">A systematic review of interventions aimed at modifiable risk factor control for secondary prevention of stroke revealed improvement in achieving BP target. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0022\\">22</span> However, as opposed to our study the review showed no significant change in systolic og diastolic BP.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In a study of integrated care with five prearranged visits to patients’ general practitioner versus usual care systolic BP at target set to 140 mm Hg was found in 75% versus 58% at 12-month follow up. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0019\\">19</span> We set individual targets for BP according to patients’ type of stroke, comorbidities and age. This is well in line with recommendations given by European Society of Hypertension, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0023\\">23</span> but as stated by Boan et al., not quite in accordance with international stroke guidelines. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0024\\">24</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In a study where patients with minor stroke were randomized to six clinic visits by a pharmacist (intervention) or by a nurse (active control) aiming at treating both BP and LDL-cholesterol to target, 43% of patients in the pharmacist-led clinic met those two targets and so did 31% in the nurse-led clinic. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0025\\">25</span> In our study this combined endpoint was met in 22 (61%) of patients in the intervention group. Regarding BP in control 80% of patients in the pharmacist led clinic had systolic BP in control after six months versus 90% in the nurse led clinic. This is a far greater proportion than the 69% in our study. However, almost two thirds of patients had a baseline BP within the limits. The opposite was the case in our study with two thirds presenting with elevated BP. Both studies show that a dedicated follow up with stepwise escalation of preventive medication may be the way to reach the targets of the two important risk factors for recurrent stroke. In both studies five-six visits were needed, which is far beyond our usual treatment. However, despite visits to the outpatient clinic as well as to the general practitioner the proportion of patients with unchanged medication since discharge in the control group illustrate the necessity of frequent visits to a dedicated preventive facility. Considering the preventive effect of BP lowering, and - though insignificant - the difference in time to first event as well as the smaller proportion of events in the intervention group as found in our study, it may be well worth the time and resources for patients, their relatives and society.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "label": "4.1",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 19,
    "title": "Strengths and limitations",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Our study has some limitations. Most participants had a minor stroke and patients had to be independent and without severe cognitive deficits, which is not representative of a general stroke population. With only 73 participants caution is called for in the drawing of conclusions from the results. Nonetheless, we decided to reorganize the outpatient clinic of our stroke unit as of October 2014 implementing strategies of the present study.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The strength of the study is the individual target for BP taking into account the diagnosis of stroke as well as important comorbidity as recommended by Boan et al. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0024\\">24</span> Five-year follow up on vascular complications and death is another important advantage.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:conclusions",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "label": "5",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 20,
    "title": "CONCLUSIONS",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In conclusion, the feasibility study has demonstrated that timely follow up of stroke patients in a dedicated preventive outpatient clinic may result in BP and cholesterol treated to target in most patients. To some extent it may postpone time to stroke recurrence, MI and death.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:availability",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 21,
    "title": "DATA AVAILABILITY",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The data that support the findings of this study are not available due to national privacy or ethical restrictions.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:con",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 22,
    "title": "Contributor Information",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Agnete Hviid Hornnes, Email: agnete.hviid.hornnes@regionh.dk <a href=\\"https://orcid.org/0000-0003-2217-5904\\">https//orcid.org/0000-0003-2217-5904</a> Mai Bang Poulsen, Email: mai.bang.poulsen.02@regionh.dk</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Both authors have made substantial contributions to conception and design and acquisitions and analyses  and interpretation of data and have; and been involved in writing the manuscript and given final approval of the version to be published. Both authors have participated sufficiently in the work to take public responsibility for the content; and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:competing-interests",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 23,
    "title": "CONFLICT OF INTEREST",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">None.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:acknowledgement",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 24,
    "title": "ACKNOWLEDGMENTS",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">None. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"BRB3-2019-12-0787-bib-0021\\">21</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPFigureElement",
    "elements": Array [
      "MPFigureElement:test",
      "MPFigureElement:test",
      "MPFigureElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPTableElement",
    "elements": Array [
      "MPTableElement:test",
      "MPTableElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPCommentAnnotation:test",
    "contents": "Check meaning - US English uses different spellings for the noun &quot;analyses&quot; (more than one analysis) and the verb form &quot;analyzes&quot;",
    "contributions": Array [
      Object {
        "_id": "MPContribution:test",
        "objectType": "MPContribution",
        "profileID": "MPUserProfile:test",
        "timestamp": 1111111111,
      },
    ],
    "objectType": "MPCommentAnnotation",
    "selector": Object {
      "from": 638,
      "to": 638,
    },
    "target": "MPParagraphElement:test",
  },
  Object {
    "_id": "MPCommentAnnotation:test",
    "contents": "Check meaning - US English uses different spellings for the noun &quot;analyses&quot; (more than one analysis) and the verb form &quot;analyzes&quot;",
    "contributions": Array [
      Object {
        "_id": "MPContribution:test",
        "objectType": "MPContribution",
        "profileID": "MPUserProfile:test",
        "timestamp": 1111111111,
      },
    ],
    "objectType": "MPCommentAnnotation",
    "selector": Object {
      "from": 230,
      "to": 230,
    },
    "target": "MPParagraphElement:test",
  },
  Object {
    "_id": "MPCommentAnnotation:test",
    "contents": "Check meaning - US English uses different spellings for the noun &quot;analyses&quot; (more than one analysis) and the verb form &quot;analyzes&quot;",
    "contributions": Array [
      Object {
        "_id": "MPContribution:test",
        "objectType": "MPContribution",
        "profileID": "MPUserProfile:test",
        "timestamp": 1111111111,
      },
    ],
    "objectType": "MPCommentAnnotation",
    "selector": Object {
      "from": 261,
      "to": 261,
    },
    "target": "MPParagraphElement:test",
  },
]
`;

exports[`JATS importer parses JATS front only example to Manuscripts models 1`] = `
Array [
  Object {
    "_id": "MPManuscript:test",
    "articleType": "other",
    "equationCount": 0,
    "figureCount": 0,
    "genericCounts": Array [
      Object {
        "count": 0,
        "countType": "box",
      },
    ],
    "objectType": "MPManuscript",
    "referencesCount": 2,
    "tableCount": 0,
    "wordCount": 2910,
  },
  Object {
    "_id": "MPTitles:test",
    "objectType": "MPTitles",
    "title": "A complete manuscript",
  },
  Object {
    "ISSNs": Array [],
    "_id": "MPJournal:test",
    "abbreviatedTitles": Array [],
    "journalIdentifiers": Array [],
    "objectType": "MPJournal",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "User",
      "given": "Developer",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 0,
    "role": "author",
  },
]
`;

exports[`JATS importer parses full JATS example to Manuscripts models 1`] = `
Array [
  Object {
    "_id": "MPManuscript:test",
    "acceptanceDate": 899683200,
    "articleType": "research-article",
    "objectType": "MPManuscript",
    "receiveDate": 886636800,
    "revisionReceiveDate": 898646400,
    "revisionRequestDate": 892512000,
  },
  Object {
    "_id": "MPTitles:test",
    "objectType": "MPTitles",
    "title": "WHEN ELECTIONS FAIL TO RESOLVE UNCERTAINTY: THE CASE OF THE 2016 U.S. <b>PRESIDENTIAL ELECTION</b>",
  },
  Object {
    "ISSNs": Array [
      Object {
        "ISSN": "1878-108X",
      },
    ],
    "_id": "MPJournal:test",
    "abbreviatedTitles": Array [
      Object {
        "abbrevType": "pubmed",
        "abbreviatedTitle": "NLM-Export",
      },
    ],
    "journalIdentifiers": Array [
      Object {
        "journalID": "NLM-Export",
        "journalIDType": "publisher-id",
      },
      Object {
        "journalID": "NLM-Export",
        "journalIDType": "nlm-ta",
      },
    ],
    "objectType": "MPJournal",
    "publisherName": "Inera",
    "title": "NLM-Export",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Cox",
      "given": "Justin",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 0,
    "role": "author",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [
      "MPAffiliation:test",
    ],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "Griffith",
      "given": "Todd",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 1,
    "role": "author",
  },
  Object {
    "_id": "MPAffiliation:test",
    "institution": "",
    "objectType": "MPAffiliation",
    "priority": 0,
  },
  Object {
    "_id": "MPAffiliation:test",
    "institution": "",
    "objectType": "MPAffiliation",
    "priority": 1,
  },
  Object {
    "_id": "MPKeywordsElement:test",
    "contents": "<div></div>",
    "elementType": "div",
    "objectType": "MPKeywordsElement",
  },
  Object {
    "_id": "MPKeywordGroup:test",
    "objectType": "MPKeywordGroup",
    "type": "author",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "D80",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "G00",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "G12",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPKeyword:test",
    "containedGroup": "MPKeywordGroup:test",
    "name": "G14",
    "objectType": "MPKeyword",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:abstract",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 1,
    "title": "Abstract",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In this article, we examine whether certain political election outcomes create, rather than resolve, uncertainty in financial markets. We posit that the uncertainty associated with unanticipated election outcomes is not resolved before or on the election dates. To test this claim, we use the surprise outcome of the 2016 U.S. presidential election and two previous U.S. presidential elections as benchmarks. In contrast to prior elections, we find that the 2016 U.S. presidential election outcome did not resolve market uncertainty. Specifically, we show significant increases in transactions costs, adverse selection costs, and volatility in the days following the election date. We contribute to the literature by suggesting that unexpected elections can engender, rather than resolve, market uncertainty.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:introduction",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPFigureElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "label": "I",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 2,
    "title": "Introduction",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Do political elections resolve financial market uncertainty? This study examines precise measures of stock liquidity surrounding the 2016 U.S. presidential election. First, we investigate whether market liquidity changes in anticipation of the election outcome. Second, we analyze whether the election outcome resolved uncertainty, resulting in better market liquidity and less adverse selection risk. Third, we examine the effect of election uncertainty on systematic and idiosyncratic volatility. Fourth, we examine whether election uncertainty induced greater informational asymmetries across various stock characteristics and for stocks in politically sensitive industries.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We contend that not all election outcomes are created equal and that the 2016 U.S. presidential election engendered, rather than resolved, financial market uncertainty. This became apparent as media outlets reported Donald Trump’s victory late Tuesday night, November 8, 2016, and Dow futures dropped almost 900 points and the S&amp;P 500 lost nearly 5% that same evening.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">1</span><sup>,</sup><span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">2</span> We use the 2012 U.S. presidential election as a benchmark, as the outcome of that election appears to have been known in the weeks leading up to the election date, which is clearly not the case for the 2016 election.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">3</span> <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure I</b></span></span> provides a time-series depiction of the daily Iowa Election Markets (IEM) winner-takes-all probabilities for both the Democratic and Republican candidates during the 2012 and 2016 election campaigns.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">4</span> Panel A shows that the Democratic candidate led the Republican candidate throughout the 2016 election cycle, with the gap widening in the final three months before the election date, but failed to win the election. Panel B shows that the Democratic candidate led the Republican candidate for the entire final year of the 2012 election cycle, and eventually was voted into the presidential office. Thus, voter expectations during the 2012 election campaign were more consistent with the eventual result relative to the 2016 election.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><b>Iowa Election Markets Winner Takes All.</b> The figure displays the daily results of the Iowa Election Markets winner takes all (WTA) for both the 2012 and 2016 U.S. presidential elections (available at <u><a href=\\"https://iemweb.biz.uiowa.edu/closed/\\">https://iemweb.biz.uiowa.edu/closed/</a>)</u>. [Color figure can be viewed at wileyonlinelibrary.com.]</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">A. 2016 U.S. Presidential Election</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">B. 2012 U.S. Presidential Election</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "Figure I",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image001",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image002",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">To the extent that election uncertainty affects market conditions, we focus on an extended event window that accounts for the various stages of the political process. Pantzalis, Strangeland, and Turtle (2000) argue that market participants incorporate both news and political information into prices in anticipation of election outcomes in three stages. In the first stage, market participants weigh potential policy changes before the election event. In the second stage, market participants use available sources to continually update their expectations about the future political outcome. In the final stage as election outcomes become certain, market participants update their previous probability distributions of not only the policies to be implemented but also the long-term economic response to these policies. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Brown, Harlow, and Tinic (1988)</span> argue that as election uncertainty resolves, market uncertainty reduces, resulting in positive price changes.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Although several studies offer evidence related to the timing of this resolution of uncertainty, no consensus exists. A host of studies suggest that uncertainty is resolved before the voting date. Pantzalis, Strangeland, and Turtle (2000) contend that uncertainty may resolve well before the actual election date, showing that much of the market uncertainty is resolved in the weeks leading up to the election. Similarly, Santa-Clara and Valkanov (2003) find no evidence that returns are driven by uncertainty surrounding elections but instead find that market prices incorporate information about a new presidency gradually during the period before the election, with minimal political uncertainty left for the election day. Pasquareillo and Zafeiridou (2014) explore nearly 20 U.S. presidential elections, finding that market liquidity worsens before the election event, only to improve in the subsequent months. This suggests that even if uncertainty is not resolved before the election date, the election itself serves as the resolution mechanism of any residual uncertainty.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Other studies document that election outcomes may create uncertainty in financial markets. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Gemmill (1992)</span> shows that inefficiencies associated with opinion polls for the British parliamentary election of 1987 resulted in a speculative bubble in the options market. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Nippani and Medlin (2002)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Nippani and Arize (2005)</span>, and <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">He et al. (2009)</span> all show that the uncertainty associated with the 2000 U.S. presidential election served as a catalyst for uncertainty in financial markets. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Li and Born (2006)</span> use a 40-year sample period covering multiple U.S. presidential elections, finding that when election uncertainty increases via candidate preference polling numbers, both stock market volatility and returns increase. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Białkowski, Gottschalk, and Wisniewski (2008)</span> use international data across 27 Organization for Economic Co-operation and Development (OECD) countries and provide evidence that stock market volatility nearly doubles during election week, which they attribute to the surprise outcomes of national elections. Finally, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Goodell and Vähämaa (2013)</span> show that the presidential election process creates rather than alleviates market concerns, forcing investors to reform their expectations about future economic policy.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The uncertainty associated with an election outcome can affect market liquidity through three channels: information asymmetry, ambiguity, and disagreement. The information asymmetry channel argues that political events widen the information gap between informed and uninformed investors, which increases the implementation shortfall in financial markets. This gap is likely to widen just before the political outcome when uncertainty is at its highest, increasing the adverse selection risk between informed and uninformed participants. The resulting higher adverse selection risk may increase the costs of market making, resulting in higher spreads and greater volatility (see <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Ho and Stoll 1981</span>; <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Kyle 1985</span>; <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Amihud and Mendelson 1986</span>). Once the election outcome is certain, informational asymmetries reduce, and market liquidity improves. The ambiguity channel assumes that uncertainty, regardless of the political component, reduces the consensus belief about liquidity information in the market.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">5</span> Thus, as fundamental information becomes inaccurate because of increased uncertainty, market participants may avoid trading altogether to evade adverse selection risk. As participants withdraw from the market, both trading volume and market liquidity decline. However, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Pasquariello and Zafeiridou (2014)</span> argue that once the election outcome is determined, the ambiguity associated with the quality of information reduces, resulting in improved liquidity conditions. Finally, the disagreement channel asserts that a lack of consensus about the fundamental value of an asset enhances the incentive to trade and, therefore, improves market liquidity. This follows from the premise that increases in the divergence of opinions among market participants results in more trading during periods of high uncertainty (i.e., before the election). Once the election outcome is known and uncertainty reduces, trading volume and liquidity decline.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">6</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We contend that the unexpected outcome of the 2016 election likely increased information asymmetries among market participants.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">7</span> Consistent with the information asymmetry argument, we predict that the surprise outcome of the 2016 election reduced financial market liquidity, defined as the ability to trade a large quantity of securities quickly, at a low cost, and without substantially moving prices (see <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Pástor and Stambaugh 2003</span>). Specifically, we expect to observe higher quoted and effective spreads (<span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Ho and Stoll, 1981</span>) and greater price impacts (<span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Easley and O’Hara 1987</span>) following the 2016 election. We also expect stock prices to fluctuate more as investors alter their expectations around unanticipated policy changes (see <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Pástor and Veronesi 2012</span>).<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">8</span><sup>,</sup><span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">9</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">The results from our empirical analysis indicate that the outcome of the 2016 election engendered more uncertainty than the 2012 election, resulting in deteriorating liquidity.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">10</span> We find that transactions costs, measured by quoted and effective spreads, increased considerably following the 2016 election, relative to the 2012 election. Furthermore, our results indicate that the higher transactions costs associated with the 2016 election persisted for nearly two months following the outcome. We find similar results when analyzing the effects of the 2016 election on measures of adverse selection costs. In fact, both the price impact component of the bid–ask spread and <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Amihud’s (2002)</span> illiquidity increased significantly following the 2016 election, relative to the 2012 election. Additionally, we find that total, systematic, and idiosyncratic volatility increased substantially following the 2016 election. Although systematic volatility subsided four weeks after the 2016 election, idiosyncratic volatility continued to increase.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In our next set of tests, we attempt to identify the economic channels through which election uncertainty creates market illiquidity. We find differential effects across stock characteristics around the 2016 election. More infrequently traded and small-cap securities experienced the greatest illiquidity shock following the 2016 election, relative to the 2012 election. We also document that stocks within politically sensitive industries (e.g. healthcare, pharmaceutical, banking, trading, natural gas, defense, and tobacco) experienced more adverse liquidity effects after the 2016 election. The latter finding is consistent with studies showing that firms in politically sensitive industries are more exposed to higher political uncertainty (see Boutchkova, Doshi, and Durnev 2011; <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Julio and Yook 2012</span>; <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Hong and Kostovetsky 2012</span>).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Our article contributes to the literature linking political uncertainty and financial market outcomes in the following ways.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">11</span> First, our analysis differs from previous studies (Pantzalis, Strangeland, and Turtle 2000; Santa-Clara and Valkanov 2003; Pasqauriello and Zafeiridou 2014) in that we contend that not all election outcomes are known in advance and that certain elections may create, rather than reduce, uncertainty. Using the 2004 and 2012 elections as benchmarks, we detail that the uncertainty associated with the 2016 election resulted in greater illiquidity and worsened trading conditions for market participants. Second, in contrast to <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Pasquariello and Zafeiridou (2014)</span>, who examine the effects of election uncertainty on market liquidity using monthly data, we use more precise measurements of stock liquidity based on intraday New York Stock Exchange (NYSE) Trade and Quote (TAQ) files. Finally, we argue that our empirical design and analysis provide inferences from pinpointing the economic channel through which election uncertainty affects market liquidity. Specifically, our findings support the information asymmetry channel, but not the disagreement channel, as illiquidity after the 2016 election persisted for several weeks and stocks more exposed to information asymmetries (i.e. infrequently traded small-cap stocks in politically sensitive industries) experienced the most significant decrease in liquidity. Overall, our findings provide evidence that uncertainty is not necessarily resolved before the political event, or on the political event day itself, and that unanticipated political outcomes can be detrimental to financial market liquidity.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [],
    "label": "II",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 3,
    "title": "Measures of Liquidity and Data Description",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPEquationElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPEquationElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPEquationElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 4,
    "title": "Measuring Liquidity",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We follow <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Holden and Jacobsen (2014)</span> and analyze standard measures of market liquidity. First, we evaluate the quoted bid–ask spread, which is the difference between the prices quoted for an immediate sale and an immediate buy for one share of stock. For a given time interval <i>t</i>, the percent quoted spread is measured as</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPEquationElement:test",
    "containedObjectID": "eq1",
    "elementType": "div",
    "label": "(1)",
    "objectType": "MPEquationElement",
  },
  Object {
    "_id": "eq1",
    "contents": "<mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m1\\">
          <mml:mrow>
            <mml:mi>P</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo> </mml:mo><mml:mi>Q</mml:mi><mml:mi>u</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mo> </mml:mo><mml:mi>S</mml:mi><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mo> </mml:mo><mml:mfrac>
            <mml:mrow>
              <mml:mi>A</mml:mi><mml:mi>s</mml:mi><mml:msub>
              <mml:mi>k</mml:mi>
              <mml:mi>t</mml:mi>
            </mml:msub>
              <mml:mo>−</mml:mo><mml:mi>B</mml:mi><mml:mi>i</mml:mi><mml:msub>
              <mml:mi>d</mml:mi>
              <mml:mi>t</mml:mi>
            </mml:msub>
            </mml:mrow>
            <mml:mrow>
              <mml:msub>
                <mml:mi>M</mml:mi>
                <mml:mi>t</mml:mi>
              </mml:msub>
            </mml:mrow>
          </mml:mfrac>
          </mml:mrow>
        </mml:math>",
    "format": "mathml",
    "objectType": "MPEquation",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">where <i>Ask<sub>t</sub></i> is the National Best Ask and <i>Bid<sub>t</sub></i> is the National Best Bid assigned to time <i>t</i> and <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m2\\">
          <mml:mrow>
            <mml:msub>
              <mml:mi>M</mml:mi>
              <mml:mi>t</mml:mi>
            </mml:msub>
          </mml:mrow>
        </mml:math></span> is the midpoint, which is the average of <i>Ask<sub>t</sub></i> and <i>Bid<sub>t</sub></i>.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">To more accurately measure the round-trip trading costs when trades occur at prices inside the posted bid and ask quotes, we estimate the effective spread. For a given security, the percent effective spread on the <i>k</i>th trade is defined as</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPEquationElement:test",
    "containedObjectID": "eq2",
    "elementType": "div",
    "label": "(2)",
    "objectType": "MPEquationElement",
  },
  Object {
    "_id": "eq2",
    "contents": "<mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m3\\">
          <mml:mrow>
            <mml:mi>P</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo> </mml:mo><mml:mi>E</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mo> </mml:mo><mml:mi>S</mml:mi><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mi>k</mml:mi>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mo> </mml:mo><mml:mfrac>
            <mml:mrow>
              <mml:mn>2</mml:mn><mml:msub>
              <mml:mi>D</mml:mi>
              <mml:mi>k</mml:mi>
            </mml:msub>
              <mml:mfenced>
                <mml:mrow>
                  <mml:msub>
                    <mml:mi>P</mml:mi>
                    <mml:mi>k</mml:mi>
                  </mml:msub>
                  <mml:mo>−</mml:mo><mml:msub>
                  <mml:mi>M</mml:mi>
                  <mml:mi>k</mml:mi>
                </mml:msub>
                </mml:mrow>
              </mml:mfenced></mml:mrow>
            <mml:mrow>
              <mml:msub>
                <mml:mi>M</mml:mi>
                <mml:mi>k</mml:mi>
              </mml:msub>
            </mml:mrow>
          </mml:mfrac>
            <mml:mo> </mml:mo><mml:mo>,</mml:mo></mml:mrow>
        </mml:math>",
    "format": "mathml",
    "objectType": "MPEquation",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">where <i>D<sub>k</sub></i> is an indicator variable that equals +1 if the <i>k</i>th trade is a buy and −1 if the <i>k</i>th trade is a sell, <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m4\\">
          <mml:mi>P</mml:mi>
        </mml:math></span><i><sub>k</sub></i> is the price of the <i>k</i>th trade, and <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m5\\">
          <mml:mi>M</mml:mi>
        </mml:math></span><i><sub>k</sub></i> is the midpoint of the National Best Bid and Offer (NBBO) quotes assigned to the <i>k</i>th trade. We use the <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Lee and Ready (1991)</span> algorithm to determine whether a given trade is a buy or sell. Under this convention, a trade is a buy when <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m6\\">
          <mml:mrow>
            <mml:msub>
              <mml:mi>P</mml:mi>
              <mml:mi>k</mml:mi>
            </mml:msub>
          </mml:mrow>
        </mml:math></span> &gt; <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m7\\">
          <mml:mrow>
            <mml:msub>
              <mml:mi>M</mml:mi>
              <mml:mi>k</mml:mi>
            </mml:msub>
          </mml:mrow>
        </mml:math></span>, a sell when <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m8\\">
          <mml:mrow>
            <mml:msub>
              <mml:mi>P</mml:mi>
              <mml:mi>k</mml:mi>
            </mml:msub>
          </mml:mrow>
        </mml:math></span> &lt; <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m9\\">
          <mml:mrow>
            <mml:msub>
              <mml:mi>M</mml:mi>
              <mml:mi>k</mml:mi>
            </mml:msub>
          </mml:mrow>
        </mml:math></span>, and the tick test is used when <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m10\\">
          <mml:mrow>
            <mml:msub>
              <mml:mi>P</mml:mi>
              <mml:mi>k</mml:mi>
            </mml:msub>
          </mml:mrow>
        </mml:math></span> = <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m11\\">
          <mml:mrow>
            <mml:msub>
              <mml:mi>M</mml:mi>
              <mml:mi>k</mml:mi>
            </mml:msub>
          </mml:mrow>
        </mml:math></span>. The tick test determines a trade is a buy (sell) if the most recent prior trade at a different price was at a lower (higher) price.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">To measure the adverse selection component of the bid–ask spread, we calculate price impact. For a given security, the percent price impact on the <i>k</i>th trade are defined as</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPEquationElement:test",
    "containedObjectID": "eq3",
    "elementType": "div",
    "label": "(3)",
    "objectType": "MPEquationElement",
  },
  Object {
    "_id": "eq3",
    "contents": "<mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m12\\">
          <mml:mrow>
            <mml:mi>P</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo> </mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mo> </mml:mo><mml:mi>I</mml:mi><mml:mi>m</mml:mi><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:msub>
            <mml:mi>t</mml:mi>
            <mml:mi>k</mml:mi>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mo> </mml:mo><mml:mfrac>
            <mml:mrow>
              <mml:mn>2</mml:mn><mml:msub>
              <mml:mi>D</mml:mi>
              <mml:mi>k</mml:mi>
            </mml:msub>
              <mml:mfenced>
                <mml:mrow>
                  <mml:msub>
                    <mml:mi>M</mml:mi>
                    <mml:mrow>
                      <mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mn>5</mml:mn></mml:mrow>
                  </mml:msub>
                  <mml:mo>−</mml:mo><mml:msub>
                  <mml:mi>M</mml:mi>
                  <mml:mi>k</mml:mi>
                </mml:msub>
                </mml:mrow>
              </mml:mfenced></mml:mrow>
            <mml:mrow>
              <mml:msub>
                <mml:mi>M</mml:mi>
                <mml:mi>k</mml:mi>
              </mml:msub>
            </mml:mrow>
          </mml:mfrac>
            <mml:mo> </mml:mo><mml:mo>,</mml:mo></mml:mrow>
        </mml:math>",
    "format": "mathml",
    "objectType": "MPEquation",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">where <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m13\\">
          <mml:mrow>
            <mml:msub>
              <mml:mi>M</mml:mi>
              <mml:mi>k</mml:mi>
            </mml:msub>
          </mml:mrow>
        </mml:math></span> is the midpoint of the NBBO quotes assigned to the <i>k</i>th trade, <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m14\\">
          <mml:mrow>
            <mml:msub>
              <mml:mi>M</mml:mi>
              <mml:mrow>
                <mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mn>5</mml:mn></mml:mrow>
            </mml:msub>
            <mml:mo> </mml:mo></mml:mrow>
        </mml:math></span>is the midpoint five minutes after the <i>k</i>th trade, and <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m15\\">
          <mml:mrow>
            <mml:msub>
              <mml:mi>D</mml:mi>
              <mml:mi>k</mml:mi>
            </mml:msub>
          </mml:mrow>
        </mml:math></span> is an indicator variable that equals +1 if the <i>k</i>th trade is a buy and −1 if the <i>k</i>th trade is a sell.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">12</span> A low-frequency proxy of price impact often used in the literature is <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Amihud (2002)</span> illiquidity, which is defined as the absolute daily return divided by dollar volume, scaled by 10<sup>6</sup>, where larger values indicate greater illiquidity.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Finally, we estimate three measures of stock volatility: total, systematic, and idiosyncratic. Total volatility is the 30-day rolling standard deviation of daily stock returns. Systematic volatility is the 30-day rolling beta coefficient estimated from the capital asset pricing model (CAPM) using Center for Research in Security Prices (CRSP) value-weighted market returns. Idiosyncratic volatility is the 30-day rolling standard deviation of the residuals obtained from the CAPM.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPTableElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 5,
    "title": "Data Description",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">To examine the effects of both the 2012 and 2016 U.S. presidential elections on financial market liquidity, we obtain NYSE TAQ files for the 121 days (90 days before and 31 days after) surrounding the election dates. These data include all trades and quotes for all issues traded on NYSE, NASDAQ, and regional exchanges. We calculate the NBBO in accordance with <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Holden and Jacobsen (2014)</span>, who account for most of the official NBBO quotes from the Securities Industries Processors.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">13</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We make the following adjustments to the initial sample. We retain quotes between 9:00 a.m. and 4:00 p.m. to observe all trades during regular trading hours 9:30 a.m. and 4:00 p.m. For each exchange, or market maker, we delete instances where the bid price of one exchange is greater than or equal to the ask price of the same exchange (i.e., crossed quotes). We remove quotes with non-normal conditions and when the bid/ask price or bid/ask size is equal to zero or missing. We merge the TAQ data with closing prices and shares outstanding from CRSP and retain only common stocks (i.e., share codes 10 and 11). We also require the stock to have a closing price greater than $5 with nonzero trading volume.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">14</span> To reduce the influence of outliers and potential data errors, we winsorize the market liquidity measures at the 5th and 95th percentile levels of their distributions.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\"><span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span> displays summary statistics for the market liquidity measures, along with stock and trade characteristics for the sample before the 2012 and 2016 elections. The event window for the summary statistics is [−90,−10], which allows us to control for liquidity changes at various stages of the political process and potential illiquidity run-up in the 10 days before the elections. Our sample consists of 3,042 unique stocks around the 2012 election and 3,106 unique stocks around the 2016 election.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">15</span> In Panel A, we report that the average percentage quoted and effective spreads for the sample of stocks in the days before the 2012 election are 52.55 and 36.08 basis points (bps), with standard deviations of 71.31 and 52.07 bps, respectively. We also show that the average price impact is 11.78 bps, whereas <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Amihud (2002)</span> illiquidity is 0.4258. The average trading price and market capitalization for the sample of 2012 stocks are $29.66 and $5,059 million, respectively.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPTableElement:test",
    "caption": "",
    "containedObjectID": "MPTable:test",
    "elementType": "table",
    "listingID": "MPListing:test",
    "objectType": "MPTableElement",
    "tableElementFooterID": "MPTableElementFooter:test",
    "title": "Descriptive Statistics.",
  },
  Object {
    "_id": "MPTable:test",
    "contents": "<table xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPTableElement:test\\" class=\\"MPElement\\" data-contained-object-id=\\"MPTable:test\\"><colgroup><col width=\\"12.55%\\" /><col width=\\"7%\\" /><col width=\\"8.01%\\" /><col width=\\"6.95%\\" /><col width=\\"8.82%\\" /><col width=\\"8.42%\\" /><col width=\\"9.44%\\" /><col width=\\"11.26%\\" /><col width=\\"9.73%\\" /><col width=\\"8.06%\\" /><col width=\\"9.76%\\" /></colgroup><thead style=\\"display: table-header-group;\\"><tr><th data-placeholder-text=\\"Data\\" valign=\\"bottom\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"bottom\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><i>Quoted Spread</i></th><th data-placeholder-text=\\"Data\\" valign=\\"bottom\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><i>Effective Spread</i></th><th data-placeholder-text=\\"Data\\" valign=\\"bottom\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><i>Price Impact</i></th><th data-placeholder-text=\\"Data\\" valign=\\"bottom\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><i>Amihud Illiquidity</i></th><th data-placeholder-text=\\"Data\\" valign=\\"bottom\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><i>Total Volatility</i></th><th data-placeholder-text=\\"Data\\" valign=\\"bottom\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><i>Systematic Volatility</i></th><th data-placeholder-text=\\"Data\\" valign=\\"bottom\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><i>Idiosyncratic Volatility</i></th><th data-placeholder-text=\\"Data\\" valign=\\"bottom\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><i>Trading Volume</i></th><th data-placeholder-text=\\"Data\\" valign=\\"bottom\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><i>Price</i></th><th data-placeholder-text=\\"Data\\" valign=\\"bottom\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><i>MCAP</i><br />($millions)</th></tr></thead><tbody><tr><td colspan=\\"11\\" data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt\\">Panel A. 2012 U.S. Presidential Election (3,042 common stocks)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\">Mean</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.5255</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.3608</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.1178</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.4258</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0232</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">1.0778</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0201</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">1,284,758</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$29.66</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$5,059</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\">Std. Dev.</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.7131</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.5207</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.1197</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.8455</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0140</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.6787</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0139</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">4,800,735</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$56.26</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$21,535</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\">25th percentile</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0955</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0575</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0311</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0057</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0153</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.6463</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0122</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">49,313</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$10.02</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$225</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\">Median</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.2097</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.1268</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0665</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0368</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0206</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">1.0501</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0171</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">245,033</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$18.67</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$735</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\">75 percentile</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.5553</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.3505</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.1675</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.3028</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0277</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">1.4754</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0242</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">860,998</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$36.41</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$2,610</td></tr><tr><td colspan=\\"11\\" data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"col\\">Panel B. 2016 U.S. Presidential Election (3,106 common stocks)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\">Mean</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.4694</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.3953</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.1541</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.2674</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0229</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">1.2043</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0197</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">1,131,824</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$39.97</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$6,935</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\">Std. Dev.</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.6017</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.5762</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.1639</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.5198</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0219</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.8005</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0219</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">3,225,708</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$86.59</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$27,028</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\">25th percentile</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0844</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0552</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0465</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0038</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0139</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.7759</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0106</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">69,435</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$11.91</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$272</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\">Median</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.1951</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.1286</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0945</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0221</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0188</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">1.1691</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">0.0154</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">282,248</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$23.42</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\">$957</td></tr></tbody><tfoot style=\\"display: table-footer-group;\\"><tr><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"left\\" scope=\\"row\\" style=\\"border-bottom: solid 0.50pt\\">75 percentile</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">0.5500</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">0.4304</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">0.1951</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">0.1869</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">0.0263</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">1.5961</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">0.0232</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">961,105</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">$46.57</td><td data-placeholder-text=\\"Data\\" valign=\\"middle\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">$3,306</td></tr></tfoot></table>",
    "objectType": "MPTable",
  },
  Object {
    "_id": "MPTableElementFooter:test",
    "containedObjectIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPTableElementFooter",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Note: This table reports average daily summary statistics for common stocks with a share price greater than $5 and nonzero trading volume in U.S. equities before the 2012 and 2016 U.S. presidential elections. The event window for the summary statistics is [−90,−10]. All variables are first averaged by stock and then averaged across stocks. <i>Quoted Spread</i> is defined as <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m16\\">
            <mml:mrow>
              <mml:mfenced close=\\"]\\" open=\\"[\\">
                <mml:mrow>
                  <mml:mfenced>
                    <mml:mrow>
                      <mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:msub>
                      <mml:mi>k</mml:mi>
                      <mml:mi>t</mml:mi>
                    </mml:msub>
                      <mml:mo>−</mml:mo><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:msub>
                      <mml:mi>d</mml:mi>
                      <mml:mi>t</mml:mi>
                    </mml:msub>
                    </mml:mrow>
                  </mml:mfenced><mml:mo>/</mml:mo><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:msub>
                  <mml:mi>t</mml:mi>
                  <mml:mi>t</mml:mi>
                </mml:msub>
                </mml:mrow>
              </mml:mfenced><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow>
          </mml:math></span>. <i>Effective Spread</i> is measured as <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m17\\">
            <mml:mrow>
              <mml:mfenced close=\\"]\\" open=\\"[\\">
                <mml:mrow>
                  <mml:mn>2</mml:mn><mml:msub>
                  <mml:mi>D</mml:mi>
                  <mml:mi>k</mml:mi>
                </mml:msub>
                  <mml:mfenced>
                    <mml:mrow>
                      <mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:msub>
                      <mml:mi>e</mml:mi>
                      <mml:mi>k</mml:mi>
                    </mml:msub>
                      <mml:mo>−</mml:mo><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:msub>
                      <mml:mi>t</mml:mi>
                      <mml:mi>k</mml:mi>
                    </mml:msub>
                      <mml:mo>/</mml:mo><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:msub>
                      <mml:mi>t</mml:mi>
                      <mml:mi>k</mml:mi>
                    </mml:msub>
                    </mml:mrow>
                  </mml:mfenced></mml:mrow>
              </mml:mfenced><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow>
          </mml:math></span>, where <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m18\\">
            <mml:mrow>
              <mml:msub>
                <mml:mi>D</mml:mi>
                <mml:mi>k</mml:mi>
              </mml:msub>
            </mml:mrow>
          </mml:math></span> is an indicator variable that equals +1 if the <i>k</i>th trade is a buy and −1 if the <i>k</i>th trade is a sell (trade direction is defined as in <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Lee and Ready, 1991</span>). <i>Price Impact</i> is defined as <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m19\\">
            <mml:mrow>
              <mml:mfenced close=\\"]\\" open=\\"[\\">
                <mml:mrow>
                  <mml:mn>2</mml:mn><mml:msub>
                  <mml:mi>D</mml:mi>
                  <mml:mi>k</mml:mi>
                </mml:msub>
                  <mml:mfenced>
                    <mml:mrow>
                      <mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:msub>
                      <mml:mi>t</mml:mi>
                      <mml:mrow>
                        <mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mn>5</mml:mn></mml:mrow>
                    </mml:msub>
                      <mml:mo>−</mml:mo><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:msub>
                      <mml:mi>t</mml:mi>
                      <mml:mi>k</mml:mi>
                    </mml:msub>
                    </mml:mrow>
                  </mml:mfenced><mml:mo>/</mml:mo><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:msub>
                  <mml:mi>t</mml:mi>
                  <mml:mi>k</mml:mi>
                </mml:msub>
                </mml:mrow>
              </mml:mfenced><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow>
          </mml:math></span>, where <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m20\\">
            <mml:mrow>
              <mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:msub>
              <mml:mi>t</mml:mi>
              <mml:mrow>
                <mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mn>5</mml:mn></mml:mrow>
            </mml:msub>
            </mml:mrow>
          </mml:math></span> is the midpoint five minutes following the <i>k</i>th trade. <i>Amihud Illiquidity</i> is defined as the absolute value of the daily return divided by dollar volume scaled by 10<sup>6</sup>. <i>Total Volatility</i> is measured as the 30-day rolling standard deviation of returns. <i>Systematic Volatility</i> is the 30-day rolling beta coefficient estimated from the capital asset pricing model (CAPM) using Center for Research in Security Prices (CRSP) value-weighted market returns. <i>Idiosyncratic Volatility</i> is the 30-day rolling standard deviation of the residuals obtained from the CAPM. <i>Trading Volume</i> is the average daily share volume. <i>Price</i> is the average daily CRSP closing price. <i>MCAP</i> is a security’s market capitalization defined as price times shares outstanding. We also report the average closing price and the average daily trading volume (number of shares).</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Panel B of <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span> reports descriptive statistics for the sample of stocks before the 2016 election. Although differences exist between the two election periods, most of the liquidity and trading measures are comparable. In fact, the median percentage effective spread in 2016 is nearly identical to that of 2012. The mean percentage quoted and effective spreads for the sample of stocks in the days before the 2016 election are 46.94 and 39.53 bps, with standard deviations of 60.17 and 57.62 bps, respectively. The average daily five-minute price impact for stocks in the 2016 election sample is 0.1541, with a standard deviation of 0.1639. The average price and market capitalization are slightly higher in the 2016 sample, $39.97 and $6,935 million, respectively.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:materials-method",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPEquationElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPEquationElement:test",
      "MPParagraphElement:test",
    ],
    "label": "III",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 6,
    "title": "Empirical Methodology",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In our empirical analysis, we use the highly unexpected victory of Trump in the 2016 U.S. presidential election to assess the effects of political uncertainty on market liquidity. Again, this event is chosen as its outcome provides a source of political uncertainty, rather than the resolution of uncertainty. We use the 2012 U.S. presidential election as our primary benchmark, although we show that our results are robust to an alternative election. We estimate the following general fixed-effects regression equation for common stock observations in the 121 days [−90,30] surrounding both the 2012 and 2016 elections:</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPEquationElement:test",
    "containedObjectID": "eq4",
    "elementType": "div",
    "label": "(4)",
    "objectType": "MPEquationElement",
  },
  Object {
    "_id": "eq4",
    "contents": "<mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m21\\">
        <mml:mrow>
          <mml:mi>L</mml:mi><mml:mi>i</mml:mi><mml:msub>
          <mml:mi>q</mml:mi>
          <mml:mrow>
            <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow>
        </mml:msub>
          <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
          <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
          <mml:mrow>
            <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
          <mml:mrow>
            <mml:mn>30</mml:mn></mml:mrow>
        </mml:munderover>
          <mml:mi>β</mml:mi><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
          <mml:mi>d</mml:mi>
          <mml:mi>t</mml:mi>
        </mml:msub>
          <mml:mo>+</mml:mo><mml:msub>
          <mml:mi>φ</mml:mi>
          <mml:mi>i</mml:mi>
        </mml:msub>
          <mml:mo>+</mml:mo><mml:msub>
          <mml:mi>ε</mml:mi>
          <mml:mrow>
            <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow>
        </mml:msub>
          <mml:mo> </mml:mo><mml:mo>,</mml:mo></mml:mrow>
      </mml:math>",
    "format": "mathml",
    "objectType": "MPEquation",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">where the dependent variable is one of seven liquidity metrics: <i>Quoted Spread, Effective Spread, Price Impact, Amihud Illiquidity, Total Volatility, Systematic Volatility,</i> or <i>Idiosyncratic Volatility</i>. We include 10 pre-trend indicator variables for the 10 trading days leading up to the election, 31 post-trend indicator variables for the 31 trading days following the election (election day included), and stock fixed effects.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">16</span> All indicator variables are interpreted in comparison to the 80-day pre-election period. We estimate <span class=\\"cross-reference\\" data-reference-id=\\"MPEquationElement:test\\"><span class=\\"kind elementIndex\\"><b>equation (4)</b></span></span> for each election separately and cluster standard errors at the stock level. Rather than report coefficient estimates in a table setting, we provide the plot of the beta coefficient estimates with 95% confidence intervals across the 40-day event window, covering the 10 days before and 30 days after the election dates.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">To assess the statistical impact of the 2016 election on market liquidity, relative to the 2012 benchmark election, we estimate the following difference-in-difference regression equation:</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPEquationElement:test",
    "containedObjectID": "eq5",
    "elementType": "div",
    "label": "(5)",
    "objectType": "MPEquationElement",
  },
  Object {
    "_id": "eq5",
    "contents": "<mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m22\\">
        <mml:mrow>
          <mml:mi>L</mml:mi><mml:mi>i</mml:mi><mml:msub>
          <mml:mi>q</mml:mi>
          <mml:mrow>
            <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
        </mml:msub>
          <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
          <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
          <mml:mrow>
            <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
          <mml:mrow>
            <mml:mn>30</mml:mn></mml:mrow>
        </mml:munderover>
          <mml:mi>β</mml:mi><mml:mo stretchy=\\"false\\">(</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
          <mml:mi>d</mml:mi>
          <mml:mi>t</mml:mi>
        </mml:msub>
          <mml:mo>×</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
          <mml:mi>p</mml:mi>
          <mml:mi>j</mml:mi>
        </mml:msub>
          <mml:mo stretchy=\\"false\\">)</mml:mo><mml:mo>+</mml:mo><mml:mi>τ</mml:mi><mml:mfenced>
          <mml:mrow>
            <mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
            <mml:mi>p</mml:mi>
            <mml:mi>j</mml:mi>
          </mml:msub>
          </mml:mrow>
        </mml:mfenced><mml:mo>+</mml:mo><mml:msub>
          <mml:mi>φ</mml:mi>
          <mml:mi>i</mml:mi>
        </mml:msub>
          <mml:mo>+</mml:mo><mml:msub>
          <mml:mi>δ</mml:mi>
          <mml:mi>t</mml:mi>
        </mml:msub>
          <mml:mo>+</mml:mo><mml:msub>
          <mml:mi>ε</mml:mi>
          <mml:mrow>
            <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
        </mml:msub>
          <mml:mo>,</mml:mo><mml:mo> </mml:mo></mml:mrow>
      </mml:math>",
    "format": "mathml",
    "objectType": "MPEquation",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">where the dependent variable is one of seven liquidity measures: <i>Quoted Spread, Effective Spread, Price Impact, Amihud Illiquidity, Total Volatility, Systematic Volatility,</i> or <i>Idiosyncratic Volatility</i>. We include 10 pre-trend interaction variables for the 10 days leading up to each election, 31 post-trend interaction variables for the 31 days following the election outcomes (election days included), time trends, level effects, and stock fixed effects. The interaction terms serve as difference-in-difference estimators between the pre- and post-election windows and the 2012 and 2016 elections. The <i>Trump</i> indicator variable equals 1 if the observation is during the 2016 election cycle and 0 otherwise, which controls for differences in liquidity between the two election periods. The event fixed effects, <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m23\\">
        <mml:mrow>
          <mml:msub>
            <mml:mi>δ</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
        </mml:mrow>
      </mml:math></span>, control for variation in liquidity surrounding the election outcomes. The stock fixed effects, <span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m24\\">
        <mml:mrow>
          <mml:msub>
            <mml:mi>φ</mml:mi>
            <mml:mi>i</mml:mi>
          </mml:msub>
        </mml:mrow>
      </mml:math></span>, control for stock-specific factors that influence liquidity. As before, we forgo traditional tables and plot the beta coefficients with 95% confidence intervals. Standard errors are clustered at the stock level to account for possible serial correlation.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">17</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:results",
    "elementIDs": Array [],
    "label": "IV",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 7,
    "title": "Empirical Results",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPFigureElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPFigureElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPFigureElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 8,
    "title": "Election Uncertainty and Market Liquidity",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We begin by examining the effect of election uncertainty on stock transactions costs. We estimate <span class=\\"cross-reference\\" data-reference-id=\\"MPEquationElement:test\\"><span class=\\"kind elementIndex\\"><b>equations (4)</b></span></span> and <span class=\\"cross-reference\\" data-reference-id=\\"MPEquationElement:test\\"><span class=\\"kind elementIndex\\"><b>(5)</b></span></span> using either quoted spreads or effective spreads as the dependent variable. <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure II</b></span></span> plots the beta coefficient estimates, where circles are the mean estimates for the 2012 election, triangles are the mean estimates for the 2016 election, and squares are the difference-in-difference estimates. In Panel A, we find a large difference in quoted spreads following the 2016 election outcome. In economic terms, we find that the average quoted spread is 13.2 bps higher the second day following the 2016 election, relative to the 80-day pre-event period. This represents a 28% increase above the average pre-election quoted spread level. The average quoted spread remains elevated throughout the 31-day post-2016 election period. The plots for the 2012 election indicate moderate positive differences in quoted spreads in the post-event period, relative to the 80-day pre-event period. However, the differences become negative, starting two weeks after the 2012 election day. In Panel B, we provide the difference-in-difference plot estimates, where statistical significance is inferred if the “notches” associated with the box do not touch the horizontal axis. The difference-in-difference plot estimates indicate that the increase in quoted spreads around the election date are significantly higher for the 2016 election relative to the 2012 election.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><b>Election Uncertainty and Transactions Costs.</b> This figure reports the results of estimating the following fixed-effects regression equations for common stock observations in the 121 days [−90,30] surrounding the 2012 and 2016 U.S. presidential elections:</p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m25\\">
          <mml:mrow>
            <mml:mi>S</mml:mi><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
            <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
            <mml:mrow>
              <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
            <mml:mrow>
              <mml:mn>30</mml:mn></mml:mrow>
          </mml:munderover>
            <mml:mi>β</mml:mi><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>φ</mml:mi>
            <mml:mi>i</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>ε</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>&nbsp;</mml:mo><mml:mo>,</mml:mo><mml:mo>&nbsp;</mml:mo></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m26\\">
          <mml:mrow>
            <mml:mtext>and</mml:mtext></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m27\\">
          <mml:mrow>
            <mml:mi>S</mml:mi><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
            <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
            <mml:mrow>
              <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
            <mml:mrow>
              <mml:mn>30</mml:mn></mml:mrow>
          </mml:munderover>
            <mml:mi>β</mml:mi><mml:mo stretchy=\\"false\\">(</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>×</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
            <mml:mi>p</mml:mi>
            <mml:mi>j</mml:mi>
          </mml:msub>
            <mml:mo stretchy=\\"false\\">)</mml:mo><mml:mo>+</mml:mo><mml:mi>τ</mml:mi><mml:mfenced>
            <mml:mrow>
              <mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
              <mml:mi>p</mml:mi>
              <mml:mi>j</mml:mi>
            </mml:msub>
            </mml:mrow>
          </mml:mfenced><mml:mo>+</mml:mo><mml:msub>
            <mml:mi>φ</mml:mi>
            <mml:mi>i</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>δ</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>ε</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>&nbsp;</mml:mo><mml:mo>,</mml:mo><mml:mo>&nbsp;</mml:mo><mml:mo>&nbsp;</mml:mo></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">where the dependent variable is either <i>Quoted Spread</i> or <i>Effective Spread</i>. The variables are defined in <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span>. We estimate the first equation for each election separately and plot the beta coefficients with 95% confidence bands in Panels A and C. We include 10 pre-trend indicator variables for the 10 days leading up to each election, 31 post-trend indicator variables for the 31 days following the election outcomes (election days included), and stock fixed effects. We then estimate the second equation for the two elections jointly where we control for time trends, level effects, and stock fixed effects and plot the beta coefficients with 95% confidence intervals in Panels B and D. Standard errors in both equations are clustered at the stock level. [Color figure can be viewed at wileyonlinelibrary.com.]</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">A. <i>Quoted Spread</i> (Differences)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">B. <i>Quoted Spread</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">C. <i>Effective Spread</i> (Differences)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">D. <i>Effective Spread</i> (Diff-in-Diff)</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "Figure II",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image003",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image004",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image005",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image006",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In Panel C of <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure II</b></span></span>, we provide plot estimates for the difference in effective spreads around each election. We find an increase in transactions costs in the 10 days before the 2016 election; however, transactions costs peak the day following the election date. In fact, the average effective spread is 7.3 bps higher the second day after the 2016 election relative to the 80-day pre-event period. Economically, this represents 18.5% of the pre-election effective spread level. The average effective spread remains significantly higher in the 31-day post-event period relative to the pre-event period. The results in Panel D confirm the statistical difference-in-difference between the two elections. In sum, the evidence provided in <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure II</b></span></span> indicates that election uncertainty causes an increase in transactions costs.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Next, we analyze how election uncertainty affects information asymmetries in financial markets. We estimate <span class=\\"cross-reference\\" data-reference-id=\\"MPEquationElement:test\\"><span class=\\"kind elementIndex\\"><b>equations (4)</b></span></span> and <span class=\\"cross-reference\\" data-reference-id=\\"MPEquationElement:test\\"><span class=\\"kind elementIndex\\"><b>(5)</b></span></span> using price impact and <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Amihud (2002)</span> illiquidity in as the dependent variables. <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure III</b></span></span> plots the beta coefficients for the 2012 election (circles), 2016 election (triangles), and difference-in-difference (squares). In Panel A, we report the pre- and post-event differences in price impact across the 2012 and 2016 elections. Consistent with the premise the election uncertainty increases informational asymmetries and results in greater adverse selection risk, we find large positive differences for the 2016 election. In economic terms, the average price impact the fifth day after the 2016 election is 5 bps higher than the 80-day pre-event average, which represents roughly a 32% increase above pre-event levels. Although the larger positive differences following the 2016 election subside in the following weeks, they remain significantly higher than the 80-day pre-event benchmark. In Panel B, we provide the plot estimates for our difference-in-difference analysis, showing that the price impact differences between the pre- and post-event periods are significantly higher in the 2016 election relative to the 2012 election. Our results also show that except for the three or four trading days in the two weeks following the election, the difference-in-difference estimates are significantly higher in the 31-day post-event period for the 2016 election.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><b>Election Uncertainty and Adverse Selection.</b> This figure reports the results of estimating the following fixed-effects regression equations for stock observations in the 121 days [−90,30] surrounding the 2012 and 2016 U.S. presidential elections:</p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m28\\">
          <mml:mrow>
            <mml:mi>A</mml:mi><mml:mi>d</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>&nbsp;</mml:mo><mml:mi>S</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:msub>
            <mml:mi>n</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
            <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
            <mml:mrow>
              <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
            <mml:mrow>
              <mml:mn>30</mml:mn></mml:mrow>
          </mml:munderover>
            <mml:mi>β</mml:mi><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>φ</mml:mi>
            <mml:mi>i</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>ε</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>&nbsp;</mml:mo><mml:mo>,</mml:mo><mml:mo>&nbsp;</mml:mo><mml:mo>&nbsp;</mml:mo></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m29\\">
          <mml:mrow>
            <mml:mtext>and</mml:mtext></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m30\\">
          <mml:mrow>
            <mml:mi>A</mml:mi><mml:mi>d</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>&nbsp;</mml:mo><mml:mi>S</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:msub>
            <mml:mi>n</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
            <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
            <mml:mrow>
              <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
            <mml:mrow>
              <mml:mn>30</mml:mn></mml:mrow>
          </mml:munderover>
            <mml:mi>β</mml:mi><mml:mo stretchy=\\"false\\">(</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>×</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
            <mml:mi>p</mml:mi>
            <mml:mi>j</mml:mi>
          </mml:msub>
            <mml:mo stretchy=\\"false\\">)</mml:mo><mml:mo>+</mml:mo><mml:mi>τ</mml:mi><mml:mfenced>
            <mml:mrow>
              <mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
              <mml:mi>p</mml:mi>
              <mml:mi>j</mml:mi>
            </mml:msub>
            </mml:mrow>
          </mml:mfenced><mml:mo>+</mml:mo><mml:msub>
            <mml:mi>φ</mml:mi>
            <mml:mi>i</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>δ</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>ε</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>,</mml:mo><mml:mo>&nbsp;</mml:mo><mml:mo>&nbsp;</mml:mo></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">where the dependent variable is either the <i>Price Impact</i> component of the bid–ask spread or <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Amihud’s (2002)</span> illiquidity measure (<i>Amihud Illiquidity</i>). The variables are defined in <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span>. We estimate the first equation for each election separately and plot the beta coefficients with 95% confidence bands in Panels A and C. We include 10 pre-trend indicator variables for the 10 days leading up to each election, 31 post-trend indicator variables for the 31 days following the election outcomes (election days included), and stock fixed effects. We then estimate the second equation for the two elections jointly where we control for time trends, level effects, and stock fixed effects and plot the beta coefficients with 95% confidence intervals in Panels B and D. Standard errors in both equations are clustered at the stock level. [Color figure can be viewed at wileyonlinelibrary.com.]</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">A. <i>Price Impact</i> (Differences)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">B. <i>Price Impact</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">C. <i>Amihud Illiquidity</i> (Differences)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">D. <i>Amihud Illiquidity</i> (Diff-in-Diff)</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "Figure III",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image007",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image008",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image009",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image010",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">To test for robustness, we analyze whether the low-frequency proxy of price impact, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Amihud (2002)</span> illiquidity, increases following the 2016 election. In Panel C of <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure III</b></span></span>, we find that illiquidity spikes following both the 2012 and 2016 election days. However, the post-event differences become negative for the 2012 election, whereas they remain positive for the 2016 election. In Panel D, we show that the post-event increases in illiquidity are significantly higher for the 2016 election than for the 2012 election. Thus, the results in <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure III</b></span></span> provide compelling evidence that election uncertainty associated with the 2016 election increases information asymmetries among market participants, resulting in higher adverse selection costs.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In our next set of tests, we examine whether election uncertainty and the aftermath of the 2016 election increase market volatility. We posit that election uncertainty increases informational asymmetries, creating a larger equity risk premium and greater volatility (<span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Pástor and Veronesi 2012</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">2013</span>). We replace the liquidity variable in <span class=\\"cross-reference\\" data-reference-id=\\"MPEquationElement:test\\"><span class=\\"kind elementIndex\\"><b>equations (4)</b></span></span> and <span class=\\"cross-reference\\" data-reference-id=\\"MPEquationElement:test\\"><span class=\\"kind elementIndex\\"><b>(5)</b></span></span> with one of three measures of volatility: total volatility, systematic volatility, or idiosyncratic volatility. We then plot the beta coefficients with 95% confidence intervals surrounding the elections. In Panel A of <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure IV</b></span></span>, we report the pre- and post-event differences in total volatility across the 2012 and 2016 elections. We find a significant increase in total volatility surrounding the 2016 election, which peaks roughly four weeks after the outcome. In fact, average daily total volatility increases by 0.0047 at the highest point ex post, which represents a 20.5% increase above the 80-day pre-event average.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><b>Election Uncertainty and Volatility.</b> This figure reports the results of estimating the following fixed-effects regression equations for stock observations in the 121 days [−90,30] surrounding the 2012 and 2016 U.S. presidential elections:</p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m31\\">
          <mml:mrow>
            <mml:mi>V</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:msub>
            <mml:mi>y</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
            <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
            <mml:mrow>
              <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
            <mml:mrow>
              <mml:mn>30</mml:mn></mml:mrow>
          </mml:munderover>
            <mml:mi>β</mml:mi><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>φ</mml:mi>
            <mml:mi>i</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>ε</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>&nbsp;</mml:mo><mml:mo>,</mml:mo><mml:mo>&nbsp;</mml:mo><mml:mo>&nbsp;</mml:mo></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m32\\">
          <mml:mrow>
            <mml:mtext>and</mml:mtext></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m33\\">
          <mml:mrow>
            <mml:mi>V</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:msub>
            <mml:mi>y</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
            <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
            <mml:mrow>
              <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
            <mml:mrow>
              <mml:mn>30</mml:mn></mml:mrow>
          </mml:munderover>
            <mml:mi>β</mml:mi><mml:mo stretchy=\\"false\\">(</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>×</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
            <mml:mi>p</mml:mi>
            <mml:mi>j</mml:mi>
          </mml:msub>
            <mml:mo stretchy=\\"false\\">)</mml:mo><mml:mo>+</mml:mo><mml:mi>τ</mml:mi><mml:mfenced>
            <mml:mrow>
              <mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
              <mml:mi>p</mml:mi>
              <mml:mi>j</mml:mi>
            </mml:msub>
            </mml:mrow>
          </mml:mfenced><mml:mo>+</mml:mo><mml:msub>
            <mml:mi>φ</mml:mi>
            <mml:mi>i</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>δ</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>ε</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>,</mml:mo><mml:mo>&nbsp;</mml:mo><mml:mo>&nbsp;</mml:mo></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">where the dependent variable is either <i>Total Volatility</i>, <i>Systematic Volatility</i>, or <i>Idiosyncratic Volatility</i>. The variables are defined in <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span>. We estimate the first equation for each election separately and plot the beta coefficients with 95% confidence bands in Panels A, C, and E. We include 10 pre-trend indicator variables for the 10 days leading up to each election, 31 post-trend indicator variables for the 31 days following the election outcomes (election days included), and stock fixed effects. We then estimate the second equation for the two elections jointly where we control for time trends, level effects, and stock fixed effects and plot the beta coefficients with 95% confidence intervals in Panels B, D, and F. Standard errors in both equations are clustered at the stock level. [Color figure can be viewed at wileyonlinelibrary.com.]</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">A. <i>Total Volatility</i> (Differences)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">B. <i>Total Volatility</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">C. <i>Systematic Volatility</i> (Differences)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">D. <i>Systematic Volatility</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">E. <i>Idiosyncratic Volatility</i> (Differences)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">F. <i>Idiosyncratic Volatility</i> (Diff-in-Diff)</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "Figure IV",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image011",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image012",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image013",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image014",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image015",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image016",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In contrast to the 2016 election, the difference estimates for the 2012 election are either negative or not significantly different from zero, suggesting either a decrease or no change in total volatility around the election outcome. The plot estimates in Panel B of <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure IV</b></span></span> show that the differences between the two elections are significant at the .05 level. We argue that the elevated differences in total volatility displayed in Panels A and B are likely attributed to the uncertainty surrounding potential policy changes. To the extent that the 2012 election resulted in the re-election of the incumbent, investor expectations did not fluctuate as no major shift in policy changes were expected. Conversely, the surprise outcome associated with the 2016 election likely forced investors to revise their expectations about new governmental policies as a new political party was placed into power.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">To identify whether the increase in total risk is market wide or firm specific, we separate volatility into systematic and idiosyncratic. The plot estimates provided in Panel C of <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure IV</b></span></span> show that systematic volatility increases significantly around the 2016 election. In economic terms, beta risk increases by an average of 0.1679 at the highest point following the 2016 election, which indicates a 13.9% increase above the 80-day pre-event average. The shock to market volatility around the 2016 election disappears three weeks after the outcome. We do not find a significant increase in systematic volatility surrounding the 2012 election. The results in Panels E and F show a significant increase in idiosyncratic volatility around the 2016 election relative to the 2012 election. We find that firm-specific risk continues to increase up to a month after the 2016 election. The results in <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure IV</b></span></span> have important economic implications, as investors appear exposed to multiple layers of risk during times of political unrest. Because systematic risk is not diversifiable for investors, we argue that despite proper asset allocation and diversification strategies of individual and professional traders, the election uncertainty associated with the 2016 election exposed all investors to greater risk.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPFigureElement:test",
      "MPParagraphElement:test",
      "MPFigureElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 9,
    "title": "Election Uncertainty and Market Liquidity—Stock Characteristics",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In this next section, we examine whether certain stocks are more, or less, exposed to election uncertainty. We believe this provides a direct test of the information asymmetry hypothesis that asserts that the information gap between informed and uninformed investors widens during times of political unrest. For instance, both smaller capitalized stocks and those with lower trading volume are likely to possess greater firm-specific informational asymmetry and adverse selection risk.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">18</span> Thus, we examine the effects of the two presidential elections on market liquidity across varying stock-level characteristics.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We estimate <span class=\\"cross-reference\\" data-reference-id=\\"MPEquationElement:test\\"><span class=\\"kind elementIndex\\"><b>equation (5)</b></span></span> for various liquidity measures and for stocks in the top and bottom quintiles of average daily trading volume during the pre-election period. In Panel A of <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure V</b></span></span>, we analyze whether the positive difference-in-differences in round-trip transaction costs are higher among low-volume stocks. In fact, we find no significant change in either effective spread or price impact measures for high-volume stocks. Consistent with the premise that election uncertainty has a greater effect on stocks more susceptible to information asymmetries, we find that differences in round-trip costs are higher for less frequently traded stocks. In Panel B, we show that increases in adverse selection risks are also higher among less actively traded securities. In Panels C and D, we find that the increase in average volatility around the 2016 election, relative to the 2012 election, is generally higher for low-volume stocks.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><b>Election Uncertainty and Liquidity—By Stock Trading Volume.</b> This figure reports the results of estimating specifications of the following fixed-effects regression equation for stock observations in the 121 days [−90,30] surrounding the 2012 and 2016 U.S. presidential elections:</p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m34\\">
          <mml:mrow>
            <mml:mi>L</mml:mi><mml:mi>i</mml:mi><mml:msub>
            <mml:mi>q</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
            <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
            <mml:mrow>
              <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
            <mml:mrow>
              <mml:mn>30</mml:mn></mml:mrow>
          </mml:munderover>
            <mml:mi>β</mml:mi><mml:mo stretchy=\\"false\\">(</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>×</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
            <mml:mi>p</mml:mi>
            <mml:mi>j</mml:mi>
          </mml:msub>
            <mml:mo stretchy=\\"false\\">)</mml:mo><mml:mo>+</mml:mo><mml:mi>τ</mml:mi><mml:mfenced>
            <mml:mrow>
              <mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
              <mml:mi>p</mml:mi>
              <mml:mi>j</mml:mi>
            </mml:msub>
            </mml:mrow>
          </mml:mfenced><mml:mo>+</mml:mo><mml:msub>
            <mml:mi>φ</mml:mi>
            <mml:mi>i</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>δ</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>ε</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>,</mml:mo><mml:mo>&nbsp;</mml:mo><mml:mo>&nbsp;</mml:mo></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">where the dependent variable is one of four liquidity measures: <i>Effective Spread</i>, <i>Price Impact</i>, <i>Systematic Volatility</i>, or <i>Idiosyncratic Volatility</i>. The variables are defined in <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span>. We separate the Trump sample into pre-election trading volume quintiles and estimate the equation above separately for the top and bottom quintiles. We include 10 pre-trend interaction variables for the 10 days leading up to each election, 31 post-trend interaction variables for the 31 days following the election outcomes (election days included), time trends, level effects, and stock fixed effects. We plot the beta coefficients with 95% confidence intervals below. Standard errors are clustered at the stock level. [Color figure can be viewed at wileyonlinelibrary.com.]</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">A. <i>Effective Spread</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">B. <i>Price Impact</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">C. <i>Systematic Volatility</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">Panel D. <i>Idiosyncratic Volatility</i> (Diff-in-Diff)</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "Figure V",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image017",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image018",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image019",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image020",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Next, we estimate <span class=\\"cross-reference\\" data-reference-id=\\"MPEquationElement:test\\"><span class=\\"kind elementIndex\\"><b>equation (5)</b></span></span> for stocks in the top and bottom quintiles of average daily market capitalization ex ante. We posit that small-cap stocks likely experience greater fluctuations in liquidity and volatility during times of election uncertainty. In Panel A of <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure VI</b></span></span>, we plot the difference-in-difference estimates in effective spreads for large- and small-cap stocks. We find that the increase in transactions costs around the 2016 election, relative to the 2012 election, is isolated to small-cap securities. We report similar findings in Panel B for price impact. Though to a lesser extent, the results in Panels C and D provide corroborating evidence that small-cap stocks are more exposed to election uncertainty, resulting in greater volatility.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><b>Election Uncertainty and Liquidity—By Stock Market Capitalization.</b> This figure reports the results of estimating specifications of the following fixed-effects regression equation for stock observations in the 121 days [−90,30] surrounding the 2012 and 2016 U.S. presidential elections:</p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m35\\">
          <mml:mrow>
            <mml:mi>L</mml:mi><mml:mi>i</mml:mi><mml:msub>
            <mml:mi>q</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
            <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
            <mml:mrow>
              <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
            <mml:mrow>
              <mml:mn>30</mml:mn></mml:mrow>
          </mml:munderover>
            <mml:mi>β</mml:mi><mml:mo stretchy=\\"false\\">(</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>×</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
            <mml:mi>p</mml:mi>
            <mml:mi>j</mml:mi>
          </mml:msub>
            <mml:mo stretchy=\\"false\\">)</mml:mo><mml:mo>+</mml:mo><mml:mi>τ</mml:mi><mml:mfenced>
            <mml:mrow>
              <mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
              <mml:mi>p</mml:mi>
              <mml:mi>j</mml:mi>
            </mml:msub>
            </mml:mrow>
          </mml:mfenced><mml:mo>+</mml:mo><mml:msub>
            <mml:mi>φ</mml:mi>
            <mml:mi>i</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>δ</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>ε</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>,</mml:mo><mml:mo>&nbsp;</mml:mo><mml:mo>&nbsp;</mml:mo></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">where the dependent variable is one of four liquidity measures: <i>Effective Spread</i>, <i>Price Impact</i>, <i>Systematic Volatility</i>, or <i>Idiosyncratic Volatility</i>. The variables are defined in <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span>. We separate the Trump sample into pre-election market capitalization quintiles and estimate the above equation separately for the top and bottom quintiles. We include 10 pre-trend interaction variables for the 10 days leading up to each election, 31 post-trend interaction variables for the 31 days following the election outcomes (election days included), time trends, level effects, and stock fixed effects. We plot the beta coefficients with 95% confidence intervals below. Standard errors are clustered at the stock level. [Color figure can be viewed at wileyonlinelibrary.com.]</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">A. <i>Effective Spread</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">B. <i>Price Impact</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">C. <i>Systematic Volatility</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">Panel D. <i>Idiosyncratic Volatility</i> (Diff-in-Diff)</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "Figure VI",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image021",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image022",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image023",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image024",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In summary, we find that the surprise victory of Trump in 2016 reduced market liquidity for less frequently traded small-cap stocks, consistent with the notion that stock-level characteristics associated with greater adverse selection risk are an important consideration in determining how political uncertainty can affect financial market outcomes.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPFigureElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
      "MPSection:test",
    ],
    "priority": 10,
    "title": "Election Uncertainty and Market Liquidity—Politically Sensitive Industries",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Several studies suggest that political uncertainty can have more severe effects on stocks operating in politically sensitive industries given their increased exposure to potential policy changes (Boutchkova, Doshi, and Durnev 2011; <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Julio and Yook 2012</span>; <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Hong and Kostovetsky 2012</span>). We next examine the impact on stocks operating in politically sensitive industries. According to a report published one month before the 2016 election, several industries (i.e., healthcare, financials, energy, and infrastructure) were identified as being the most sensitive to potential policy changes.<span class=\\"footnote\\" data-reference-id=\\"MPFootnote:test\\">19</span> For example, the financial sector was considered “highly sensitive” given that the two leading candidates had distinct perspectives on bank regulations and support for the Dodd–Frank Act, and the healthcare industry was considered more sensitive because of the candidates’ opposing views on the Affordable Care Act. In our analysis, we classify a stock as politically sensitive if it falls into the healthcare (Standard Industrial Classification [SIC] 8000–8099), pharmaceutical (SIC 2830–2836), banking (SIC 6000–6199), trading (SIC 6200–6299 and 6700–6799), natural gas (SIC 1300–1389, 2900–2912, and 2990–2999), defense (SIC 3760–3769, 3795, and 3480–3489), or tobacco (SIC 2100–2199) industry.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We estimate <span class=\\"cross-reference\\" data-reference-id=\\"MPEquationElement:test\\"><span class=\\"kind elementIndex\\"><b>equation (5)</b></span></span> for various liquidity measures and for politically sensitive and “nonsensitive” stocks. The results are reported in <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure VII</b></span></span>, where we plot the beta coefficients with 95% confidence intervals. In Panel A, we plot difference-in-difference estimates for average effective spreads and find that stocks operating in politically sensitive industries are more exposed to greater election uncertainty. Specifically, we find that differences in round-trip costs are generally higher among stocks in politically sensitive industries. In Panel B, we show that the difference-in-difference estimates in adverse selection costs, measured as percentage price impact, are higher among stocks in politically sensitive industries. In Panels C and D, we show that difference-in-difference estimates in systematic and idiosyncratic volatility are higher among firms in politically sensitive industries. In fact, the difference in firm-specific risk increases over the post-election period.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><b>Election Uncertainty and Liquidity—Politically Sensitive Industries.</b> The figure reports the results of estimating specifications of the following fixed-effects regression equation for stock observations in the 121 days [−90,30] surrounding the 2012 and 2016 U.S. presidential elections:</p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m36\\">
          <mml:mrow>
            <mml:mi>L</mml:mi><mml:mi>i</mml:mi><mml:msub>
            <mml:mi>q</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
            <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
            <mml:mrow>
              <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
            <mml:mrow>
              <mml:mn>30</mml:mn></mml:mrow>
          </mml:munderover>
            <mml:mi>β</mml:mi><mml:mo stretchy=\\"false\\">(</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
            <mml:mi>d</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>×</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
            <mml:mi>p</mml:mi>
            <mml:mi>j</mml:mi>
          </mml:msub>
            <mml:mo stretchy=\\"false\\">)</mml:mo><mml:mo>+</mml:mo><mml:mi>τ</mml:mi><mml:mfenced>
            <mml:mrow>
              <mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
              <mml:mi>p</mml:mi>
              <mml:mi>j</mml:mi>
            </mml:msub>
            </mml:mrow>
          </mml:mfenced><mml:mo>+</mml:mo><mml:msub>
            <mml:mi>φ</mml:mi>
            <mml:mi>i</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>δ</mml:mi>
            <mml:mi>t</mml:mi>
          </mml:msub>
            <mml:mo>+</mml:mo><mml:msub>
            <mml:mi>ε</mml:mi>
            <mml:mrow>
              <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
          </mml:msub>
            <mml:mo>,</mml:mo><mml:mo>&nbsp;</mml:mo><mml:mo>&nbsp;</mml:mo></mml:mrow>
        </mml:math></span></p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">where the dependent variable is one of four liquidity measures: <i>Effective Spread</i>, <i>Price Impact</i>, <i>Systematic Volatility</i>, or <i>Idiosyncratic Volatility</i>. The variables are defined in <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span>. We separate the sample by industry and define those in the healthcare (Standard Industrial Classification [SIC] 8000–8099), pharmaceutical (SIC 2830–2836), banking (SIC 6000–6199), trading (SIC 6200–6299 and 6700–6799), natural gas (SIC 1300–1389, 2900–2912, and 2990–2999), defense (SIC 3760–3769, 3795, and 3480–3489), and tobacco (SIC 2100–2199) industries as politically sensitive. We estimate the equation above separately for politically sensitive and insensitive stocks. We include 10 pre-trend interaction variables for the 10 days leading up to each election, 31 post-trend interaction variables for the 31 days following the election outcomes (election days included), time trends, level effects, and stock fixed effects. We plot the beta coefficients with 95% confidence intervals below. Standard errors are clustered at the stock level. [Color figure can be viewed at wileyonlinelibrary.com.]</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">A. <i>Effective Spread</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">B. <i>Price Impact</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">C. <i>Systematic Volatility</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">D. <i>Idiosyncratic Volatility</i> (Diff-in-Diff)</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "Figure VII",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image025",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image026",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image027",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image028",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPFigureElement:test",
    ],
    "label": "V",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 11,
    "title": "Robustness",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">To this point, our results indicate that relative to the 2012 U.S. presidential election, the 2016 election induced, rather than resolved, market uncertainty, resulting in deteriorating market liquidity. We also account for an alternative benchmark election. Our intraday data allow us to use both the 2004 and 2008 U.S. presidential elections as comparable events. However, the confounding effects associated with the financial crisis, short-selling ban, and government bailouts surrounding the 2008 U.S. presidential election hinder our ability to make any proper statistical inferences. Therefore, we exclude the 2008 election from our analysis and include the 2004 U.S. presidential election as an additional benchmark. The 2004 U.S. presidential election is a unique benchmark given that the race was tightly contested yet the winning candidate was an incumbent, presumably resulting in less uncertainty surrounding future policy changes.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">In <span class=\\"cross-reference\\" data-reference-id=\\"MPFigureElement:test\\"><span class=\\"kind elementIndex\\"><b>Figure VIII</b></span></span>, we plot the difference-in-difference estimates comparing the pre- and post-event differences in effective spreads, price impact, and volatility across both the 2004 and 2016 U.S. presidential elections. Consistent with our earlier findings using the 2012 U.S. presidential election as a benchmark, we find that the election uncertainty associated with the 2016 election resulted in greater illiquidity relative to the changes experienced in the 2004 election. In fact, the difference-in-difference estimates provided in Panel A indicate that the higher transaction costs remained elevated throughout the entire post-event period. We provide similar findings in Panels B–D for our measures of price impact and volatility. Hence, we suggest that the surprise outcome of the 2016 U.S. presidential election worsened market liquidity more than the two U.S. presidential election benchmarks. Furthermore, our results indicate that the effects of the 2016 U.S. presidential election were not transitory and, in fact, appear to have increased in the subsequent 30 trading days.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><b>Election Uncertainty and Liquidity—2004 U.S. Presidential Election as a Benchmark.</b> This figure reports the results of estimating specifications of the following fixed-effects regression equation for stock observations in the 121 days [−90,30] surrounding the 2004 and 2016 U.S. presidential elections:</p><p class=\\"caption-description placeholder\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\"><span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"mathml\\"><mml:math xmlns:mml=\\"http://www.w3.org/1998/Math/MathML\\" id=\\"m37\\">
        <mml:mrow>
          <mml:mi>L</mml:mi><mml:mi>i</mml:mi><mml:msub>
          <mml:mi>q</mml:mi>
          <mml:mrow>
            <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
        </mml:msub>
          <mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:munderover>
          <mml:mstyle mathsize=\\"140%\\" displaystyle=\\"true\\"><mml:mo>∑</mml:mo></mml:mstyle>
          <mml:mrow>
            <mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mn>10</mml:mn></mml:mrow>
          <mml:mrow>
            <mml:mn>30</mml:mn></mml:mrow>
        </mml:munderover>
          <mml:mi>β</mml:mi><mml:mo stretchy=\\"false\\">(</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:msub>
          <mml:mi>d</mml:mi>
          <mml:mi>t</mml:mi>
        </mml:msub>
          <mml:mo>×</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
          <mml:mi>p</mml:mi>
          <mml:mi>j</mml:mi>
        </mml:msub>
          <mml:mo stretchy=\\"false\\">)</mml:mo><mml:mo>+</mml:mo><mml:mi>τ</mml:mi><mml:mfenced>
          <mml:mrow>
            <mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:msub>
            <mml:mi>p</mml:mi>
            <mml:mi>j</mml:mi>
          </mml:msub>
          </mml:mrow>
        </mml:mfenced><mml:mo>+</mml:mo><mml:msub>
          <mml:mi>φ</mml:mi>
          <mml:mi>i</mml:mi>
        </mml:msub>
          <mml:mo>+</mml:mo><mml:msub>
          <mml:mi>δ</mml:mi>
          <mml:mi>t</mml:mi>
        </mml:msub>
          <mml:mo>+</mml:mo><mml:msub>
          <mml:mi>ε</mml:mi>
          <mml:mrow>
            <mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow>
        </mml:msub>
          <mml:mo>,</mml:mo><mml:mo>&nbsp;</mml:mo><mml:mo>&nbsp;</mml:mo></mml:mrow>
      </mml:math></span></p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">where the dependent variable is one of four liquidity measures: <i>Effective Spread</i>, <i>Price Impact</i>, <i>Systematic Volatility</i>, or <i>Idiosyncratic Volatility</i>. The variables are defined in <span class=\\"cross-reference\\" data-reference-id=\\"MPTableElement:test\\"><span class=\\"kind elementIndex\\"><b>Table 1</b></span></span>. We include 10 pre-trend interaction variables for the 10 days leading up to each election, 31 post-trend interaction variables for the 31 days following the election outcomes (election days included), time trends, level effects, and stock fixed effects. We plot the beta coefficients with 95% confidence intervals below. Standard errors are clustered at the stock level. [Color figure can be viewed at wileyonlinelibrary.com.]</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">A. <i>Effective Spread</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">B. <i>Price Impact</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">C. <i>Systematic Volatility</i> (Diff-in-Diff)</p><p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">D. <i>Idiosyncratic Volatility</i> (Diff-in-Diff)</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "Figure VIII",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image029",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image030",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image031",
  },
  Object {
    "_id": "MPFigure:test",
    "objectType": "MPFigure",
    "src": "Wiley-JFR-Final Manuscript-MT-Image032",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:conclusions",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "label": "VI",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 12,
    "title": "Conclusion",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This study contributes to the growing literature investigating the relation between politics and financial markets. We examine whether the recent surprise outcome of the 2016 U.S. presidential election induced, or resolved, uncertainty in financial markets. Using two U.S. presidential elections (2004 and 2012) as comparable benchmarks, we provide evidence that the uncertainty from the 2016 U.S. presidential election increased information asymmetries among market participants, which reduced liquidity. Specifically, we find that post-event liquidity following the 2016 U.S. presidential election worsened with respect to transaction costs, adverse selection costs, and volatility, relative to previous elections.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">From an economic perspective, our results suggest that election uncertainty can have significant consequences for market participants. First, an increase in transactions costs affects investors’ net returns and may deter future market participation. Second, an increase in price impact suggests a widening of the information gap between uninformed and informed traders. Third, shocks to both idiosyncratic and systematic volatility expose investors to multiple layers of risk, regardless of their diversification strategies. Overall, our article contributes to the literature in presenting evidence that not all election outcomes are created equal and that election uncertainty can have severe and persistent consequences for financial market participants. We argue that our findings are useful to investors attempting to diversify and hedge against potential shocks to political and policy uncertainty.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:endnotes",
    "elementIDs": Array [
      "MPFootnotesElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 13,
    "title": "Footnotes",
  },
  Object {
    "_id": "MPFootnotesOrder:test",
    "containedObjectID": "MPFootnotesElement:test",
    "footnotesList": Array [
      Object {
        "id": "MPFootnote:test",
        "index": 0,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 1,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 2,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 3,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 4,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 5,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 6,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 7,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 8,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 9,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 10,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 11,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 12,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 13,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 14,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 15,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 16,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 17,
      },
      Object {
        "id": "MPFootnote:test",
        "index": 18,
      },
    ],
    "objectType": "MPFootnotesOrder",
  },
  Object {
    "_id": "MPFootnotesElement:test",
    "contents": "<div></div>",
    "elementType": "div",
    "objectType": "MPFootnotesElement",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">See Matt Egan, “Wall Street Welcomes Trump with a Bang” CNN Money (November 9, 2016), available at <u><a href=\\"http://money.cnn.com/2016/11/09/investing/dow-jones-trump-wins-election/index.html\\">http://money.cnn.com/2016/11/09/investing/dow-jones-trump-wins-election/index.html</a></u></p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">See Matt Egan, “Wall Street Welcomes Trump with a Bang” CNN Money (November 9, 2016), available at <u><a href=\\"http://money.cnn.com/2016/11/09/investing/dow-jones-trump-wins-election/index.html\\">http://money.cnn.com/2016/11/09/investing/dow-jones-trump-wins-election/index.html</a></u></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">Overseas markets also experienced dramatic swings following initial selloffs around the Trump election (see Jethro Mullen and Matt Egan, “Global Markets Drop as U.S. Election Results Shock Investors” CNN Money (November 9, 2016), available at <u><a href=\\"http://money.cnn.com/2016/11/08/investing/global-markets-stocks-trump-clinton-us-presidential-election/index.html\\">http://money.cnn.com/2016/11/08/investing/global-markets-stocks-trump-clinton-us-presidential-election/index.html</a></u></p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Overseas markets also experienced dramatic swings following initial selloffs around the Trump election (see Jethro Mullen and Matt Egan, “Global Markets Drop as U.S. Election Results Shock Investors” CNN Money (November 9, 2016), available at <u><a href=\\"http://money.cnn.com/2016/11/08/investing/global-markets-stocks-trump-clinton-us-presidential-election/index.html\\">http://money.cnn.com/2016/11/08/investing/global-markets-stocks-trump-clinton-us-presidential-election/index.html</a></u></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">As an alternative benchmark, we use the 2004 U.S. presidential election.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">As an alternative benchmark, we use the 2004 U.S. presidential election.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">Full results are available at <u><a href=\\"https://iemweb.biz.uiowa.edu/closed/\\">https://iemweb.biz.uiowa.edu/closed/</a></u></p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Full results are available at <u><a href=\\"https://iemweb.biz.uiowa.edu/closed/\\">https://iemweb.biz.uiowa.edu/closed/</a></u></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Ozsoylev and Werner (2011)</span> argue that ambiguous information results in potential market illiquidity because it reduces market arbitrage opportunities.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Ozsoylev and Werner (2011)</span> argue that ambiguous information results in potential market illiquidity because it reduces market arbitrage opportunities.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Pasquariello and Zafeiridou (2014)</span> argue that this may not hold when informed participants are reluctant to reveal information via transacting, resulting in lower trading activity before the election outcome.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Pasquariello and Zafeiridou (2014)</span> argue that this may not hold when informed participants are reluctant to reveal information via transacting, resulting in lower trading activity before the election outcome.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">According to FiveThirtyEight’s election forecasts, the probability of the Republican candidate, Donald Trump, winning was 28.16% on election day. These election forecasts are available at <u><a href=\\"https://projects.fivethirtyeight.com/2016-election-forecast/\\">https://projects.fivethirtyeight.com/2016-election-forecast/</a></u></p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">According to FiveThirtyEight’s election forecasts, the probability of the Republican candidate, Donald Trump, winning was 28.16% on election day. These election forecasts are available at <u><a href=\\"https://projects.fivethirtyeight.com/2016-election-forecast/\\">https://projects.fivethirtyeight.com/2016-election-forecast/</a></u></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Voth (2002)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Mei and Guo (2004)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Li and Born (2006)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Białkowski, Gottschalk, and Wisniewski (2008)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Boutchkova et al. (2012)</span>, and <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Baker, Bloom, and Davis (2016)</span> all provide evidence that increased political uncertainty is associated with increased return volatility in the equity markets. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Kelly, Pástor, and Veronesi (2016)</span> show that political uncertainty is priced into the option markets as it pertains to implied volatility.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Voth (2002)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Mei and Guo (2004)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Li and Born (2006)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Białkowski, Gottschalk, and Wisniewski (2008)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Boutchkova et al. (2012)</span>, and <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Baker, Bloom, and Davis (2016)</span> all provide evidence that increased political uncertainty is associated with increased return volatility in the equity markets. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Kelly, Pástor, and Veronesi (2016)</span> show that political uncertainty is priced into the option markets as it pertains to implied volatility.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Pástor and Veronesi (2013)</span> provide evidence that both the magnitude of a political shock and the state of the economy help determine the risk premium required by investors.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Pástor and Veronesi (2013)</span> provide evidence that both the magnitude of a political shock and the state of the economy help determine the risk premium required by investors.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">We also compare the 2004 and 2016 U.S. presidential elections in a difference-in-difference setting and show that liquidity deteriorates for the 30 trading days following the 2016 election.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We also compare the 2004 and 2016 U.S. presidential elections in a difference-in-difference setting and show that liquidity deteriorates for the 30 trading days following the 2016 election.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">This study is related to the growing literature surrounding the role of political uncertainty in financial markets surrounding political event outcomes. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Boutchkova et al. (2012)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Pástor and Veronesi (2012</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">2013</span>), <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Brogaard and Detzel (2015)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Gungoraydinoglu, Çolak, and Öztekin (2017)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Bonaparte, Kumar, and Page (2017)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Bhattacharya et al. (2017)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Marshall et al. (2017)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Liu, Shu, and Wei (2017)</span>, and <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Perignon and Vallée (2017)</span> all examine the effects of political <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">test-author</span>uncertainty of financial markets as it relates to prices, volatility, risk premia, politically sensitive industries, financial intermediation, innovation activity, investment decisions, and corporate governance.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This study is related to the growing literature surrounding the role of political uncertainty in financial markets surrounding political event outcomes. <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Boutchkova et al. (2012)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Pástor and Veronesi (2012</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">2013</span>), <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Brogaard and Detzel (2015)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Gungoraydinoglu, Çolak, and Öztekin (2017)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Bonaparte, Kumar, and Page (2017)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Bhattacharya et al. (2017)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Marshall et al. (2017)</span>, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Liu, Shu, and Wei (2017)</span>, and <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Perignon and Vallée (2017)</span> all examine the effects of political <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">test-author</span>uncertainty of financial markets as it relates to prices, volatility, risk premia, politically sensitive industries, financial intermediation, innovation activity, investment decisions, and corporate governance.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">We also estimate price impact based on shorter windows such as one minute and 30 seconds, and our results are robust.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We also estimate price impact based on shorter windows such as one minute and 30 seconds, and our results are robust.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Holden and Jacobsen (2014)</span> show that the NBBO file is incomplete by itself, but the complete official NBBO can be constructed using the NBBO file and the quote file.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Holden and Jacobsen (2014)</span> show that the NBBO file is incomplete by itself, but the complete official NBBO can be constructed using the NBBO file and the quote file.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">Because our analysis uses liquidity metrics such as bid–ask spreads that are directly influenced by the minimum tick size, we remove stocks that are included in the U.S. Securities and Exchange Commission (SEC) 2016 Tick Size Pilot Program, and our results are robust.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Because our analysis uses liquidity metrics such as bid–ask spreads that are directly influenced by the minimum tick size, we remove stocks that are included in the U.S. Securities and Exchange Commission (SEC) 2016 Tick Size Pilot Program, and our results are robust.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">We rerun the entire analysis enforcing a balanced panel and our results are identical.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We rerun the entire analysis enforcing a balanced panel and our results are identical.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">To test for robustness, we include firm-specific control variables such as price, volume, market capitalization, and turnover in each of our regression equations, and our results are robust.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">To test for robustness, we include firm-specific control variables such as price, volume, market capitalization, and turnover in each of our regression equations, and our results are robust.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">We also bootstrap the standard errors and our results are robust.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">We also bootstrap the standard errors and our results are robust.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Amihud (2002)</span> documents that smaller, illiquid stocks are associated with greater adverse selection costs. Similarly, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Barry and Brown (1984)</span> document that investors command higher returns on small stocks as compensation for having less available information.</p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\"><span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Amihud (2002)</span> documents that smaller, illiquid stocks are associated with greater adverse selection costs. Similarly, <span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem:test\\">Barry and Brown (1984)</span> document that investors command higher returns on small stocks as compensation for having less available information.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPFootnote:test",
    "containingObject": "MPFootnotesElement:test",
    "contents": "<div xmlns=\\"http://www.w3.org/1999/xhtml\\" class=\\"footnote-text\\" id=\\"MPFootnote:test\\" data-kind=\\"footnote\\"><p id=\\"MPParagraphElement:test\\">“Trump vs. Clinton: The Destiny of These 4 Major Stock Industries Is at Stake,” IHODL (August 31, 2016), available at: <u><a href=\\"https://en.insider.pro/economics/2016-08-31/trump-vs-clinton-destiny-these-4-major-stock-industries-stake/\\">https://en.insider.pro/economics/2016-08-31/trump-vs-clinton-destiny-these-4-major-stock-industries-stake/</a></u></p></div>",
    "kind": "footnote",
    "objectType": "MPFootnote",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">“Trump vs. Clinton: The Destiny of These 4 Major Stock Industries Is at Stake,” IHODL (August 31, 2016), available at: <u><a href=\\"https://en.insider.pro/economics/2016-08-31/trump-vs-clinton-destiny-these-4-major-stock-industries-stake/\\">https://en.insider.pro/economics/2016-08-31/trump-vs-clinton-destiny-these-4-major-stock-industries-stake/</a></u></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:appendices",
    "elementIDs": Array [
      "MPTableElement:test",
    ],
    "label": "Appendix",
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 14,
    "title": "Table A1",
  },
  Object {
    "_id": "MPTableElement:test",
    "containedObjectID": "MPTable:test",
    "elementType": "table",
    "listingID": "MPListing:test",
    "objectType": "MPTableElement",
    "tableElementFooterID": "MPTableElementFooter:test",
  },
  Object {
    "_id": "MPTable:test",
    "contents": "<table xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPTableElement:test\\" class=\\"MPElement\\" data-contained-object-id=\\"MPTable:test\\"><thead style=\\"display: table-header-group;\\"><tr><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><b>Exporter</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><b>EU exporter</b></th><th data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" scope=\\"col\\" style=\\"border-top: solid 0.50pt; border-bottom: solid 0.50pt\\"><b>HIC exporter</b></th></tr></thead><tbody><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"border-top: solid 0.50pt\\">Average number of employed (log)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" style=\\"border-top: solid 0.50pt\\">1.4904***<br />(.0107)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" style=\\"border-top: solid 0.50pt\\">.6878***<br />(.0225)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" style=\\"border-top: solid 0.50pt\\">.6473***<br />(.0222)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Average number of female employed (log)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">1.0341***<br />(.0104)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">.6266***<br />(.0220)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">.5870***<br />(.0219)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Female employment share</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">-.1245***<br />(.0023)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">.0271***<br />(.0036)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">.0355***<br />(.0036)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Average wages (log)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">.9177***<br />(.0089)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">.2975***<br />(.0138)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">.2755***<br />(.0136)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Average female wages (log)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">.8062***<br />(.0089)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">.2322***<br />(.0142)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">.2103***<br />(.0141)</td></tr><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\">Female-to-male wage ratio</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">-.0572***<br />(.0122)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">-.0316<br />(.0194)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\">-.0488**<br />(.0192)</td></tr></tbody><tfoot style=\\"display: table-footer-group;\\"><tr><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"left\\" scope=\\"row\\" style=\\"border-bottom: solid 0.50pt\\">Average turnover (log)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">2.5000***<br />(.0171)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">.9636***<br />(.0292)</td><td data-placeholder-text=\\"Data\\" valign=\\"top\\" align=\\"center\\" style=\\"border-bottom: solid 0.50pt\\">.9103***<br />(.0288)</td></tr></tfoot></table>",
    "objectType": "MPTable",
  },
  Object {
    "_id": "MPTableElementFooter:test",
    "containedObjectIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPTableElementFooter",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Source: GEOSTAT Statistics Survey of Enterprises for 2006-2017.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">Notes: HIC = high income country. Exporters are firms that exported in at least 1 year of the sample. EU / HIC exporters are firms that exported to the EU / high income country in at least 1 year of the sample. Column 2: difference in means in log workers, log wages, log turnover between exporters and non-exporters, controlling for year and 1-digit industry. Column 3: difference in means between firms that export to at least one EU destination and non-EU exporters, controlling for year and 1-digit industry. Column 4: difference in means between firms that export to at least one HIC destination and non-HIC exporters, controlling for year and 1-digit industry. ***Significant at the 1% level, **Significant at the 5% level, *Significant at the 10% level.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPFigureElement",
    "elements": Array [
      "MPFigureElement:test",
      "MPFigureElement:test",
      "MPFigureElement:test",
      "MPFigureElement:test",
      "MPFigureElement:test",
      "MPFigureElement:test",
      "MPFigureElement:test",
      "MPFigureElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPTableElement",
    "elements": Array [
      "MPTableElement:test",
      "MPTableElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPEquationElement",
    "elements": Array [
      "MPEquationElement:test",
      "MPEquationElement:test",
      "MPEquationElement:test",
      "MPEquationElement:test",
      "MPEquationElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:bibliography",
    "elementIDs": Array [
      "MPBibliographyElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 99,
    "title": "References",
  },
  Object {
    "_id": "MPBibliographyElement:test",
    "containedObjectIDs": Array [
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
    ],
    "contents": "",
    "elementType": "div",
    "objectType": "MPBibliographyElement",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Amihud",
        "given": "Y.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Markets",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2002",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "31-56",
    "title": "Illiquidity and stock returns: Cross-section and time-series effects",
    "type": "article-journal",
    "volume": "5",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Amihud",
        "given": "Y.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Mendelson",
        "given": "H.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Economics",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "1986",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "223-49",
    "title": "Asset pricing and the bid-ask spread",
    "type": "article-journal",
    "volume": "17",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Baker",
        "given": "S. R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Bloom",
        "given": "N.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Davis",
        "given": "S. J.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Quarterly Journal of Economics",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2016",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1593-1636",
    "title": "Measuring economic policy uncertainty",
    "type": "article-journal",
    "volume": "131",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Barry",
        "given": "C. B.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Brown",
        "given": "S. J.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Economics",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "1984",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "283-94",
    "title": "Differential information and the small firm effect",
    "type": "article-journal",
    "volume": "13",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Bhattacharya",
        "given": "U.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Hsu",
        "given": "P. H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Tian",
        "given": "X.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Xu",
        "given": "Y.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial and Quantitative Analysis",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1869-1901",
    "title": "What affects innovation more: Policy or policy uncertainty?",
    "type": "article-journal",
    "volume": "52",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Białkowski",
        "given": "J.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Gottschalk",
        "given": "K.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Wisniewski",
        "given": "T. P.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Banking & Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2008",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1941-53",
    "title": "Stock market volatility around national elections",
    "type": "article-journal",
    "volume": "32",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Bonaparte",
        "given": "Y.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kumar",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Page",
        "given": "J. K.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Markets",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "69-94",
    "title": "Political climate, optimism, and investment decisions",
    "type": "article-journal",
    "volume": "34",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Boutchkova",
        "given": "M.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Doshi",
        "given": "H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Durnev",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Molchanov",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Review of Financial Studies",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2011",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1111-1154",
    "title": "Precarious politics and return volatility.",
    "type": "article-journal",
    "volume": "25",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Boutchkova",
        "given": "M.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Doshi",
        "given": "H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Durnev",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Molchanov",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Review of Financial Studies",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2012",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1111-54",
    "title": "Precarious politics and return volatility",
    "type": "article-journal",
    "volume": "25",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Brogaard",
        "given": "J.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Detzel",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Management Science",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2015",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "3-18",
    "title": "The asset-pricing implications of government economic policy uncertainty",
    "type": "article-journal",
    "volume": "61",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Brown",
        "given": "K. C.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Harlow",
        "given": "W. V.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Tinic",
        "given": "S. M.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Economics",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "1988",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "355-85",
    "title": "Risk aversion, uncertain information, and market efficiency",
    "type": "article-journal",
    "volume": "22",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Easley",
        "given": "D.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "O’Hara",
        "given": "M.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Economics",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "1987",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "69-90",
    "title": "Price, trade size, and information in securities markets",
    "type": "article-journal",
    "volume": "19",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Gemmill",
        "given": "G.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Banking & Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "1992",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "211-31",
    "title": "Political risk and market efficiency: Tests based in British stock and options markets in the 1987 election",
    "type": "article-journal",
    "volume": "16",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Goodell",
        "given": "J. W.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Vähämaa",
        "given": "S.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Banking & Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2013",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1108-17",
    "title": "US presidential elections and implied volatility: The role of political uncertainty",
    "type": "article-journal",
    "volume": "37",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Gungoraydinoglu",
        "given": "A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Çolak",
        "given": "G.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Öztekin",
        "given": "Ö.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Corporate Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "167-92",
    "title": "Political environment, financial intermediation costs, and financing patterns",
    "type": "article-journal",
    "volume": "44",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "He",
        "given": "Y.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Lin",
        "given": "H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Wu",
        "given": "C.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Dufrene",
        "given": "U. B.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Markets",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2009",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "54-86",
    "title": "The 2000 presidential election and the information cost of sensitive versus non-sensitive S&amp;P 500 stocks",
    "type": "article-journal",
    "volume": "12",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Ho",
        "given": "T.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Stoll",
        "given": "H. R.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Economics",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "1981",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "47-73",
    "title": "Optimal dealer pricing under transactions and return uncertainty",
    "type": "article-journal",
    "volume": "9",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Holden",
        "given": "C. W.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Jacobsen",
        "given": "S.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2014",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1747-85",
    "title": "Liquidity measurement problems in fast, competitive markets: Expensive and cheap solutions",
    "type": "article-journal",
    "volume": "69",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Hong",
        "given": "H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kostovetsky",
        "given": "L.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Economics",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2012",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1-19",
    "title": "Red and blue investing: Values and finance",
    "type": "article-journal",
    "volume": "103",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Julio",
        "given": "B.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Yook",
        "given": "Y.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2012",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "45-83",
    "title": "Political uncertainty and corporate investment cycles",
    "type": "article-journal",
    "volume": "67",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kelly",
        "given": "B.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Pástor",
        "given": "L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Veronesi",
        "given": "P.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2016",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "2417-79",
    "title": "The price of political uncertainty: Theory and evidence from the option market",
    "type": "article-journal",
    "volume": "71",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Kyle",
        "given": "A. S.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Econometrica",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "1985",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1315-35",
    "title": "Continuous auctions and insider trading",
    "type": "article-journal",
    "volume": "53",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Lee",
        "given": "C.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Ready",
        "given": "M. J.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "1991",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "733-46",
    "title": "Inferring trade direction from intraday data",
    "type": "article-journal",
    "volume": "46",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Li",
        "given": "J.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Born",
        "given": "J. A.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Research",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2006",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "609-22",
    "title": "Presidential election uncertainty and common stock returns in the United States",
    "type": "article-journal",
    "volume": "29",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Liu",
        "given": "L. X.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Shu",
        "given": "H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Wei",
        "given": "K. J.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Economics",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "286-310",
    "title": "The impacts of political uncertainty on asset prices: Evidence from the Bo scandal in China",
    "type": "article-journal",
    "volume": "125",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Marshall",
        "given": "B. R.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Nguyen",
        "given": "H. T.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Nguyen",
        "given": "N. H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Visaltanachoti",
        "given": "N.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Markets",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1-13",
    "title": "Politics and liquidity",
    "type": "article-journal",
    "volume": "38",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Mei",
        "given": "J.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Guo",
        "given": "L.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "European Financial Management",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2004",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "639-57",
    "title": "Political uncertainty, financial crisis and market volatility",
    "type": "article-journal",
    "volume": "10",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Nippani",
        "given": "S.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Arize",
        "given": "A. C.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Economics and Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2005",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "271-79",
    "title": "US presidential election impact on Canadian and Mexican stock markets",
    "type": "article-journal",
    "volume": "29",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Nippani",
        "given": "S.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Medlin",
        "given": "W. B.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Economics and Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2002",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "162-69",
    "title": "The 2000 presidential election and the stock market",
    "type": "article-journal",
    "volume": "26",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Ozsoylev",
        "given": "H.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Werner",
        "given": "J.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Economic Theory",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2011",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "469-91",
    "title": "Liquidity and asset prices in rational expectations equilibrium with ambiguous information",
    "type": "article-journal",
    "volume": "48",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Pantzalis",
        "given": "C.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Stangeland",
        "given": "D. A.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Turtle",
        "given": "H. J.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Banking & Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2000",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1575-1604",
    "title": "Political elections and the resolution of uncertainty: The international evidence",
    "type": "article-journal",
    "volume": "24",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "literal": "Pasquariello, P., and C. Zafeiridou, 2014, Political uncertainty and financial market liquidity, Working Paper, University of Michigan.",
    "objectType": "MPBibliographyItem",
    "type": "article-journal",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Pástor",
        "given": "L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Stambaugh",
        "given": "R.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Political Economy",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2003",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "642-85",
    "title": "Liquidity risk and expected stock returns",
    "type": "article-journal",
    "volume": "111",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Pástor",
        "given": "L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Veronesi",
        "given": "P.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2012",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1219-64",
    "title": "Uncertainty about government policy and stock prices",
    "type": "article-journal",
    "volume": "67",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Pástor",
        "given": "L.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Veronesi",
        "given": "P.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Financial Economics",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2013",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "520-45",
    "title": "Political uncertainty and risk premia",
    "type": "article-journal",
    "volume": "110",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Pérignon",
        "given": "C.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Vallée",
        "given": "B.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Review of Financial Studies",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2017",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1903-34",
    "title": "The political economy of financial innovation: Evidence from local governments",
    "type": "article-journal",
    "volume": "30",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "author": Array [
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Santa‐Clara",
        "given": "P.",
        "objectType": "MPBibliographicName",
      },
      Object {
        "_id": "MPBibliographicName:test",
        "family": "Valkanov",
        "given": "R.",
        "objectType": "MPBibliographicName",
      },
    ],
    "container-title": "Journal of Finance",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2003",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "1841-72",
    "title": "The presidential puzzle: Political cycles and the stock market",
    "type": "article-journal",
    "volume": "58",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "literal": "Voth, H. J., 2002, Stock price volatility and political uncertainty: Evidence from the interwar period, Working Paper, University of Zurich.",
    "objectType": "MPBibliographyItem",
    "type": "article-journal",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "literal": "test-authorJintest reference which contains unparsed text",
    "objectType": "MPBibliographyItem",
    "type": "article-journal",
  },
  Object {
    "_id": "MPCommentAnnotation:test",
    "contents": "eXtyles test comment",
    "contributions": Array [
      Object {
        "_id": "MPContribution:test",
        "objectType": "MPContribution",
        "profileID": "MPUserProfile:test",
        "timestamp": 1111111111,
      },
    ],
    "objectType": "MPCommentAnnotation",
    "target": "MPBibliographyItem:test",
  },
]
`;

exports[`JATS importer parses full JATS no back example to Manuscripts models 1`] = `
Array [
  Object {
    "_id": "MPManuscript:test",
    "articleType": "other",
    "equationCount": 0,
    "figureCount": 0,
    "genericCounts": Array [
      Object {
        "count": 0,
        "countType": "box",
      },
    ],
    "objectType": "MPManuscript",
    "referencesCount": 2,
    "tableCount": 0,
    "wordCount": 2910,
  },
  Object {
    "_id": "MPTitles:test",
    "objectType": "MPTitles",
    "title": "A complete manuscript",
  },
  Object {
    "ISSNs": Array [],
    "_id": "MPJournal:test",
    "abbreviatedTitles": Array [],
    "journalIdentifiers": Array [],
    "objectType": "MPJournal",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "User",
      "given": "Developer",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 0,
    "role": "author",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 1,
    "title": "Paragraphs",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">A paragraph.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPListElement:test",
      "MPListElement:test",
      "MPListElement:test",
      "MPListElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 2,
    "title": "Lists",
  },
  Object {
    "_id": "MPListElement:test",
    "contents": "<ol xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPListElement:test\\" list-type=\\"order\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">An ordered list</li><li data-placeholder-text=\\"List item\\">With two items</li></ol>",
    "elementType": "ol",
    "listStyleType": "order",
    "objectType": "MPListElement",
  },
  Object {
    "_id": "MPListElement:test",
    "contents": "<ol xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPListElement:test\\" list-type=\\"order\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">An ordered list<ol id=\\"MPListElement:test\\" list-type=\\"order\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">With a nested ordered list</li><li data-placeholder-text=\\"List item\\">With two items</li></ol></li></ol>",
    "elementType": "ol",
    "listStyleType": "order",
    "objectType": "MPListElement",
  },
  Object {
    "_id": "MPListElement:test",
    "contents": "<ul xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPListElement:test\\" list-type=\\"bullet\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">A bullet list<ul id=\\"MPListElement:test\\" list-type=\\"bullet\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">With a nested bullet list</li><li data-placeholder-text=\\"List item\\">With two items</li></ul></li></ul>",
    "elementType": "ul",
    "listStyleType": "bullet",
    "objectType": "MPListElement",
  },
  Object {
    "_id": "MPListElement:test",
    "contents": "<ul xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPListElement:test\\" list-type=\\"bullet\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">A bullet list<ol id=\\"MPListElement:test\\" list-type=\\"order\\" class=\\"MPElement\\" data-object-type=\\"MPListElement\\"><li data-placeholder-text=\\"List item\\">With a nested ordered list</li><li data-placeholder-text=\\"List item\\">With two items</li></ol></li></ul>",
    "elementType": "ul",
    "listStyleType": "bullet",
    "objectType": "MPListElement",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPFigureElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 3,
    "title": "Figures",
  },
  Object {
    "_id": "MPFigureElement:test",
    "caption": "<p class=\\"caption-description\\" data-placeholder-text=\\"Caption...\\" contenteditable=\\"true\\">Test</p>",
    "containedObjectIDs": Array [
      "MPFigure:test",
    ],
    "elementType": "figure",
    "label": "",
    "listingID": "MPListing:test",
    "objectType": "MPFigureElement",
  },
  Object {
    "_id": "MPFigure:test",
    "contentType": "image/jpeg",
    "objectType": "MPFigure",
    "src": "graphic/MPFigure_035B52CA-C486-4AC1-B44E-40F36F422686.jpeg",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPTableElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 4,
    "title": "Tables",
  },
  Object {
    "_id": "MPTableElement:test",
    "caption": "Test",
    "containedObjectID": "MPTable:test",
    "elementType": "table",
    "listingID": "MPListing:test",
    "objectType": "MPTableElement",
  },
  Object {
    "_id": "MPTable:test",
    "contents": "<table xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPTableElement:test\\" class=\\"MPElement\\" data-contained-object-id=\\"MPTable:test\\"><thead style=\\"display: table-header-group;\\"><tr><th data-placeholder-text=\\"Data\\">Test</th><th data-placeholder-text=\\"Data\\">Test</th></tr></thead><tbody><tr><td data-placeholder-text=\\"Data\\">Test</td><td data-placeholder-text=\\"Data\\"></td></tr><tr><td data-placeholder-text=\\"Data\\">Test</td><td data-placeholder-text=\\"Data\\"></td></tr></tbody><tfoot style=\\"display: table-footer-group;\\"><tr><td data-placeholder-text=\\"Data\\"></td><td data-placeholder-text=\\"Data\\">Test</td></tr></tfoot></table>",
    "objectType": "MPTable",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPEquationElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 5,
    "title": "Equations",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph contains an inline equation:<span id=\\"InlineMathFragment:test\\" class=\\"MPInlineMathFragment\\" data-equation-format=\\"tex\\">2+3=5</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPEquationElement:test",
    "containedObjectID": "MPEquation:test",
    "elementType": "div",
    "label": "",
    "objectType": "MPEquationElement",
  },
  Object {
    "_id": "MPEquation:test",
    "contents": "E=mc^2",
    "format": "tex",
    "objectType": "MPEquation",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPListingElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 6,
    "title": "Listings",
  },
  Object {
    "_id": "MPListingElement:test",
    "caption": "",
    "containedObjectID": "MPListing:test",
    "elementType": "figure",
    "objectType": "MPListingElement",
  },
  Object {
    "_id": "MPListing:test",
    "contents": "",
    "languageKey": "null",
    "objectType": "MPListing",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 7,
    "title": "Inline",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph contains <b>bold</b>, <i>italic</i>, <u>underlined</u>, <sup>superscript</sup> and <sub>subscript</sub> text.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph contains <a href=\\"https://example.com\\">a link</a>.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPQuoteElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 8,
    "title": "Quotes",
  },
  Object {
    "_id": "MPQuoteElement:test",
    "contents": "<blockquote xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPQuoteElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPQuoteElement\\"><p id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This is a block quote.</p><footer>It came from here.</footer></blockquote>",
    "elementType": "div",
    "objectType": "MPQuoteElement",
    "placeholderInnerHTML": "",
    "quoteType": "block",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This is a block quote.</p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPSection:test",
    "elementIDs": Array [
      "MPParagraphElement:test",
      "MPParagraphElement:test",
      "MPParagraphElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 9,
    "title": "Citations",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph ends with a citation.<span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem_787BD4C1-3074-4076-9707-0227D29C1F10\\">1</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph ends with two citations.<span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem_E9EFF971-4380-4DEB-83CF-B0CAA6C32BDF MPBibliographyItem_36EDAD5A-EBA0-47AE-88E6-EBAD385166AE\\">2,3</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPParagraphElement:test",
    "contents": "<p xmlns=\\"http://www.w3.org/1999/xhtml\\" id=\\"MPParagraphElement:test\\" class=\\"MPElement\\" data-object-type=\\"MPParagraphElement\\">This paragraph ends with all three citations.<span class=\\"citation\\" data-id=\\"MPCitation:test\\" data-reference-id=\\"MPBibliographyItem_787BD4C1-3074-4076-9707-0227D29C1F10 MPBibliographyItem_36EDAD5A-EBA0-47AE-88E6-EBAD385166AE MPBibliographyItem_E9EFF971-4380-4DEB-83CF-B0CAA6C32BDF\\">1–3</span></p>",
    "elementType": "p",
    "objectType": "MPParagraphElement",
    "placeholderInnerHTML": "",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPFigureElement",
    "elements": Array [
      "MPFigureElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPTableElement",
    "elements": Array [
      "MPTableElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPEquationElement",
    "elements": Array [
      "MPEquationElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
  Object {
    "_id": "MPElementsOrder:test",
    "elementType": "MPListingElement",
    "elements": Array [
      "MPListingElement:test",
    ],
    "objectType": "MPElementsOrder",
  },
]
`;

exports[`JATS importer parses full JATS no body example to Manuscripts models 1`] = `
Array [
  Object {
    "_id": "MPManuscript:test",
    "articleType": "other",
    "equationCount": 0,
    "figureCount": 0,
    "genericCounts": Array [
      Object {
        "count": 0,
        "countType": "box",
      },
    ],
    "objectType": "MPManuscript",
    "referencesCount": 2,
    "tableCount": 0,
    "wordCount": 2910,
  },
  Object {
    "_id": "MPTitles:test",
    "objectType": "MPTitles",
    "title": "A complete manuscript",
  },
  Object {
    "ISSNs": Array [],
    "_id": "MPJournal:test",
    "abbreviatedTitles": Array [],
    "journalIdentifiers": Array [],
    "objectType": "MPJournal",
  },
  Object {
    "_id": "MPContributor:test",
    "affiliations": Array [],
    "bibliographicName": Object {
      "_id": "MPBibliographicName:test",
      "family": "User",
      "given": "Developer",
      "objectType": "MPBibliographicName",
    },
    "objectType": "MPContributor",
    "priority": 0,
    "role": "author",
  },
  Object {
    "_id": "MPSection:test",
    "category": "MPSectionCategory:bibliography",
    "elementIDs": Array [
      "MPBibliographyElement:test",
    ],
    "objectType": "MPSection",
    "path": Array [
      "MPSection:test",
    ],
    "priority": 99,
    "title": "References",
  },
  Object {
    "_id": "MPBibliographyElement:test",
    "containedObjectIDs": Array [
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
      "MPBibliographyItem:test",
    ],
    "contents": "",
    "elementType": "div",
    "objectType": "MPBibliographyElement",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "container-title": "Cartographic Perspectives",
    "issue": "62",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2009",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "52-54",
    "title": "Creating Graphically Complex Indexes With InDesign",
    "type": "article-journal",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "container-title": "The KIPS Transactions:PartD",
    "issue": "4",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2003",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "603-612",
    "title": "Technique for extracting reusable XML Schema from schema-less XML Documents",
    "type": "article-journal",
    "volume": "10D",
  },
  Object {
    "_id": "MPBibliographyItem:test",
    "container-title": "The KIPS Transactions:PartD",
    "issue": "1",
    "issued": Object {
      "_id": "MPBibliographicDate:test",
      "date-parts": Array [
        Array [
          "2009",
        ],
      ],
      "objectType": "MPBibliographicDate",
    },
    "objectType": "MPBibliographyItem",
    "page": "27-42",
    "title": "XML Fragmentation for Resource-Efficient Query Processing over XML Fragment Stream",
    "type": "article-journal",
    "volume": "16D",
  },
]
`;
